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ABSTRACT 
 
Mycothiol is found only in Actinobacteria including M. tuberculosis, and appears to play 
an important role in the bacterium’s defence against xenobiotics and oxidative stress. 
The biosynthetic pathway to this pseudo-disaccharide has been elucidated and a range 
of mycothiol-dependent enzymes have been identified. Compounds A.3, which have 
naphthoquinonyl units tethered to the pseudodisaccharide core, have significant 
inhibitory activity against mshB and mca in the biosynthetic pathway. These findings, 
together with the independent discovery of anti-TB activity associated with carbazole 
quinones such as B, led to the design and synthesis of a new class of hybrid molecules C 
which have the carbazole quinone motif tethered to the pseudodisaccharide core. The 
synthesis of these hybrid molecules involved initial preparation of phenylthio- or 
methyl-glucosides having either an amine or a suitably-functionalized carbon side-chain 
at C-2. Carbazole-quinones 37 and 39, bearing carboxyalkyl substituents, were prepared 
using Knölker methodology, and coupled to phenylthio-2-amino-glucoside 36 to 
generate, after deprotection, the desired hybrid structures 38 and 40. The preferred 
strategy for preparing 2-C-alkylglucosides was via initial preparation of a 2-C-
carboxymethyl glucoside 44 from D-glucal, and conversion of this to the Weinreb amide 
45 for intended coupling with Grignard and other organometallic reagents to form 
ketones. The Weinreb amide was shown to only react with simple metal-aryl reagents, 
and but not with those derived from the required tri-substituted benzenes. In the 
exploration of alternative strategies, the side-chain in 44 was successfully converted to 
either a 2-C-vinyl or the corresponding (E)-vinyl bromide side-chain, but both proved 
unreactive in attempts at Pd-mediated cross-coupling reactions to further develop the 
side-chain.  Compound 44 could also be readily converted to either a 2-C-haloethyl or 2-
C-aminoethyl derivative: the former resisted conversion to Wittig reagents, while the 
latter was unreactive in attempted Buchwald-Hartwig amination but successfully 
underwent reductive amination with a substituted benzaldehyde to give an advanced 
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precursor of the target hybrid molecules. Compounds 38 and 40 together with similar 
analogues prepared in parallel with this study showed significant inhibitory activity 
against mshB, allowing for a preliminary SAR conclusion that the inhibitory activity is 
dependent on the covalent association of the glycoside and the carbazole-quinone, the 
point of attachment of the sugar unit to the carbazole quinone, and the length of the 
tether.  
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CHAPTER 1 
 
INTRODUCTION 
 
1.1. Tuberculosis 
 
Tuberculosis (TB) is a common and often deadly infectious disease caused by the 
bacillus Mycobacterium tuberculosis (Mtb), it threatens the lives of millions of people, 
and has been ranked as the second leading cause of death after the human 
immunodeficiency virus (HIV) worldwide.1 In many cases, TB attacks the lungs 
(pulmonary TB), but can also affect other parts of the body.1 The infection is spread via 
air droplets released when people who have active TB (pulmonary TB) cough, sneeze, 
spit or talk. TB infection can be either active or latent and the following symptoms are 
often present in actively infected people: fever, chest pain, weight loss, fatigue, night 
sweats, cough, shortness of breath and a prolonged cough producing sputum. These 
symptoms are potentially contagious because they are caused by actively replicating 
tubercle bacilli in the lungs. However, no symptoms or evidence of disease can be seen 
in people with latent infection. It remains risky to everyone since the infection can be 
reactivated during their lifetime. There is a probability that Mtb infected people will 
develop TB disease but this probability is much higher with people co-infected with 
HIV.1 Mtb is an aerobic, non-motile bacillus, and has a slow rate of division (16 to 20 
hours) compared to other bacteria such as Escherichia coli that can divide roughly every 
20 minutes.2 A characteristic of the cell surface of Mtb, is the waxy coating (mycolic acid) 
which makes the cells impervious to Gram staining because of the high lipid content in 
its cells.3 Hence, Ziehl-Neelsen staining or acid-fast staining techniques detections are 
used. Due to the lack of outer cell membrane, the Mtb is classified as acid-fast Gram 
positive bacteria, when the mycobacteria do not retain the crystal violet stain.3 
1.1.1. Global incidence 
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TB is one of the world's deadliest diseases and more than 2 billion people (are estimated 
to be infected with Mtb.4 According to World Health Organization (WHO) studies in 
2012, there were an estimated 8.6 million TB cases and ~1.3 million people died from 
the disease, including among the latter 940 000 who were HIV-negative and 320 000 
who were HIV-positive.1 
 
 
 
Figure 1.1. Estimate TB incidence rate, 2012.
1
 
 
1.1.2. HIV and Tuberculosis 
 
HIV is the most important risk factor for developing TB in patients already infected with 
M. tuberculosis.4,5,6 People living with HIV are more exposed than others to be infected 
with TB. In 2012, it was observed that among TB patients with HIV test results 13% were 
HIV positive worldwide.6 Consequently, HIV and TB can work together and shorten 
lifespan if TB is found untreated. Moreover, the development of the TB disease in a 
person living with both HIV infection and untreated latent TB infection is higher than 
someone without HIV infection. On the other hand, a person who has both HIV infection 
and TB disease has an AIDS-defining condition,7,8 but latent TB infection or TB disease 
can be effectively treated. In order to prevent TB disease and reduce the rate of death in 
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HIV infected patients with TB, the use of combination antiretroviral therapy (CART)9,10 
has been recommended. One of the strategies in developing countries to decrease the 
mortality of TB in HIV infected, is to ensure that people living with HIV are tested for TB 
infection, and treatments are recommended if TB test is positive because it can quickly 
progress to TB disease in people infected with HIV since the immune system is already 
weakened.11 After knowing health status of HIV infected person with regard to TB, the 
next challenge would be to treat the infection. It has been discovered that TB disease 
has developed some resistance to most of the available drugs.1 
 
1.1.3. Drug-resistant TB  
 
The emergence of multidrug-resistant TB (MDR-TB) to at least rifampicin (RMP) and 
isoniazid (INH) associated with treatment failure, complications and mortality, presents 
additional challenges in TB control. Globally, the WHO estimated about 3.6% of new 
cases and 20.2 % of previously treated cases have MDR-TB.1 There is an increasing 
recognition of the importance of drug-resistant (DR-TB) at younger ages, which  has led 
to the usage of second-line anti-TB drugs, which are less potent, more toxic, more 
expensive and requires a long treatment (Figure 1.2).12-15 The generation of MDR-TB is a 
result of poor clinical and control practice of new patients with TB. The WHO revealed 
that a poor management and erratic use of second line drugs may lead to extensively 
drug-resistant (XDR-TB).1 It was discovered that 9.6% of more than 3 million cases of 
MDR-TB were developing XDR-TB as a result of poor management of drug sensitive as 
well as drug resistant TB.1 Recently, there has been growing concern of XDR-TB, which 
appears also to be threatening the global effort to control TB.16  XRD-TB is a form of 
drug resistance showing resistance against rifampicin, isoniazid, a fluoroquinolone, and 
any of the second-line injectable drugs like Kanamycin, amikacin or capreomycin.  
 
a) First-line anti-tuberculosis drugs 
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b) Second-line anti-tuberculosis drugs 
 
 
 
Figure 1.2. Drugs used for TB treatment. 
 
Due to a growing resistance of the bacteria to conventional antibiotics, there is a need 
for new therapeutic strategies which will tackle both TB and the instances of drug 
resistance arising. One of the approaches has been to try to develop potential 
therapeutic agents that inhibit the biosynthesis of the unique defensive agents in 
Mycobacterium tuberculosis, typically low molecular weight thiols; one such target is 
mycothiol (MSH), an important cellular anti-oxidant. 
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1.2. Mycothiol 
 
1.2.1. Introduction 
 
Mycothiol (MSH) is a low molecular-mass thiol and has been identified as the major 
thiol in number of most actinomycetes including Mtb.13 MSH is produced at significant 
levels in mycobacteria and streptomycetes such as Micromonospora, Actinomadura, and 
Nocardiopsis spp.13 MSH plays a significant role in the detoxification of thiol-reactive 
substances, including formaldehyde in Amycolatopsis methanolica,14 various 
electrophiles, and antibiotics. The alkylating agents are detoxified by their conversion to 
an S-conjugate by MSH. MSH has functional similarities with glutathione (GSH), a major 
low-molecular-mass thiol present in nearly all eukaryotes and in many bacteria.17 During 
respiration, bacteria and the host cell internally generate toxic oxidants and reactive 
oxygen species (ROS) as anti-microbial response. GSH plays a role of protecting cells 
against these reactive species. However, actinomycetes do not have GSH but instead 
have MSH which appears to perform the same role. It was proven that MSH influences 
the susceptibility of M. smegmatis to antibiotics such as rifampin and isoniazid by 
providing growth in an oxygen-rich environment 17-20.  
 
 
 
Figure 1.3. Chemical structure of mycothiol and glutathione. 
 
1.2.2. Biosynthesis of Mycothiol 
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The biosynthesis of MSH proceeds through a five step pathway (Scheme 1.1)13 and  the 
initial substrates 1L-inositol-1-phosphate combines with UDP-N-acetylglucosamine to 
form N-acetylglucosaminylinositol phosphate, a reaction catalysed by N-
acetylglucosamine transferase, MshA.21,22 The removal of the phosphate group by the 
phosphatase MshA2 gives N-acetylglucosaminylinositol,22 which is then N-deacetylated 
in a reaction catalysed by MshB deacetylase.23,24 The resulting glucosaminylinositol 
(GlcN-Ins) is then ligated with L-cysteine in a reaction catalyzed by a ligase MshC to form 
cysteinylglucosaminylinositol (Cys-GlcN-Ins).25 Acetylation of Cys-GlcN-Ins by an 
acetyltransferase (MshD) produces mycothiol .26  
O
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Scheme 1.1. Biosynthetic pathway for synthesis of MSH. 
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In M. smegmatis, the lack of mycothiol ligase activity affects the sensitivity of mycothiol 
to many alkylating agents, antibiotics and oxidative stress.27 Thus, the enzymes involved 
in MSH biosynthesis appear to have potential for the development of new drugs. 
MshB,23 MshC 25 and MShD26 were identified using a variety of approaches and was 
found that their enzymatic activities are required for MSH production in the M. 
smegmatis; homologues of these genes were identified in the Mtb  genomes.  
A glycosyltransferase MshA (Rv0486) was also identified by transposon mutagenesis,21 
but the biochemical reaction catalysed was not defined. In the mycothiol biosynthesis, 
the MshB was the first gene to be identified, and the mycothiol S-conjugate amidase 
(Mca) was discovered and shown to have two homologs in the M. smegmatis. The 
Rv1082 encodes for an amidase that cleaves mycothiol S-conjugates was found in the 
M. tuberculisis genome, while the Rv1170 was efficient catalyst for the deacetylation of 
GlcNAc-Ins.23 
 
1.2.2.1. Mycothiol Glycosyltransferase, MshA, and Phosphatase MshA2. 
 
The transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to 1-L-myo-inositol-1-
phosphate (L-I1P) is catalysed by MshA, and its mechanism involves the formation of 
substantial oxocarbenium character in the transition state, which is similar to 
glycosidase enzymes.28 Campell et al29 identified for the first time the mshA gene 
Rv0486, which is required for the growth of Mtb21, and essential for the production of 
GlcNAc-Ins in the M. smegmatis.30 After the establishment of GlcN-Ins as intermediate 
in MSH biosynthesis, the most definitive test for substrate identity production using a 
cell-free extract as catalyst was provided by the assay based upon GlcN-Ins production. 
1DL-Ins-1-P was identified as a strong substrate, whereas 1D-Ins-1-P as a poor substrate. 
This led to suggest that 1L-Ins-1-P is the GlcNAc-acceptor for MshA. Therefore, UDP-
GlcNAc is an effective donor substrate for MshA, which is involved in the biosynthesis of 
glycolipids 1 and 2, precursors of the linkage region of the cell wall.30 An additional 
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enzyme, the GlcNAc-Ins-P phosphatase designated MshA2, is required to complete the 
mycothiol biosynthetic pathway.31 The existence of an epimerase activity was 
demonstrated by Bewley et al32 when the 1D-Ins-1P was served directly as an acceptor. 
This could lead to the wrong stereoisomer because the dephosphorylation will produce 
GlcNAc-(α1,1)-1L-Ins, which is inactive to MshB, whereas GlcNAc-(α1,1)-1D-Ins is fully 
active. The proposed mechanism suggests being the attack nucleophilic by the hydroxyl 
of 1-L-Ins-1-P and the departure of UDP occurs on the same face, resulting in the 
retention of anomeric configuration (Scheme 1.2).33  
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Scheme 1.2: Proposed mechanism: substrate-assisted catalysis mechanism, featuring oxycarbenium-ion 
like transition state, with asymmetric phosphor bond breakage, and glycosidic bond formation. 
 
1.2.2.2. Mycothiol Deacetylase, MshB 
 
A deacetylase (MshB, TB gene Rv1170) an enzyme involved in the biosynthesis pathway 
of mycothiol, moves the acetyl group from the precursor GlcNAc-Ins to yield GlcN-Ins. 
Steenkamp and Spies34 were the first to identify the substrate as well as the products 
involved in the fourth and the fifth step of MSH biosynthesis and which was later 
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confirmed by Anderberg et al.35 MshB is a Zn2+ metalloprotein, and its activity is 
completely dependent on the presence of a divalent metal cation. The X-ray 
crystallographic reveals a protein that folds in a manner resembling a C-terminal domain 
consisting of two β-sheets and two helices and lactate dehydrogenase in the N-terminal 
domain.36 The zinc binding site is in the N-terminal domain occupying a position 
equivalent to that of the NAD+ co-factor of lactate dehydrogenase, and the cation Zn2+ is 
5 coordinate with two water molecules and three residues from MshB (His-13, Asp-16, 
His-147) (Scheme 1.3).  
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O OH
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O
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HO HO
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Scheme 1.3: Proposed catalytic mechanism for MshB. 
 
One water molecule would be displaced upon binding of substrate (GlcNAc-Ins), while 
the other water molecule acted as nucleophile assisted by the general base carboxylate 
of Asp-15. In addition to the Zn2+ acting an electrophilic centre in the hydrolysis, His-144 
imidazole could form a hydrogen bond to the oxyanion of the tetrahedral 
intermediate.36,20 Although the MshB is not essential for MSH synthesis or growth of 
Mtb, the inactivation of the mshB gene does not fully block MSH biosynthesis because 
the mycothiol S-conjugate amidase (Mca) has been shown to have a low GlcNAc-Ins 
deacetylase activity that enable the production of MSH in the absence of MshB. The 
Mca may assist in the removal of an antibiotics from the infectious bacteria by cleaving 
the S-conjugate formed by the reaction of MSH and an antibiotic.13,17 
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1.2.2.3. Mycothiol Ligase, MshC 
 
The Mshc catalyses the ATP-dependent condensation of cysteine and GlcN-Ins. It 
became the second MSH biosynthesis gene to be identified from M. smegmatis protein. 
The mshC gene identified from the N-terminal protein sequence, and the ligase activity 
was demonstrated from the crude extract of M.smegmati.37 The mshC gene and MshC 
have been shown to be essential for the growth38,39 and production of MSH in M. 
smegmatis.19 An ortholog (Rv 2130c) was found in the Mtb genome with 78% identity, 
which has been previously annoted as CysS2, a second cysteinyl-tRNA synthetase gene. 
It was shown that the CysS is the functional cysteinyl-tRNA synthetase gene of Mtb 
when its sequence was compared to that homologous CysS of the E.coli. The mshc 
(CysS2) gene probably occurs from the duplication of CysS gene early in the evolution of 
actinomycetes.38,39 The kinetic mechanism of MshC, based on steady state kinetic as 
well as positional isotope exchange (PIX) studies demonstrated that enzymatic process 
occurs in two steps: cysteine adenylation and the subsequent ligation of cysteine to GlN-
Ins. Therefore, MshC is a Bi Uni Uni Bi Ping Pong mechanism (Figure 1.4), with ATP 
binding followed by cysteine binding, release of pyrophosphate (PPi), binding of GlcN-
Ins, followed by the release of Cys-GlcN-Ins and AMP.40,41 A stable bisubstrate analog of 
the adenylate (CSA), which is 5’-O-[N-(L-cysteinyl)sulfamonyl]adenosine exhibits 
competitive inhibition versus ATP (Ki ~ 300 nM) and non-competitive inhibition versus 
cysteine.40  
 
ATP L-cys
E-ATP
E-cys
E E-ATP-cys
ATPL-cys
E-cysadenylate-PPi
PPi
E-cysadenylate
GlcN-Ins des-AC
mycothiol
E-AMP
AMP
E-cysadenylate-GlcN-Ins
E-AMP-desACmycothiol E
 
 
Figure 1.4. The proposed Bi Uni Uni Bi Ping Pong kinetic mechanism of MshC. 
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1.2.2.4. Mycothiol Acetylase, MshD. 
 
The GCN5 acetyl-transferase, MshD,14 catalyses the transfer of an acetyl group from 
acetyl-CoA to the amino group of Cys-GlcN-Ins to yield MSH. The MshD is the third MSH 
biosynthesis gene found and was identified in the Mtb as ORF Rv0819, coding for a 
protein of 315 amino acids.14 The MshD has been shown to have activity in the cell 
extracts of E. coli when cloning the Rv0819 gene. In a binary complex was determined 
the structure of Mtb MshD with AcCoA and ternary complex with CoA and 
desacetylmycothiol (DAM) to a resolution of 1.7 and 1.8 Å, respectively.42,43 
 
1.2.2.5. Mycothiol –S-Conjugate Amidase, Mca. 
 
Newton et al17 characterised the enzyme mycothiol-S-conjugate amidase (Mca). Mca 
cleaves the amide bond linking cysteine and glucosamine in MSH-S-conjugates to form 
D-glucosamine-α-(1-1)myo-D-inositol, having specificity for S-conjugates. It can be then 
recycled into MSH biosynthesis.23 The Mca is key enzyme in the detoxification pathway 
of MSH and is unique, and has been purified from M. smegmatis. The Mtb homologue 
Rv1082 has been cloned and expressed in E. coli. As glutathione GSH, the MSH reacts 
with electrophile and alkylating reagents to form S-conjugates, which latter serve as a 
substrate for Mca. The process involved the hydrolysis of the cysteinyl-glucosamine 
bond of MSH S-conjugates (MSR) to produce the cysteine-S-conjugates (mercapturic 
acid) for excretion from the cell into the medium and GlcN-Ins for the intracellular 
regeneration of MSH (Figure 1.5).17  
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Figure 1.5. Scheme for cellular detoxification of thiol-reactive. 
 
The pure enzyme of Mca contains Zn2+ and Ca2+ as the only divalents metals. This led to 
suggestion that the Mca is strongly zinc metalloenzyme since the Zn2+ is the metal ion 
associated with the activity, the common catalytic component in amidases. Fahey et al44 
demonstrated that the Mca exhibits high activity with 14 substrates (mycothiol-S-
conjugates) while its deacetylase activity is very low and significant with GlcNAc-Ins for 
the production of GlcN-Ins when GlcNAc-Ins levels are high. Under physiologically 
relevant conditions, the mycothiol-S-conjugate of rifamycin showed to be a substrate 
for Mca in oxidized and reduced form. In addition, the mycothiol S-conjugate of the 
antibiotic cerulenin as a substrate for Mca displayed significant activity. Bewley and co-
worker elucidated the conformation of mycothiol-S-bimane in aqueous solution by 
nuclear magnetic resonance.45 Mca can be important target for the TB drugs and its 
activity with MSmB as substrate has been used to screen marine extracts and synthetic 
libraries to identify potential inhibitors. In the M.smegmatis, the conversion of the 
cellular mycothiol to its biname derivative (MsmB) was possible in the presence of the 
alkylating agent monobromobimane (mBBr). The cleavage of amide bond of the stable 
fluorescent MsmB gives GlCN-Ins and the biname derivative of N-acetylcysteine 
(AcCySmB), a mercuric acid will be exported from the cell into the medium.46,47 
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Scheme 1.4: Mca (amidase) catalyses MsmB. 
 
A series of bromotyrosine-derived compounds, including marine natural products and 
members of a psammaplin A-inspired combinatorial synthetic library, were screened for 
their ability to inhibit the Mtb detoxification enzyme mycothiol-S-conjugate amidase 
(Mca).46,48 
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Figure 1.6. Inhibition of mycothiol-S-conjugate amidase from Mtb by synthetic and natural 
bromotyrosine-derived compounds. 
 
1.2.2.6. Mycothiol Disulfide Reductase, Mtr 
 
The oxidation of MSH to mycothiol disulphide (MSSM) can be achieved using another 
route in the mycobacteria. The disulphide reductase Mtr is the enzyme responsible for 
maintaining it in the reduced state. Cole et al2 identified in the genome the sequence 
similarity of the disulphide reductase gene (mtr) to the gene encoding glutathione 
reductase, and was designated gor (glutathione oxido-reductase). Cloning mtr for 
mycothione reductase, Rv2855, and expressing in M. smegmatis, it has been shown to 
reduce the MSH of AcCys-GlcN.49 In the Mtb, the pure Mtr demonstrated to be closely 
related to glutathione, trypanothione disulphide reductases,  and it has been also shown 
that the enzyme is selective for MSSM and removal of the Ins residue does not affect 
the activity.50,51 
 
1.2.2.7. Mycothiol-dependent detoxification 
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The MSH-dependent formaldehyde dehydrogenase, MD-FalDH, catalyses the oxidation 
of the thiohemiacetal of MSH with formaldehyde. The enzyme is similar to the zinc-
containing medium chain alcohol dehydrogenase and was the first enzyme of 
metabolism to be identified.14,52 As expected, the S-formylmycothiol was formed and 
subsequently hydrolysed by a hydrolase to produce formic acid and MSH (Scheme 1.5). 
This pathway is accepted by analogy with the GSH-dependent pathway. In the higher 
organism, the enzyme GSH-dependent formaldehyde dehydrogenase is responsible for 
the detoxification of small amounts of formaldehyde produced during metabolism of 
various C1 donors.
53,54 Duine proposed an alternative path involving oxidation to the 
carbonate ester followed by hydrolysis to release MSH and CO2.
54 
 
 
 
Scheme 1.5: Proposed scheme for the action of mycothiol-dependent formaldehyde dehydrogenase (MD-
FalDH). 
 
 
1.3. A potent antitubercular target. 
 
Mycothiol has anti-oxidant activity to protect the M.tuberculosis against various harmful 
compounds as well as the ability to detoxify a variety of toxic compounds. The 
sensitivity of M.smegmatis to antibiotics such as rifampin and isoniazid is also 
influenced by MSH. Because of these, MSH is a candidate for protecting M.tuberculosis 
from inactivation by the host during infection as well as for resisting anti-tubercular 
drugs. There is a strong need for the establishment of new chemo preventives and the 
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discovery of new drugs. So, targeting MSH can achieve M.tuberculosis inhibitory activity 
constituting mycothiol as an attractive and effective antitubercular target.  
 
1.4. Aims and Objectives 
 
The aim of this project concern the design and synthesis of a range of “hybrid” 
molecules as potential inhibitors of enzymes implicated in the biosynthesis of mycothiol 
in the Mycobacteria, including M.tuberculosis, the causative agent for TB. We will 
attempt the construction of molecules which combine features of the structure of 
mycothiol itself, and in particular its glucosamine unit, with heterocyclic compounds in 
the class of carbazole quinones, which have some demonstrated anti-TB activity. The 
particular challenge is how to connect these two structures through an appropriate 
linker, which provides a metabolically stable mimic of the amide bond which links the 
cysteine unit to glucosamine in mycothiol. The activity of these against a range of 
enzymes associated with the biosynthesis and role of mycothiol will be determined. 
Then, the structure–activity relationship of compounds will be evaluated.  
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CHAPTER 2 
 
RESULTS AND DISCUSSION 
 
2.1. Target molecules. 
 
This study was prompted by reports of a series of carbazoles isolated independently 
from several sources and found to have antitubercular activity.1-3 A.1.1 exhibited weak 
activity (MIC of 100 μg.mL−1) against M. tuberculosis strain H37Rv
1-7 while A.1.2 isolated 
from the stem bark of Micromelum hirsutum was found to have an MIC of 31.5 μg.mL−1 
against M. tuberculosis H37Rv and the A.1.3 (Figure 2.1) was most active with an MIC 
values of 4.0 μg.mL−1 (8 μM) against M. tuberculosis and was relatively nontoxic for the 
mammalian cell line.8,9 
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Figure 2.1. Natural occurring carbazole alkaloids with anti-TB activity. 
 
Our research was informed by two independent observations. Firstly, in a study of some 
synthetic carbazole-quinones, the carbazole-1,4-quinone A.2.2 showed poor anti-TB 
activity with an MIC of 117 μM, while carbazole-1,4-quinone A.2.1 exhibited the highest 
activity among all carbazole quinones evaluated  with an MIC of 2.2 μg.mL−1 (9.0 μM) 
against M. tuberculosis and was also relativeely nontoxic for the mammalian cell line.8 
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Figure 2.2. Chemical structure of carbazole-1,4-quinone with anti-tubercular activity. 
 
The second observation related to the fact that several synthetic routes to mycothiol 
and its analogues have been developed,10,11 and recent work12 suggested that 
compounds A.3, which have naphthoquinonyl units tethered to the glycoside core, have 
significant inhibitory activity against mshB and mca in the biosynthetic pathway (See 
table 1). 
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Figure 2.3. Naphtoquinones having anti-TB activity. 
 
It was found that the inhibition of this series of naphthoquinones was competitive and 
varies with the length of the spacer, with the highest inhibitory activity associated with 
the naphthoquinone bearing the longest spacer (n=5). A later computational study 
postulated that these compounds adopt preferred conformations where the side-chain 
naphthoquinonyl units are not extended but rather curled towards, and in hydrophobic 
interactions with the phenyl group in the aglycone.12 In the light of these findings, it 
seemed reasonable to investigate replacement of the naphthoquinonyl units with the 
carbazole-1,4-quinone analogues and to explore the extent to which this modifies the 
anti-TB effect of carbazole quinones such as B13,14 and enzyme-inhibitory activity of the 
conjugates C. 
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Table 1. Inhibition of Mca and MshB by substituted naphthoquinones analogues of mycothiol. 
 
Substrate Mca MshB 
1a 28.8 57.4 
1b 37.8 81.6 
1c 23.2 81.4 
1d 44.5 94.8 
 
A related objective was to develop synthetic routes to analogues of C such as D (Figure 
2.4) in which the amide NH in the acylglucosamine unit has been replaced by a 
methylene group, or E in which the amide has been replaced by a simple alkyl unit, or F 
in which the 2-amino group of the glucose unit has been replaced by an amino-alkyl 
substituent incorporated into the tether, with D, E and F having non-hydrolysable 
tethers. These compounds could potentially serve as inhibitors of MshB and their anti-
mycobacterial activity could be compared to the parent carbazole quinones. 
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Figure 2.4.  Proposed target molecules. 
 
2.2. Results and discussion. 
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There were a number of important considerations with regard to the synthetic approach 
to the target hybrid compounds. Firstly, it was noted that the mode of action of the anti-
TB carbazole quinones is not known, and there is therefore little information on what 
the optimum point of attachment to the tether might be. Secondly, the first generation 
of naphthoquinone-containing hybrids was also not studied with respect to optimizing 
the point of attachment of the tether. The key synthetic challenges were therefore to (a) 
prepare a series of carbazole quinones with tethers linked at various positions, and (b) 
to establish methodology for coupling the tethered carbazole quinones to an 
appropriate glycoside. The strategy is illustrated for hybrid structure C in Scheme 2.1, 
which could be obtained by amide coupling of the glucoside IV having a free amine at 
the 2-position and the carbazole-1,4-quinone III to form hybrid structure II, in this case 
with the alkyl tether attached at the 6-position. Simple deacetylation then allows the 
formation of the desired product I.  
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Scheme 2.1. Retrosynthetic pathway of analogues C. 
 
2.2.1. Synthesis of carbazole-1,4-quinone derivatives. 
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It was envisaged that carbazole-1,4-quinones having a range of different substituents 
would be synthesized, including those having a carboxyalkyl chain of variable length at 
either the 6 or 7 position. This would serve as a tether via an amide link to the 
glucosamine unit. It was recognized that the use of an amide link in the tether is 
potentially problematic, in that this may be susceptible to the deacetylase activity of 
MshB and other enzymes. For this reason, the plan was to use the amide linkage initially 
due to its ease of formation, but to then investigate alternative linkage chemistry which 
provides a metabolically stable mimic of the amide bond which links the cysteine unit to 
glucosamine in mycothiol. 
 
The selected approach for the synthesis of the carbazole-1,4-quinone V was based on 
the Knölker methodology, and is shown retrosynthetically in Scheme 2.2.13 It involves a 
catalytic oxidative cyclization of quinone derivative VI, prepared by conjugate addition 
of amine VIII, obtained commercially or by synthesis, to quinone VII. The latter is 
obtained by methylation of trimethoxybenzene IX followed by oxidative demethylation.  
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Scheme 2.2. Synthetic pathway of carbazole-1,4-quinone derivatives V. 
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Scheme 2.3. Reagents and condition: (i) 2.0 eq. n-BuLi (10.0 M in ether), THF, -78 ⁰C, 1 h, Ar: (ii) 4.0 eq. 
CH3I, rt, overnight; (iii) 1.5 eq. PIDA, MeOH/H2O (3:1), 19 h, rt, Ar. 
 
Following this plan, the first synthesis was initiated from the starting trimethoxybenzene 
6 which was sequentially treated with n-butyl lithium and methyl iodide at -78 ⁰C to 
afford the 3-methyl derivative 7 in 79 % yield. In this first step, the regioselectivity is 
understood (Scheme 2.4) to arise from the two meta-oriented directed metallation 
groups (DMG’s) on the aromatic ring interacting with the n-butyl lithium reagent in its 
specific aggregation state (R-Li)n, via the Lewis-basic oxygen atoms on the DMG and the 
Lewis-acidic lithium. The very basic n-butyl lithium then deprotonates the ring at the 
nearest ortho-position to give the lithiated intermediate 6a. The reactivity of the 
organolithiated species 6a can be explained by the low degree of solvation in THF and 
formation of the aggregated state.15-18 Treatment of the lithiated intermediate 6a with 
4.0 eq of the electrophilic reagent methyl iodide achieves the selective methylation 
(Scheme 2.4). 
 
 
 
Scheme 2.4. Metallation of the 1,2,4-trimethoxybenzene. 
 
The oxidative demethylation of the 3-methyl derivative 7 was attempted with 
phenyliodine(III) diacetate (PIDA) in the presence of ethanol and water as a co-solvents 
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to afford quinone derivative 8 (Scheme 2.4). The reaction proceeded smoothly in the 
presence of water due to its activation of the hypervalent iodine: the omission of water 
is known to lead to unwanted side reactions.15 The structure was confirmed by NMR 
spectroscopy: the 1H NMR spectrum of the product showed two doublet of doublet 
signals at δ 6.69 and 6.60 ppm respectively with large coupling J = 10.1 Hz confirming 
the presence of ortho-protons on the quinone nucleus, while two singlets at δ 4.02 and 
1.95 ppm were assigned to the methoxy and methyl groups, respectively. The proton-
decoupled 13C NMR spectrum included two signals at δ 188.3 ppm and 183.2 ppm for 
the two carbonyl carbons. 
The successfully prepared quinone 8 was thus now available for 1,4-addition reactions 
with different substituted aryl amines. 
 
 
 
Scheme 2.5. Reagents and conditions: (i) quinone 8 (2 eq.) and amine 9 (1 eq.), MeOH, rt, Ar, overnight; 
(ii) Pd(OAc)2 (5 mol%), 0.1 eq. K2CO3, 1 g PivOH, 120 ⁰C, Air, overnight. 
 
In the first instance, the formation of the quinone 10 was achieved by 1,4-addition 
reaction of commercially available para-substituted amine 9 to the quinone 8 (Scheme 
2.5). A long reaction time and an excess of quinone 8 were necessary to ensure 
complete reoxidation of intermediate C (Scheme 2.6), the tautomer of initially formed 
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enol B, and this yielded the product in 82% yield, together with a small amount of the 
hydroquinone D. In the 1H NMR spectrum of 10 (Figure 2.5), the quinone proton 
appeared as a singlet at δ 5.93 ppm, slightly upfield from the corresponding signal  in 
the 1H NMR spectrum of starting quinone 8. This can be accounted for by the nitrogen 
atom acting as an electron donor to the π system, counteracting the role of the ketone 
as electron-withdrawing group. The singlet at δ 7.50 ppm was assigned to the amine 
proton. The 13C NMR spectrum also confirmed the proposed structure, with 3 signals at 
δ 184.4 ppm, 182.5 ppm and 178.8 ppm consistent with the presence of the two 
quinone carbonyl groups and carboxyl carbon. 
 
Figure 2.5. 
1
H NMR spectrum of the quinone 10 in CDCl3. 
The regioselectivity of the reaction could be explained by the presence of the methoxy 
group at C-3, which releases electrons into the adjacent enone (pathway I, Scheme 
below), thus favouring development of electrophilic character (or a low-energy LUMO) 
at C-6 (pathway III in Scheme below) rather than at C-5 (pathway II in Scheme below). 
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The 1,4-addition of the amine at position C-6 gives rise to the species A, which 
undergoes proton transfer to form enol B. Tautomerisation to C followed by oxidation in 
the presence of the starting material quinone leads exclusively to the quinone 10 
(Scheme 2.6).  
 
 
 
 
Scheme 2.6. Proposed mechanism of the formation of 1,4-addition product. 
 
The palladium (II)-catalysed oxidative cyclization of diarylamines is one of the 
transformations described by Akermark et al19 to create the C-C bond in the formation 
of carbazole alkaloids. Moreover, the double C-H activation in the presence of 
stoichiometric amount of Palladium (II) and copper (II) salts described by Knölker et 
al13,14 also resulted in the formation of the bi-aryl C-C bond and confirmed the approach.  
In this study the palladium (II)-mediated cyclization of 10 was conducted using 5 mol% 
of the catalyst and 0.1 eq. K2CO3 at 120 ⁰C in pivalic acid to afford carbazole quinone 11 
(Scheme 2.5) in 85% yield. During the reaction, the flask was left open to ensure the 
reoxidation of Pd(0) to Pd(II) by atmospheric oxygen. The addition of a further 
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equivalent of catalyst did not improve either reaction time or yield. The 1H NMR 
spectrum of 11 showed the expected disappearance of the singlet at δ 5.93 ppm in the 
1H NMR spectrum of 10 for the proton attached to the quinone moiety. In addition, no 
ortho-coupling was observed between H-5 and H-4b since the 1H NMR of 11 displayed a 
singlet at δ 7.80 ppm for H-5.  
This confirmed the effective cyclisation of the quinone 10 with palladium acetate to give 
the carbazole quinone 11. The ESI mass spectrum also displayed the expected molecular 
ion at m/z = 350.2 corresponding to [M+Na]+. 
 
 
 
Scheme 2.7. Reagents and conditions: 2 eq. of quinone 8, 1 eq. of Amine 10, MeOH, rt, overnight, Ar; (ii) 
Pd(OAc)2 (10 mol%), 0.1 eq. K2CO3, 2 g PivOH, 120 ⁰C, Air, overnight. 
 
In a repeat of the approach described above, the quinone 8 and the readily available 
meta-substituted amine 12 were combined in methanol at room temperature in order 
to achieve a further 1,4-addition reaction (Scheme 2.7). The reaction proceeded to 
completion overnight, and yielded a violet solid in 76% yield after filtration.  The 1H 
NMR spectrum of 13 confirmed the structure with; in particular, two singlets at δ 7.53 
and 5.97 ppm corresponding to the NH proton and the proton attached to the quinone 
moiety (H-6), while the 13C NMR spectrum gave, inter alia, signals corresponding to the 
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three carbonyl carbons. In the ESI mass spectrum, the ion with m/z = 316.1 
corresponded to the ion [M+H]+. The palladium-catalysed cyclization of 13 was then 
attempted using 10 mol% of catalyst over 24 h. Carbazole quinone 14 was obtained in a 
moderate yield of 51% as sole product and increasing the amount of catalyst to 15 mol% 
or shortening of the reaction time did not improve the yield. More importantly, 
prolonged reaction time resulted in the decomposition of starting material. The 
disappearance of the proton at 4a in the 1HNMR spectrum of 14, as well as the 
appearance of two doublets (δ 7.89 and 7.14 ppm), which were assigned to protons at 
positions 5 and 6, and a singlet at δ 7.31 ppm for H-8, confirmed the structural 
assignment of the carbazole quinone 14. The HSQC spectrum confirmed that seven 
carbon atoms have no attached protons. In addition, ESI-MS gave expected molecular 
ions at m/z = 314.1 [M+H]+ and 336.1 [M+Na]+. 
 
 
 
Scheme 2.8. Reagents and conditions: (i) 1.3 eq. TIPSCl, 1.5 eq. imidazole, DMF, 14 h, rt,  Ar; (ii) 1 eq. 
amine 15, 1.6 eq. quinone 8, MeOH, 2 h, rt, Ar; (iii) Pd(OAc)2  (10 mol%), 0.1 eq. K2CO3, PivOH, 120 ⁰C, air, 
3 h; (iv) 1.0 eq. of 18, 1.2 eq. TBAF, DCM, 30 min, rt. 
 
A key consideration in devising a strategy for the synthesis of the 8-hydroxy analogue of 
the carbazole quinone was the possibility that a free hydroxyl group in a starting 
material such as 2-aminophenol 15 (Scheme 2.8) would be incompatible with the 
sequence established above, viz. conjugate addition of amine to the quinone followed 
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by oxidative cyclization. The availability of TIPSCl at low cost, together with its thermal 
stability and resistance to oxidation led to it being preferred for the protection of 
hydroxyl group. The hydroxyl group in 15 was therefore first protected as the TIPS ether 
16 in quantitative yield by treating 15 with TIPSCl in THF at room temperature for 14 h in 
the presence of imidazole.20-22 The 1H NMR spectrum of 16 showed a doublet at δ 1.14 
ppm with J = 7.6 Hz, integrating for 18 protons of the six methyl groups attached to the 
methine carbon of isopropyl group, and a multiplet at δ 1.28-1.36 ppm corresponding to 
the three CH groups. The O-protected amine 16 and the quinone 8 were then combined 
for the 1,4-addition reaction in methanol at room temperature. The reaction proceeded 
to completion in two hours, yielding the quinone 17 in 69% yield. The 1H NMR spectrum 
of 17 displayed a broad peak at δ 8.05 ppm for the amine proton and a one-proton 
singlet at δ 6.11 ppm corresponding to H-6 in the attached quinone moiety. The mass 
spectrum gave an ion at m/z = 416.3, corresponding to [M+H]+. The oxidative cyclization 
of 17 using a catalytic amount of the palladium acetate was conducted in an open flask 
as before, giving rise to the carbazole quinone 18 in 82 % yield after 3 h. The 1H NMR of 
18 showed the absence of signals for the characteristic protons 6 and 6’ in its precursor 
17. The signal at δ 7.16 ppm which appears as a triplet with J = 7.9 Hz corresponded to 
the proton H-6, since it has two neighbouring protons. Two doublets were also visible at 
δ 7.74 and 6.81 ppm and were assigned to either H-5 or H-7. These protons did not 
show doublets of doublets because the constant couplings of the meta protons are 
usually small. These observations confirmed the formation of the carbon-carbon bond 
between C-4a and C-4b, respectively. The carbazole quinone 18 was then deprotected in 
order to prepare hydroxylated carbazole quinone 19 in order to assay its anti-TB activity 
in relation to the known compound B. Removal of the TIPS group was achieved following 
the conventional approach by the addition of TBAF (1.2 eq.) in DCM, which yielded 19 as 
a brown solid in 53% yield. The moderate yield of reaction was possibly due to the 
water-solubility of the carbazole quinone 19 which could be lost during aqueous work-
up. The attempt to optimize using THF was unsuccessful and gave 24% yield. In the 1H 
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NMR spectrum of 19, two broad singlets were observed at δ 12.67 and 10.02 ppm 
corresponding respectively to the protons in the NH and OH groups. The absence of 
isopropyl signals and the appearance of signal for OH in the 1H NMR of 19 confirmed the 
structure of carbazole quinone 19, and  further corroborated mass spectroscopy with an 
ion at m/z = 258.1 consistent with  [M+H]+. 
 
 
 
Scheme 2.9. Reagents and conditions: (i) 1.5 eq. TEA, 0.5 eq. DMAP, 1.5 eq.TIPSCl, 2 h, rt; (ii) 1.0 eq. 
amine 21, 2.0 eq. quinone 8, MeOH, 4 h, rt; (iii) Pd(OAc)2  (5 mol%), 0.1 eq. K2CO3, PivOH, 120 ⁰C, air, 5 h; 
(iv) 1 eq. of 23, 1.2 eq. TBAF, DCM, 30 min, rt, Ar. 
 
Following a similar approach to that for preparation of 19 the protection of the hydroxyl 
group of the commercially available p-aminophenol 20 was achieved at room 
temperature in 2 hours using 0.5 eq DMAP as a catalyst and 1.5 eq. TIPSCl, giving 
protected amine 21 in a moderate yield of 64 % (Scheme 2.9). The 1H NMR spectrum of 
21 showed a doublet at δ 1.10 ppm with J = 6.9 Hz, integrating for 18 protons, which are 
attributed to six methyl groups attached to the methine carbon of isopropyl group, and 
a multiplet at δ 1.26 - 1.18 ppm corresponding to the three CH protons. The TEA as 
auxiliary base was used to deprotonate the protonated DMAP and regenerates the 
catalyst. The 1,4-addition reaction of the protected amine 21 with quinone 8 in 
methanol was conducted at room temperature. After 4 h, the reaction was complete to 
give, after purification, the quinone 22 as a red solid in 96% yield. In the 1H NMR 
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spectrum of 22, the appearance of the signal at δ 5.80 ppm for the H-6 as well as a 
singlet at δ 7.38 ppm integrating for one proton (NH) confirmed its structural 
assignment. After applying the same conditions as before for the cyclisation of the 
quinone 22 using a catalytic amount of the palladium, a brown solid was isolated in 55% 
yield and shown to be carbazole quinone 23. This moderate yield was possibly due to 
the presence of the bulky TIPS ether near the reaction site. No signal for proton 4a was 
visible in the 1HNMR spectrum of 23 compare to the 1H NMR spectrum of 22. This 
confirmed the structural assignment of the carbazole quinone 23. The triisopropylsilyl 
ether was removed by treatment with 0.1 M TBAF to give, after, purification, the 
desired carbazole quinone 24 as brown red solid in 63% yield. Its structural assignment 
showed the disappearance of triisopropyl proton signals in the 1H NMR of 24, while the 
13C NMR confirmed the absence of the triisopropyl carbon signals.    
 
Scheme 2.10. Reagents and conditions: (i) 1.0 eq. amine 25, 2.0 eq. quinone 8, MeOH, rt, overnight; (ii) 
Pd(OAc)2  (5 mol%), 0.1 eq. K2CO3, PivOH, 120 ⁰C,  air, 5 h. 
 
Reaction of the commercially available amine 25 with the quinone 8 in order to achieve 
the 1,4-addition reaction gave, after purification, a brown solid in 96% yield, which was 
revealed to be the quinone 26. The 1H NMR spectrum confirmed the structural 
assignment of 26 by displaying a singlet at δ 6.00 ppm for proton-6, with the NH 
resonating as a broad peak at δ 7.49 ppm and two singlets at δ 4.15 and 3.82 ppm 
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attributed to the two methoxy protons. In addition, ESI-MS gave molecular ions at m/z = 
274.1 [M+H]+. Oxidative cyclization of 26 with 5 mol% of Pd(OAC)2 gave, after 
purification, the desired carbazole quinone 27a as red solid in 60% yield, with no 
evidence for the alternative, less likely carbazole quinone 27b obtained from ring-
closing to the carbon between the amine and methoxy groups. This could be due to 
steric demands of the methoxy group in the transition state leading to product 27b. The 
evidence of the structure of 27a included the appearance in the 1H NMR spectrum of a 
doublet of doublets at δ 6.93 (J = 2.2, 8.5 Hz), formed by coupling of the H-6 to both an 
ortho-proton (H-5) and a meta-proton (H-8). The evidence for the structure of 27a 
included the appearance in the 1H NMR spectrum of a doublet of doublets at δ 6.93 (J = 
2.2, 8.5 Hz), resulting from coupling of the H-6 to both an ortho-proton (H-5) and a 
meta-proton (H-8). The doublet at 6.89 ppm for H-8 also confirms the structure and the 
cyclization is also confirmed by the disappearance of the characteristic signals for H-6 
and H-6’ that are present in the 1H NMR spectrum of starting material 26. This 
suggested the successful cyclisation of the quinone 26 and, the ESI-MS gave molecular 
ions at m/z = 272.0 [M+H]+. 
 
In the context of exploring the structure-activity profile of the carbazole quinones, it 
was of interest to prepare an analogue with a bulky lipophilic group such as an aromatic 
ring attached to the carbazole-1,4-quinone. The methodology described above was 
therefore applied to β-naphthylamine, in order to attempt formation of an extended 
benzo-fused carbazole quinone. 
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Scheme 2.11. Reagents and conditions: (i) 1.0 eq. amine 28, 2.0 eq. quinone 8, MeOH, overnight, rt; (ii) 
Pd(OAc)2  (10 mol%), 0.1 eq. K2CO3, PivOH, 120 ⁰C, air, overnight. 
 
The readily available β-naphthylamine 28 and quinone 8 in methanol were stirred 
overnight at room temperature to achieve the 1,4-addition reaction. This gave a darkish 
brown solid in 74% yield, which was shown to be quinone 29. The 1H NMR confirmed 
the structural assignment of 29 with the presence of the characteristic singlet at δ 6.16 
ppm for H-6 and a broad peak at δ 7.71 ppm integrating for one proton for the amine 
proton. In addition, ESI-MS gave the expected molecular ions of m/z = 294.1 [M+H]+. 
The oxidative cyclization of 29 could give rise to two compounds 30a and 30b due to the 
fact that coupling can occur at two possible positions on the aromatic ring. The 
attempted oxidative cyclization of 29 using 5 mol% of palladium did not proceed to 
completion over 24h, and prolonged reaction time led to the decomposition of the 
product. However, on repeating the reaction with 10 mol% catalyst, a black solid was 
obtained in a low 8% yield. The 1H NMR of the product revealed the absence of singlets 
expected for H-5 and H-8 in structure 30b. This instead confirms the isolation of the 
carbazole quinone 30a, and the 1H NMR displayed signals as doublets with ortho-
coupling (J = 8.2 or 9.1 Hz) or multiplets. The difficulty of insertion of palladium near the 
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bulky aromatic group might explain the poor yield of the reaction, and the starting 
material was recovered.  
Table 2. Comparison of selected 1H NMR and 13C NMR signals for the series of aryl-
quinonyl amines, precursors of the carbazole quinones. 
 
Structure  H-6 
(ppm) 
 NH 
(ppm) 
-OCH3 
(ppm) 
-CH3 
(ppm) 
C=O 
(ppm) 
C=O 
(ppm) 
 
5.93 7.50 4.14 1.96 184.4 182.5 
 
5.97 7.53 4.14 1.96 184.3 182.8 
 
6.11 8.05 4.15 1.97 184.3 182.6 
 
5.80 7.38 4.14 1.95 184.3 182.3 
 
6.00 7.49 4.15 1.96 184.3 182.5 
 
6.16 7.71 4.17 1.99 184.3 182.7 
 
With a series of aryl-quinonyl amines now in hand, where the quinonyl unit was the 
same in all compounds, it was of interest to compare the 1H NMR data to investigate 
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any diagnostic shifts. The comparison is shown in Table 2. The proton NMR chemical 
shifts (δH) of the methoxy and methyl singlets remain virtually the same throughout the 
series, as do the δC values for the quinone carbonyl and methyl groups. However, small 
differences in δH are seen for the amine-protons and H-6. Signals for the latter appear 
furthest downfield in compounds 13, 17, 26 and 29, which have either ortho- or meta-
substituted aromatic rings.  
 
2.2.2. Synthesis of the key glucosamine derivative 36. 
 
In order to achieve one of our goals as described in the Figure 2.4, the synthesis of the 
target molecule C was required, in which the sugar and carbazole quinone are linked by 
an amide bond. This would require a 2-aminoglucoside for coupling with the carboxy-
terminated alkyl chain at the 6- or 7-position of the carbazole-quinone.  Using Ernst’s 
approach,23 we successfully  synthesized the target selectively protected glucosamine 36 
from glucosamine using the diazo transfer reaction.  
 
(i)
3231
S
O
O
S
F3C CF3
O
OO
S
O
N3F3C
O
 
 
Scheme 2.12. NaN3, toluene/H2O, 0-10 ⁰C, 2.5 h 
 
Triflic azide was freshly prepared by treating triflic anhydride 31 with sodium azide in an 
emulsion of H2O/toluene at 0 ⁰C (Scheme 2.12), to provide a 1 M stock solution. (The 
reagent needs to be handled with care because it is shock-sensitive.) 
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Scheme 2.13. (i) 32, NaHCO3, CuSO4.5H2O, H2O/MeOH/toluene,15 h, r.t; (ii) Ac2O, pyridine, 0 ⁰C - r.t, 18 
h(iii) BF3.OEt2, dry CH2Cl2, PhSH, reflux; (iv)  Recristallisation from EtOH; (v)H2, Pd/C, EtOAc, 24 h. 
 
The triflic azide 32 (stock solution) was then added to glucosamine hydrochloride 33 in 
the presence of CuSO4.5H2O as catalyst to provide the 2-azido derivative, which was 
further acetylated to give an anomeric mixture (α/β isomers) of acetylated 2-azido 
glucose 34 as a white precipitate in 89% yield. Glucosyl acetate 34 was then treated with 
thiophenol (PhSH) in the presence of Lewis acid BF3.Et2O to give a mixture of anomers 
(α/β: 3/1), which on recrystallization from EtOH gave the α-thioglycoside 35a in 46% 
yield as white needles. The NMR spectra were in agreement with the literature.23 The 
hydrogenation of the α-thioglycoside 35a was conducted in EtOAc with Pd/C (10 wt %) 
under H2 atmosphere to give, after purification, the 2-amino α-thioglycoside 36 as 
colourless needles in 75 % yields. Its structure was confirmed by analysis of the 1H NMR 
spectrum, which showed a doublet of doublets for H-2, shifted upfield from its position 
at δ 3.99 ppm in 35a to 3.32 ppm in 36. It is important to note that we observed 
spontaneous O-N migration of one acetyl group to form the 2-acetamido-glucoside, 
even when the α-thioglycoside 36 was stored at low temperatures. It was therefore 
freshly prepared for each subsequent coupling reaction with substituted carbazole 
quinones. 
 
2.2.3. Amide bond formation 
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 Formation of the target hybrid structures required efficient formation of the amide 
bond. While there are many methods for achieving this, we found EDC.HCl to be an 
effective reagent for activation of the carboxylic acid in the presence of amine group. Its 
water-solubility as well as of the urea by-product formed during the reaction with the 
amine meant it was favoured over DCC, which gives a by-product difficult to remove 
from the reaction mixture.24 To promote coupling to form the peptide, additives such as 
HOBt are commonly used, and were used in this work. 
 
 
Scheme 2.14. Reagents and conditions: (i) 1.0 eq. 11, 1.5 eq. EDC.HCl, 1.0 eq. HOBt, 4.5 eq DIEA, THF, 0 
⁰C, Ar; (ii) 1.25 eq. 36, rt, overnight, Ar; (iii) MeONa, MeOH, rt, Ar, overnight. 
 
In the first attempt at formation of peptide bond, acid 11 was combined with amine 36 in 
THF at 0 ⁰C under Ar and the amide 37 was isolated after filtration in a yield of 52%. The 
1H NMR spectrum of 37 showed the appearance of a doublet at δ 5.92 ppm (J = 8.8 Hz) 
integrating for one proton assignable to the amide-proton (NHCO) (Figure 2.6). In 
addition, the 1H NMR spectrum displayed three singlets at δ 2.08, 2.07 and 2.06 ppm for 
the acetyl methyl groups, while the 13C NMR revealed six signals at δ 181.0, 179.1, 172.7, 
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171.7, 170.7 and 169.3 ppm corresponding to the six carbonyl carbons present in the 
molecule. The ESI mass spectrum showed the molecular ions at m/z = 707.5, 724.5 and 
729.5 consistent with [M+H]+, [M+NH4]
+ and [M+Na]+ ions, thus confirming the molecular 
structure of compound 37.  
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Figure 2.6. 
1
H NMR spectrum of compound 37 in CDCl3. 
 
Deacetylation of 37 with catalytic sodium methoxide in methanol afforded 38 in a very 
good yield (95%).25 The absence of acetyl signals in 1H NMR and 13C NMR spectrum of 38 
supported the successful deacetylation of compound 37. In addition, the IR spectrum 
showed an absorption band at ν (cm-1) = 3398, confirming the presence of OH functional 
groups and ESI-HRMS gave a molecular ion at m/z 603.1789, corresponding to [M+Na]+. 
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Scheme 2.15. Reagents and conditions: (i) 1.0 eq. 14, 1.5 eq. EDC.HCl, 1.0 eq. HOBt, 4.5 eq. DIEA, THF, 0 
⁰C, Ar; (ii) 1.25 eq. 36, rt, overnight, Ar; (iii) MeONa, MeOH, rt, Ar, overnight. 
 
Coupling of the carboxylic acid 14 and the amine 36 under the conditions described 
above (Scheme 2.15) resulted in the formation of the amide 39 in a moderate yield 
(60%) after filtration. In the 1H NMR spectrum, the singlet at δ 5.93 ppm corresponded 
to the proton attached to the nitrogen atom, while the 13C NMR spectrum revealed six 
signals for carbonyl carbons at δ 180.9, 179.0, 171.8, 171.8, 170.6, 169.3 ppm. In 
addition, ESI-MS gave molecular ions with m/z = 693.4 and 715.4, which were are 
attributed to the [M+H]+ and [M+Na]+ ions, respectively. The deacetylation of 39 was 
conducted with a catalytic amount of sodium methoxide in methanol to give, after 
filtration, the unprotected sugar derivative 40 in high yield (96%). The disappearance of 
the three acetyl groups was evident from the 1H NMR spectrum of 40. In addition, the 
doublet for H-1 of the sugar moiety appeared slightly upfield from δ 5.66 ppm in the 
1HNMR spectrum of 39 to 5.60 ppm in the 1HNMR spectrum of 40. The 13C NMR 
spectrum of 40 displayed three signals at δ = 180.7, 177.2, 172.1 ppm for the two 
carbonyl groups of the quinone and one of the amide.  In addition, ESI-HRMS gave an 
ion at m/z = 589.1632 corresponding to [M+Na]+. 
Chapter 2                                                            Results and Discussion 
 
 
UCT  CHEMISTRY 42 
The successful completion of the synthesis of hybrid structures 38 and 40 thus 
demonstrated a viable synthetic route to these compounds, and these were combined 
with similar structures prepared by other researchers in the research group and 
submitted for separate assays of their anti-TB activity and activity as inhibitors of mshB. 
The results of these assays are presented and discussed later in this thesis. 
 
2.2.4. Attempted synthesis of analogues D and E, involving a C–C coupling step in the 
formation of the tethered hybrid molecule (see Figure 2.4). 
 
2.2.4.1. Use of Grignard strategy  
 
Many approaches have been used for carbon-carbon bond formation resulting in the 
preparation of ketone. A classic example is the reaction of a Grignard reagent with a 
carboxylic acid derivative, but this often leads to low yield of ketones and can be 
accompanied by over-alkylation to give the tertiary alcohols. This has led to variations 
such as the acylation of organometallic reagents with carboxylic acid derivatives such as 
Weinreb amides (N-methoxy-N-methylamides), where the second nucleophilic addition 
of Grignard reagent to form a ketone is suppressed.26,27 In addition, the Weinreb amide 
displays good versatility and reacts with both organolithiums and Grignard reagents to 
form various ketones.28  
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Scheme 2.16. Retrosynthetic pathway to ketone formation. 
 
The proposed synthetic route to derivatives D therefore attempted to combine the 
strategies of assembling the carbazole-quinone unit using the Knölker methodology, 
with preparation of a 2-C-carboxyalkyl glycoside and final coupling using the Weinreb 
approach. The Weinreb amide III (Scheme 2.16) was therefore identified as a key 
intermediate for preparation of the ketone VIII, which would be obtained by 1,4 
addition of the amine VII to the quinone VI, followed by oxidative cyclisation. The 
quinone VI would be obtained by oxidation of V, which in turn was obtained by the 
reaction of the key intermediate III with the organomettalic IV. The key intermediate 
Weinreb amide III could be prepared from the hydrolysis of the ester II, and 
subsequently conversion of the corresponding acid to the Weinreb amide III in a one pot 
reaction. The selective addition of malonate to the protected glucal I, followed by 
decarboxylation could give access to the ester II (Scheme 2.16).  
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Scheme 2.17. Reagents and conditions: (i) NaOH, TBAI, THF, BnBr, 5 h, rt; (ii) Dimethyl malonate, NaHCO3, 
CAN, MeOH, 0 ⁰C, 7 h, Ar; (iii) LiI, DMSO, 180 ⁰C, reflux, 2.5 h; (iv) LiOH.H2O, Amberlite-IR120, MeOH-H2O, 
rt; (v) 2-chloro-4,6-dimethoxy-[1,3,5]-triazine, N-methylmorpholine, N,O-dimethylhydroxylamine 
hydrochloride, THF, rt. 
 
In order to implement this strategy, the first goal was to prepare the key Weinreb amide 
45 starting from readily available D-glucal 41.  Misra’s protocol29 allowed the direct one-
pot conversion of acetylated glucal 41 to the corresponding benzylated glucal 42 in very 
good yield 92%. Based on the Linker procedure,30 we then constructed the side chain at 
C-2 by treating the benzylated glucal 42 with 10.0 eq. of dimethyl malonate in the 
presence of CAN and NaHCO3. The malonate 43 was isolated in good yield (91%) and 
decarboxylation using 1.5 eq. of LiI in DMSO afforded the ester 44 in 95 % yield. To 
access the key intermediate Weinreb amide 45, the ester 44 was hydrolysed with 2.5 eq. 
of LiOH.H2O to give the carboxylic acid. Without purification, the carboxylic acid was 
then converted to the Weinreb amide 45 in the presence of N,O-dimethylhydroxylamine 
hydrochloride31 to give, after purification, the desired product in 73% yield as a 
colourless oil. The 1H NMR analysis revealed three singlets δ 3.53, 3.41 and 3.03 ppm, 
which were assigned to the methyl protons of the OCH3, NOCH3 and NCH3 groups 
respectively. This was corroborated by the 13C NMR spectrum which showed three 
carbon signals at δ 61.1 ppm (OCH3), 56.7 ppm (OCH3) and 32.4 ppm (NCH3).  In 
addition, the IR spectrum showed absorption bands at ν (cm-1) = 1646 (C=O) and 1265 
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(C-N), respectively. EI-HRMS confirmed the assigned structure, giving an ion with m/z = 
550.2799 corresponding to [M+H]+.  
 
 
 
Scheme 2.18. Synthetic pathway to analogue D. 
 
The direct reaction of magnesium metal with organic halides is the most common 
method used to prepare Grignard reagents 50 and 51. Starting with the commercially 
available 6, the aryl bromide 46 was prepared in 85% yield in Et2O at low temperature 
after sequential addition of n-BuLi and CBr4 (Scheme 2.14). The NMR analysis data was 
in agreement with that reported by Lopes et al.15 However, reaction of the aryl bromide 
46 with Mg in either Et2O or THF failed to give the desired Grignard reagent 50, with 
only the starting aryl bromide 46 recovered after purification. It is probable that the 
situation of the C–Br bond between two m-oriented methoxyl groups makes it 
inaccessible to the metal. Even the addition of small amount of the initiator (iodine) did 
not improve the reaction. To counter this steric effect of the methoxy groups, we 
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investigated the use of the alkyl bromide 49 as an alternative. It was found that the 
most efficient way of accessing this was to treat the available starting material 6 
sequentially with n-BuLi and DMF to give the aldehyde 47 in 72% yield, which on 
reduction with NaBH4 afforded the alcohol 48 in 92% yield. Subsequent treatment with 
PBr3 in pyridine gave the desired alkyl bromide 49 in 91% yield. The appearance in its 
1H 
NMR spectrum of a singlet at δ 4.68 ppm integrating for two protons provided evidence 
for the benzylic protons in the CH2Br group. The 
13C NMR spectrum displayed an 
additional carbon peak at δ 60.9 ppm (for CH2Br) compared with the 
13C NMR of starting 
material 6.32-34 However, the alkyl bromide 49 also proved to be unreactive towards Mg 
in either Et2O or THF. The methodology was, however, successful when applied to 
benzyl bromide 54 to give Grignard reagent 56 (scheme 2.19). 
 
 
 
Scheme 2.19. Synthesis pathway to the hybrid molecules 57 and 58. 
 
At this stage the possibility of forming the desired ketones was investigated using the 
simplified Grignard reagents. In the first attempt, Weinreib amide 45 was reacted with 
commercially available Grignard reagent 55 in THF at 0 ⁰C. The 1H NMR spectrum of 57 
confirmed the absence of the Weinreb amide, and multiplets integrating for the 20 
protons in four phenyl groups were apparent in the aromatic region. The absence of an 
absorption band in the IR for the amide C-N and the presence of band C=O at 1690 cm-1 
confirmed the structure of 57. The formation of the Grignard reagent from benzyl 
bromide 54 and Mg in Et2O was then carried out, and after cooling to 0 ⁰C, the Weinreb 
amide 45 was added to the reaction mixture and stirred at room temperature overnight. 
Ketone 58 was obtained in 67% yield with the 1H NMR confirming the structural 
assignment of 58 by displaying 20 protons for the four phenyl groups, and a multiplet at 
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δ 3.65-3.59 ppm corresponding to the two protons H-9 and H-9’. In addition the 
corresponding signal for C-9 was visible at δ 49.5 ppm in the 13C NMR spectrum. The ESI-
HRMS mass spectrum confirmed the structure of 58, with the ion at m/z = 598.3184 
corresponding to [M+NH4]
+ (C36H42NO6 requires 598.3169). We thus demonstrated that 
Weinreb amide 45 reacted efficiently with Grignard reagents 55 and 56 to form 
corresponding ketones.  
 
Since the synthesis of ketone 52 via Weinreb amide 45 was unsuccessful, an attempt 
was made to prepare it via the route described below (Scheme 2.20) involving reaction 
of an acid chloride with the ortho-lithiated species 6a.    
 
 
 
Scheme 2.20. Reagents and conditions: (i) (a) LiOH.H2O, Amberlite IR-120, MeOH-H2O, rt; (b) Oxalyl 
chloride, 3 drops of DMF, rt to reflux, 30 min; (ii) 2.0 eq. n-BuLi (10.0 M in ether), THF, -78 ⁰C, 1 h, Ar; (iii) -
18 ⁰C to rt, 3 h. 
 
To investigate the route, the first step was the preparation of acid chloride 59. This was 
achieved by hydrolysis of the ester 44 at room temperature, followed by addition of 
oxalyl chloride and a catalytic amount of DMF.35 However, when the crude preparation 
of 59 was added to lithiated derivative 6a it failed to give expected ketone 52  and 
trimethoxybenzene 6 was recovered after the work-up process. With this failure to 
generate the desired ketone V in Scheme 2.16 where the aryl group was suitably 
functionalized for conversion to the quinone, alternative strategies, which still avoided 
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the formation of an amide, were explored for linking the aryl and sugar units. One 
alternative envisaged exploiting the possibility of generating alcohol 60 from ester 44 
(Scheme 2.21), converting this to an iodide or bromide and then attempting formation 
of a Grignard reagent from this for coupling to a formyl derivative 47 of the 
trimethoxybenzene. 
 
 
 
Scheme 2.21. Reagents and conditions: (i) LiAlH4, 1,4-dioxane, 0 ⁰C to rt, 3 h; (ii) Imidazol, PPh3, I2, THF, 0 
⁰C to reflux, 4 h; (iii) Pyridine, PBr3, Et2O, 5 min, rt, Ar; (iv) Pyridine, p-TsCl, 0 ⁰C to rt, 4 h; (v) NaI, DMF, 60 
⁰C, 4 h; (Vi) LiBr, DMF, 60 ⁰C, overnight; (vii) Mg, reflux to 0 ⁰C, Et2O, aldehyde 47, rt.  
 
Linker et al30 have reported the reduction of the ester 44 to the alcohol 60 and the 
primary alcohol was prepared in this way in 79 % yield. However, the direct conversion 
of the alcohol 60 to the glycosyl iodide 61 or bromide 62 failed.  
 
The alcohol was therefore treated with tosyl chloride in pyridine at 0 ⁰C to room 
temperature36 to give tosylate 63 in moderate yield (60%). The NMR analysis of the 
product showed a singlet at δ 2.42 ppm corresponding to three protons of the methyl 
substituent on the aromatic ring, and also the integration of peaks showed clearly 19 
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protons attached to the aromatic rings, while the carbon of methyl group appeared at δ 
21.5 ppm in its 13C NMR spectrum. In addition, the IR spectrum showed an absorption 
band at ν (cm-1) = 1092 (S=O) and 901 (S-O). 
 
Treatment of the tosylate 63 with 5.0 eq of NaI in DMF at 60 ⁰C afforded the iodide 61 in 
66% yield.37 In the 1H NMR of glycosyl iodide 61, the anomeric proton (H-1) had shifted 
slightly downfield from its position in the spectrum of tosylate 63 and the disappearance 
of the signal for the tosyl methyl protons was evident. In addition, the IR spectrum 
showed an absorption band at ν (cm-1) = 463 (C-I). Treatment of the tosylate with 1.5 eq. 
of LiBr under the same conditions gave bromide 62 in 69% yield. However, the 
attempted synthesis of alcohol 64 was unsuccessful, apparently due to the failure to 
prepare the Grignard reagent from either the iodide or bromide with both the iodide 61 
and bromide 62 recovered unchanged after treatment with Mg turnings in Et2O or THF 
followed by the aldehyde. Following this series of failures of the Grignard approach, 
attention turned to other strategies based on metal-mediated sp2-sp3 and sp2-sp2 cross-
coupling.  
 
2.2.4.2. Use of Pd-mediated cross-coupling 
 
Aryl halides are widely used as precursors in organic synthesis for carbon-carbon 
(derivative E) and carbon-heteroatom (derivative F) bond formation in transition metal 
catalysed cross-coupling processes such as the Heck, Suzuki, Sonogashira, Stille, and 
Ullmann-type coupling reactions. 
 
 
 
 
Chapter 2                                                            Results and Discussion 
 
 
UCT  CHEMISTRY 50 
 
 
Scheme 2.22. Reagents and conditions: (i) boronic acid 65, t-BuOK, tricyclohexylphosphine (10%), 
dioxane, Pd(OAc)2, 100 ⁰C, 24 h; (ii) DBU, DMF, 80 ⁰C, 3 h; (iii) Aryl bromide 46, PPh3, Pd(OAc)2, Et3N, 
alkene 67, dioxane, 100 ⁰C, 24 h, Ar; (iv) Br2, DCM, 0 ⁰C to rt; (v) t-BuOK, THF, 60 ⁰C, 24 h or NaNH2, 
toluene, 120 ⁰C, 24 h; (vi) E-vinyl bromide 71, boronic acid 65, (PPh3)2PdCl2, K2CO3, 1,4-dioxahe/H2O, 100 
⁰C, 24, Ar.  
 
Few successes have been achieved for reactions of alkyl electrophiles, specially 
unactivated (i.e., not allylic or benzylic) substrates that possess β-hydrogens.38-42 Fu et 
al43 established the first palladium or nickel cross-coupling of boronic acid and 
unactivated alkyl bromide (electrophile) that possess β-hydrogens. He describes a 
catalyst system that achieves this objective at room temperature. The choice of the less 
bulky triphenylphosphine catalyst was important for the feasibility of the reaction, and 
the catalyst system tolerated a wide variety of functional groups such as esters, ethers, 
thioesters, amides, acetals and nitriles. Aryl, vinyl and unhindered alkyl boronic acids are 
suitable partners in the processs.43 The challenge in the present study was to attempt to 
couple alkyl iodide 61 or bromide 62 with the boronic acid 65 having three methoxy 
groups, with a view to preparing compounds 66 and 68, for further transformation to 
molecule E using the Knölker methodology,13 as described in the scheme 2.2. 
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The palladium cross-coupling of boronic acid 65 with the unactivated bromide 62 was 
conducted under conditions established by Fu et al.43 The boronic acid 65 was first 
prepared in 60% yield from the protocol described by Lopes et al.15 The NMR and MS 
spectra were in agreement with that reported in the literature.15 Two equivalents of 
boronic acid 65 were then combined with iodide 61 or bromide 62 together with three 
equivalents of t-BuOK in dioxane and Pd(OAc)2. However no reaction was observed and 
starting materials 61 or 62 were recovered, with evidence that the starting material 
boronic acid had decomposed. Attention therefore turned to the more well-established 
sp2-sp2 cross-coupling reactions. 
 
Over past several decades the Heck reaction has received intensive study,44 especially 
the palladium-catalysed arylation and vinylation which have been shown to be one of 
the most powerful means for the formation of carbon-carbon bond in organic 
synthesis.45-49 The phosphine ligands stabilize the active palladium intermediate and 
assist the initial oxidative-addition to C-X bonds.50-53 In order to explore the application 
of the Heck reaction, a strategy was adopted involving preparation of sugar derivatives 
with vinyl halides in the side chain for attempted cross-coupling with the aryl bromide. 
Alkene 67 was successfully prepared in 68% yield by treating iodide 61 or bromide 62 
with DBU.54 The 1H NMR spectrum of 67 displayed a doublet for H-1 at δ 4.21 ppm, 
while the presence of vinyl group attached at C-2 was deduced by the presence of a 
doublet of doublets of doublets (ddd) at δ 5.68 ppm for H-7, a triplet of doublets at δ 
5.30 ppm for H-8, and doublet of doublets at δ 5.25 ppm for H-8’. In the mass spectrum 
of 67, the presence of an ion with m/z = 492.2737 was consistent with the ion [M+NH4]
+. 
The IR spectrum showed an absorption band at ν (cm-1) = 3100 (=C-H), 1643 (C=C). 
 
A Heck reaction was then attempted between aryl bromide 46 and alkene 67, using 5% 
mol Pd(OAc)2 as a catalyst, in the presence of Et3N and dioxane as a solvent at 100 ⁰C for 
24 h. However, no reaction was observed, and only the starting material was recovered. 
Increasing the catalyst to 10 mol% yielded no coupling product to form the product 68. 
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A Sonogashira reaction was then considered as an alternative. The Sonogashira cross-
coupling reaction requires a terminal alkyne and aryl bromide as coupling partners, 
using a palladium (0) complex in the presence of base, with copper iodide as a co-
catalyst. It was envisaged that the required alkyne 70 could be prepared from the alkene 
67 via a bromination-dehydrobromination sequence. Alkene 67 was therefore treated 
first with 1.1 eq of bromine in DCM at 0 ⁰C to give a mixture of unseparable 
diastereoisomeric 1,2 dibromides 69 in 91% yield in a ratio of 2:1 according to the 1H 
NMR data. The 1H NMR spectra of the two diasteroisomers 69 were similar, and two 
doublets were identified as Hα-1 and Hβ-1 at δ 4.47 ppm (J = 7.9 Hz) and 4.24 ppm (J = 
8.1 Hz), corresponding to two anomeric protons of two diasteroisomers. The presence 
of an ion m/z = 652.1100 corresponding to the ion [M+NH4]
+ was visible in the mass 
spectrum of  the 1,2 dibromide 69. The 1,2 dibromoalkane 69 was then treated with 
excess potassium tert-butoxide (3.0 eq.) in refluxing THF for 24 h. Somewhat 
unexpectedly the vinylbromide 71 was isolated as the only product (66%) instead of 
expected alkyne 70. The identity of 71 was established by NMR spectroscopy: the 1H 
NMR spectrum showed a deshielded doublet at δ 6.21 ppm with a large coupling J = 
13.6 Hz, which was identified as proton H-8 and a doublet of doublet at δ  5.90 ppm 
with couplings J = 9.0, 13.6 Hz corresponding to the proton H-7. The large value of J7,8 
provided confirmation of the E-vinylbromide configuration of the isolated compound 71. 
When the NaNH2 was used as base in refluxing toluene, the E-vinyl bromide 71 was 
formed at 61% yield.55-57 
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Scheme 2.23. Analysis of the bromination-dehydrobromination sequence starting with a generalized 
terminal alkene. 
 
Bromination of the terminal alkene results in a mixture of two 1,2-dibromo 
diastereomers A and B. Examination of the three possible conformers of each of these 
reveals that only two of each (A1, A2, B2 and B3) have the required anti peri-planar 
orientation of H and Br on adjacent carbons, required for concerted elimination to take 
place. Both A2 and B2 allow for elimination of the Br from C-1, and each leads to the 
same 2-bromoalkene C which is set up for the anti-elimination to form the terminal 
alkyne. However, both of these conformations (A2 and B2) are the highest energy ones 
on account of the two unfavourable gauche interactions (Br↔Br, and Br↔R) and in 
any case approach of the hindered base to the H on C-2 would be sterically demanding. 
In contrast, conformations A1 and B3 have lower energy on account of just one 
unfavourable gauche interaction (Br↔Br) and are set up for elimination of the more 
accessible H on C-1 and the Br on C-2. In both cases, irrespective of whether the starting 
material dibromide has R or S configuration, the same E-vinyl bromide D is produced. 
This elimination is kinetically favoured and predominates, and the E-vinyl bromide does 
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not react further with base, as it does not have the configuration allowing for the 
required anti-elimination to give the alkyne.  
If the general argument presented above is now applied to the specific substrates in 
question, the significance of the stereoelectronic factors becomes apparent (Figure 2.7). 
If the most favourable conformations A1 and B3 of the dibromide are now placed in the 
context of the sugar derivative, the favourable conformation around the C2-C1’ bond 
also needs to be taken into account. This is illustrated in Figure 2.7 for both the 1’(R) 
and 1’(S) dibromo derivatives. In the 1’(R) isomer the favourable conformations are 
illustrated by Newman diagrams, and shown in structure E, which gives rise to the (E)-
vinyl bromide G when treated with base as shown. Similarly, the favoured 
conformations of the 1’(S) derivative give rise to structure F, which, as shown, also leads 
to the (E)-vinyl bromide G when treated with base. 
 
 
 
Figure 2.7. Newman projections of the diastereomeric dibromides 69 and illustration of their conversion 
to the same E-vinylbromide 71.  
 
Although the intended alkyne was not prepared, the E-vinyl bromide 71 was identified 
as a useful starting material for attempted Suzuki-Miyaura cross-coupling with the 
boronic acid 65 to potentially give the compound 68.58-59 However, when the E-vinyl 
bromide 71 was treated with boronic acid 65 in the presence of (PPh3)2PdCl2 (5 mol%) 
and K2CO3 in 1,4-dioxane/H2O at 100 ⁰C for 24 h, no coupling product 68 was observed, 
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even though TLC of the reaction mixture showed the consumption of starting materials, 
and products were difficult to identify. 
With the continuing failure of metal-mediated cross-coupling methods, alternatives 
were considered. One of these is the use of the classical Wittig and related reactions in 
which aldehydes or ketones are reacted with an ylide to give an alkene, with E/Z 
selectivity dependent inter alia on the nature of the ylide.  
 
2.2.4.3. Use of Wittig strategy 
 
 
 
Scheme 2.24. Synthetic pathway to the Wittig product 75. 
 
The formation of the desired phosphonium salt 74 failed when the glycosyl iodide 61 
was sequentially treated with PPh3 and n-BuLi. The cause may be the lack of reactivity of 
the glycosyl iodide to involve in the SN2 reaction in the presence of PPh3.  
 
2.2.4.4. Use of lithiated derivative 6a. 
 
Another method to the target molecule E was to couple the glycosyl iodide 61 and the 
lithiated derivative 6a (Scheme 2.25). Then, the resulting product 66 will be used to 
construct the target molecule E using Knölker methodology, as described in the scheme 
2.2. 
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Scheme 2.25. Reagents and conditions: (i) 2.0 eq. n-BuLi (10.0 M in ether), THF, -78 ⁰C, 1 h, Ar: (ii) 4.0 eq. 
of iodide 61 or bromide 62, rt, overnight. 
 
The commercially available starting material 6 was treated with n-BuLi at -78 ⁰C in THF 
to form the lithiated derivative 6a (See scheme 2.25). In this solution, 4.0 eq. of the 
glycosyl iodide 61 or bromide 62 was added, and the reaction failed to give the desired 
compound 66, Iodide 61 or bromide 62 were recovered, and the starting material 6 
which was obtained by protonation of 6a during work-up process. Presumably, the 
presence of methoxy groups impedes the reaction.  
 
After many attempts to form carbon-carbon bond, we then turned our attention to 
forming a carbon-nitrogen bond in order to synthesize hybrid molecule F (Figure 2.4). 
 
2.2.5. Attempted synthesis of analogues F using C–N bond formation in the key step to 
form the tethered hybrid molecule. 
 
 
2.2.5.1. The Buchwald-Hartwig amination. 
 
The Buchwald-Hartwig amination is an organic reaction used to make carbon-nitrogen 
bonds. This is essentially a cross-coupling reaction of an aryl halide with an amine using 
palladium as a catalyst (Scheme 2.26). 
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Scheme 2.26. (i) (a) NaN3, DMF, 80 ⁰C, 3 h; (b) PPh3/H2O, THF, 65 ⁰C, 3 h; (ii) Pd2db3, (±) BINAP, toluene,  
Aryl bromide 46, reflux. 
 
Our initial attempt to the amine 72 involved the displacement of the tosyl group 
employing the sodium azide as a source of amine, and reduction of the azide under 
Staudinger conditions.60 Treatment of tosyl derivative 63 with 2.0 eq. of NaN3 in DMF at 
80 ⁰C for 3 h afforded the azide, which was then immediately reduced using 2.0 eq. of 
PPh3 under Staudinger conditions to give one product, the amine 72 in 68% yield. In the 
1 HNMR spectrum of 72, the triplet corresponding to the H-8 and H-8’ had shifted from δ 
2.02 - 1.91 ppm (H-8) and δ 1.81 - 1.71 ppm (H-8’) in the spectrum of 63 to δ 2.69 ppm 
in the spectrum of 72, supported its structure as well as the absence of the methyl 
peaks attached of tosyl group in the 13C NMR. In addition, the IR spectrum showed an 
absorption band at νmax/cm
-1 3006, confirming the presence of NH group. The Buchwald-
Hartwig amination61 reaction was attempted using 1.0 eq. of amine 72, 2.0 eq of the aryl 
bromide 46, Pd2dba3 as catalyst in the presence of CsCO3, and BINAP as ligands in 
toluene. No reaction took place after refluxing the reaction mixture for 24 h. Replacing 
Pd2dba3 and toluene by Pd(OAc)2 and dioxane respectively, the reaction also failed to 
give the desired product 73 after heating at 100 ⁰C, and only the starting materials were 
recovered. Presumably, the large electrophile is problematic for all Pd-mediated cross-
coupling reactions involving the aryl bromide 64 or boronic acid 65, and the steric effect 
of the methoxy group might be the cause of failure of the reaction.  
 
2.2.5.2. Via condensation of amine and aldehyde (Reductive amination reaction).  
 
In this approach, the aldehyde 47 and amine 72 are mixed with a reducing agent such as 
NaBH4. 
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Scheme 2.27. Reagents and conditions: (i) (a) aldehyde 47, MeOH, rt, overnight; (b) NaBH4, 5 h, r; (ii) 
PIDA, MeOH/H2O, overnight, rt. 
 
We conducted a one pot reaction between the amine 72 and aldehyde 47 at room 
temperature. After stirring overnight, the reducing agent NaBH4 (1.5 eq.) was added to 
the reaction mixture.62 The reaction was complete within 5 h, and yielded a brown oil 
(72%) after filtration, shown to be the amine 76. The 1H NMR spectrum of 76 showed 
two doublet of doublet peaks characteristic of two ortho protons at δ 6.73 ppm with J = 
8.8 Hz and 6.50 ppm with J = 9.0 Hz and three singlets at 3.79, 3.78 and 3.71 ppm 
relative to three methyl groups of the trimethoxybenzene unit. The 13C NMR confirmed 
the structure of 76 by displaying four methoxy peaks at δ 61.0, 56.7, 56.3 and 55.8 ppm. 
From the mass spectrum, we detected the ion mass m/z = 672.3536, which was related 
to the ion [M+H]+. In addition, the IR spectrum showed an absorption band at νmax/cm
-1 
3059, confirming the presence of NH group. 
 
We then attempted an oxidation reaction on compound 76 using 1.5 eq of PIDA at room 
temperature, and stirred for 19 h. In the 1H NMR spectrum  of compound 77, the 
expected singlet peak characteristic of the methyl protons of the quinone moiety were 
not visible, and two signal peaks relative to two ortho protons could not be seen. The 
mass spectrum showed the ion mass m/z = 492.2748, which matches with the ion 
[M+H]+ of the amine 72. The NMR data (1H NMR and 13C NMR) was the same with the 
one reported for the amine 72. The mechanism proceed through the formation of 
imine, followed by the hydrolysis to give amine 72. In this reaction, we therefore simply 
achieved an oxidative deprotection of a benzylated amine. This had been demonstrated 
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by Honek et al,63 who described the oxidative deprotection of diphenylmethylamines I 
by the addition of DDQ to form imine II, which was hydrolysed under mildy acidic 
conditions to give the desired product as the hydrochloride salts III ( Scheme 2.28). 
 
(i) RNH3Cl
HN
R
N
R
(ii)
I II
III
 
Scheme 2.28. Reagents and conditions: (i) DDQ, benzene, crushed 4Å molecular sieves, 60 ⁰C, 1 h.; (ii) 0.1 
N HCl, diethyl ether, 6 h. 
 
The failure of a number of approaches to formation of hybrid structures through C–C, C–
N, or C–O bond forming strategies suggests that the entire approach needs to be re-
evaluated. Some commentary on this problem is given in the conclusion to this chapter. 
 
2.3. Biological evaluation and SAR interpretation. 
 
Several of the compounds prepared in this study, together with other related ones 
prepared by co-workers, were assessed for inhibitory activity against MshB, using the 
method established by Lamprecht et al.65 
 
2.3.1. Description of the assay. 
 
The determination of biological activity of compounds was based on the sequence 
described in the scheme 2.29.  
 
Scheme 2.29. Proposed formation of the chromophore IV and the mixed disulphide V. 
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The assay is based on the observation that the dinitrophenyl thioglycoside I is a 
competitive substrate for MshB. It therefore undergoes N-deacetylation in the presence 
of MshB to give the free amine II, and this product undergoes subsequent Smiles 
rearrangement to give the anomeric thiol III. This can then be reacted with DTNB to 
form the chromophore IV and the disulphide V (Scheme 2.29). The inhibitory activity of 
compounds can therefore be calculated on the basis of the extent to which production 
of disulphide V and the chromophore is diminished. This means that a good inhibitor 
will block the action of MshB, and no production of the disulphide V will be observed. 
 
The substrate for the assay was selectively prepared (Scheme 2.30)65-68 from the 
protected starting material GlcNAc-thiazoline triacetate 81 obtained from Dr Anwar 
Jardine (University of Cape Town). Acetal hydrolysis of the thiazoline 81 gave the 
mercaptan 82, and this was followed by triethylamine-mediated S-alkylation with 1-
fluoro-2,4-dinitrobenzene to afford 83, which upon O-deacetylation gave the 
unprotected 2,4-dinitrophenyl thioglucoside 84.65-68 The NMR data were in agreement 
with the literature.  
 
OAcO
AcO
AcHN
AcO
(ii) (iii)
S
NO2
NO2
OHO
HO
AcHN
HO
S
NO2
NO2
OAcO
AcO
AcHN
AcO
SH
83
82
84
OAcO
AcO
N
AcO
S
(i)
81
 
 
Scheme 2.30. Reagents and conditions: (i) 2 drops TFA, 2 drops H2O, MeOH; (ii) 1-fluoro-2,4-nitrobenzene, 
Et3N, DCM, 25 ⁰C; (iii) MeOH, H2O, acetone, Amberlite IR-400 (OH
-
). 
 
The compounds prepared in this study (B, 27, 38, 40 in Figure 2.8) were assayed for 
inhibitory activity against MshB as part of a series of compounds prepared by others in 
parallel studies. Compound B is the carbazole quinone with the highest anti-TB activity 
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among a set of carbazole quinone analogues on which this study was based, and 
compounds B1 and 27 represents variations of these. GlcNAcSPh is an analogue of the 
natural substrate of MshB, known to also have substrate activity less than the natural 
substrate.64 Compounds 38, 40, 78, 79 and 80 are the hybrid compounds which have in 
common the carbazole quinone and phenyl-2-acylamino-1-thio-α-D-glucopyranoside 
units, tethered via an alkyl chain attached at various points to the carbazole quinone 
unit.  
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Figure 2.8. Structures of compounds submitted for inhibitory activity against MshB. 
 
2.3.2 Assay results. 
 
The assay results are shown below in Figure 2.9. This data represents the activity of the 
enzyme in the presence of both the substrate and the respective potential inhibitor 
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from the list of compounds: the best inhibitor is therefore the one showing lowest 
activity of the enzyme. Firstly it is important to note that, as expected, no activity is 
observed in the absence of MshB. Furthermore, the absence of inhibitory activity for 
GlcNAcSPh is important since this demonstrates that this does not compete with the 
2,4-dinitrophenyl thioglucoside 84 as a substrate in the assay.  
 
In addition, it was noted that the compounds to be assayed were prepared in DMSO 
solution before dilution with buffer and combining with the enzyme. Therefore, the 
activity of the enzyme against the 2,4-dinitrophenyl thioglucoside (GlcNAcSDNP) as 
substrate with only DMSO present was set at 100% (bar labelled “DMSO” in Figure 2.9), 
and other activities measured relative to this, noting that these represent % inhibition at 
a given concentration of substrate (150µM). Therefore, compounds showing <100% 
activity have inhibitory activity.  
 
Taking these considerations into account, the rest of the data therefore shows that only 
three compounds show significant inhibitory activity, with 78 exhibiting about 70% 
inhibition, followed by 79 with about 50% and 80 with 40% inhibition. Compound 38, 
prepared in this study, shows about 20% inhibition, while the C-7-substituted analogue 
40 does not show any inhibitory activity. From an SAR point of view, this can be 
interpreted as follows: the absence of inhibitory activity in either the sugar unit or the 
carbazole quinone units on their own, and the presence of activity in some of the 
hybrid, tethered molecules suggest that the combination of the two is indeed important 
for inhibitory activity. Furthermore, it is clear that the point of attachment of the sugar 
unit, and to an extent the length of the tether, do contribute to inhibitory activity. 
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Figure 2.9. Inhibition of MshB by mycothiol analogues incorporating carbazole quinones. 
 
2.4. Conclusion. 
 
This project aimed to synthesize and evaluate analogues of mycothiol incorporating 
carbazole quinones as inhibitors of enzymes in the Mycobacteria. Some works suggest 
that molecules, which have naphthoquinonyl unit A.3 tethered to the 
pseudodissacharide core, have a significant inhibitory activity against mshB and mca in 
the biosynthesis pathway. The phenyl-2-acetamido-1-thio-α-D-glucoside has been 
shown to be substrate for MshB. These findings, together with the independent 
discovery of anti-TB activity associated with carbazole quinone led to establish a 
methodology for the construction of the hybrid molecule 38 and 40, which involves the 
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Pd-mediated coupling for the formation of carbazole quinone using Knölker’s strategy. 
We also studied the reactivity of Weinreb amide 45 in the presence of Grignard reagents 
to provide ketone 57 and 58. We were also able to link the amine 74 and the aldehyde 
47 in one pot reaction. Unfortunately, the attempt to oxidize failed to provide the 
quinone 77. Again, the attempt to create carbon-carbon bond with Pd failed to provide 
the desired hybrid 66 and 68. Biological results proved that the combination of 
carbazole quinone unit and the sugar unit is very important for the inhibitory activity. 
The compound 78 has the highest inhibitory activity against MshB among a set of series 
of carbazole quinone analogues assayed. This demonstrated that the structure-activity 
relationship do contribute to inhibitory activity, which depend on the point of 
attachment as long as the length of tether. 
 
In terms of ongoing work, it is suggested that the preparation of the target hybrid 
molecule F could be achieved via the 1,4-addition of a nucleophile such as amine 72 (or 
possibly the corresponding alcohol) to the carbazole quinone 88 to provide the hybrid 
molecule 89 (or the corresponding ether). The carbazole quinone 88 would be prepared 
by the standard Knölker methodology (scheme 2.31).  
 
 
 
Scheme 2.31. Retrosythetic pathway to compound F. 
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CHAPTER 3 
 
EXPERIMENTAL 
 
3.1. General 
 
All solvents were dried and distilled before use. Commercially available reagents were 
used without purification. Reactions were performed under an inert atmosphere of 
nitrogen or argon in flame dried glassware. Reactions were monitored by thin-layer 
chromatography (TLC) carried out on Merck silica gel 60-F254 pre-coated plates and 
products visualized under ultraviolet light or by wetting the plate with either a solution 
of anisaldehyde in ethanolic sulphuric acid, ceric ammonium sulphate or ninhydrin 
followed by heating. Column chromatography was performed on silica gel 60, eluting 
with the mixtures of light petroleum and ethyl acetate, or on a Biotage Isolera system, 
using prepacked silica columns. Nuclear magnetic resonance spectra (1H, 13C and 2D 
NMR) were recorded either on a Varian Mercury 300 MHz, a Varian Unity 400 MHz or a 
Bruker Advance III with Ultra Shield 400 Plus magnet, at 25 ⁰C in deuterated CDCl3 or 
DMSO as the solvent. The 1H, 13C and 2D NMR spectra of carbazole quinone derivatives 
were recorded on a Bruker 300 or 400 MHz, or DRX-500 spectrometer. Infrared spectra 
were recorded on a Perkin-Elmer Spectrum 100 FT-IR spectrometer in the range 4000 – 
600 cm-1 using thin films of compound on NaCl disks. Microanalyses were determined 
using a Fisons EA1108 CHNS-O instrument. Chemical shifts are given in ppm relative to 
tetramethylsilane (TMS, δ = 0.00 ppm), which is used as internal standard. Assignments 
were confirmed by COSY and HSQC analysis. Coupling constants (J) are reported in Hertz 
(Hz). The spin multiplicities are indicated by the symbol s (singlet), d (doublet), dd 
(doublet of doublet), t (triplet), m (multiplet), and br (broad). Melting points were 
determined using a Reichert-Jung Thermovar hot-plate microscope and are uncorrected. 
IR spectra were recorded on a Perkin-Elmer FT-IR spectrometer and absorption 
frequencies given in cm-1. Mass spectra were recorded on a JEOL GC MATE ΙΙ magnetic 
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sector mass spectrometer and the base peaks are given. Mass Spectra results for the 
carbazole quinone derivatives were obtained using an Agilent 6890N GC/5973N MSD 
gas chromatography/mass spectrometry system. HRMS data were obtained using a 
Waters Synapt G2 with direct injection (1 μL) into a stream into a stream of 80% 
acetonitrile, 0.1% formic acid using a Waters UPLC at flow rate of 0.1mL/min. Source: 
Electrospray positive/negative, Capillary voltage 3 kV, Cone Voltage 25 V. 
 
2-Methyl-3-methoxy-1,4-benzoquinone (8) 
 
O
O
H3CO
H3C
8
1
2
3
4
5
6
 
 
 A solution of 1,2,4-trimethoxybenzene 6 (4.50 g, 26.8 mmol) in dry THF (50 mL) was 
cooled to -78 ⁰C. n-BuLi (10.0 M, 5.34 mL, 53.4  mmol) was added dropwise and the 
resulting mixture was stirred at the same temperature for 1 h. Methyl iodide (30.37 g, 
214 mmol) was then added dropwise and the reaction allowed to warm to room 
temperature gradually overnight. The mixture was quenched with saturated aqueous 
NH4Cl solution and extracted with ether (50 mL x 3). The combined organic phase was 
washed with water and brine, dried over MgSO4, filtered and the filtrate evaporated 
under reduced vacuum to afford compound 7 as a yellow oil. Without further 
purification, the crude product 7 was taken up in a mixture of H2O (61 mL) and MeOH 
(20 mL) and iodobenzene diacetate (13.14 g, 40.79 mmol) added with stirring at room 
temperature. The mixture was stirred for 19 h at room temperature and then extracted 
with ether (50 mL x 3). The combined organic layer was washed with saturated NaHCO3, 
water and brine, dried MgSO4, filtered and the filtrate evaporated under reduced 
vacuum to afford an orange oil. The product was purified by column chromatography on 
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silica gel using pentane-ethyl acetate (8:1) as eluent to give 8 as an orange oil (3.21 g, 79 
%, over two steps, lit.13). 1H NMR (500 MHz, chloroform-d) δ = 6.69 (dd, J = 1.0, 10.1 Hz, 
1 H), 6.60 (dd, J = 1.0, 10.1 Hz, 1 H), 4.02 (s, 3 H, OCH3), 1.95 (s, 3 H, CH3). 
13C NMR (125 
MHz, chloroform-d) δ = 188.3 (C=O), 183.2 (C=O), 155.6 (C), 136.3 (CH), 134.7 (CH), 
129.0 (C), 60.8 (OCH3), 8.6 (CH3).
 IR (ATR): ν (cm-1) = 1699, 1643. (UV) (MeOH): λ (nm) = 
96, 203, 251, 366. ESI-MS (+10 V): m/z = 153.2 [M+H]+. 
 
2-Methoxy-3-methyl-5-[(4’-(3”-carboxypropyl(anilino)]-1-4-benzoquinone (10) 
 
 
 
Quinone 8 (276 mg, 1.81 mmnol) and amine 9 (152 mg, 0.921 mmol) were mixed in 
methanol (5 mL). The solution was stirred at room temperature overnight under argon. 
A precipitate formed and was isolated by filtration, then washed with methanol and 
dried under reduced vacuum to afford the quinone 10 (223 mg, 82%) as a violet solid, 
mp 129-131 ⁰C (decomp). 1H NMR (500 MHz, chloroform-d) δ = 7.50 (s, 1 H, NH), 7.23 - 
7.19 (m, 2 H), 7.15 - 7.12 (m, 2 H), 5.93 (s, 1 H, H-6), 4.14 (s, 3 H, OCH3), 2.68 (t, J = 7.3, 
8.2 Hz, 2 H), 2.39 (t, J = 7.4, 7.4 Hz, 2 H), 2.02 - 1.96 (m, 2 H), 1.96 (s, 3 H, CH3). 
13C NMR 
(125 MHz, chloroform-d) δ = 184.4 (C=O), 182.5 (C=O), 178.8 (C=O), 157.9 (C), 143.2 (C), 
138.7 (C), 135.5(C), 129.6 (2 x CH), 122.9 (C), 122.4 (2 x CH), 98.4 (CH), 61.5 (CH3), 34.4 
(CH2), 33.1 (CH2), 26.1 (CH2), 8.5 (CH3). IR (ATR): ν (cm
-1) = 3303, 2939, 1711, 1633, 1588, 
1527, 1445, 14.17, 1346, 1272, 1214, 1158, 1001, 811, 686, 635. (UV) (MeOH): λ (nm) = 
196, 202, 207, 254 (sh), 279 (sh), 321 (sh). ESI-MS (+50 V): m/z = 330.2 [M+H]+, 352.1 
[M+Na]+, 681.3 [2M+Na]+. ESI-MS (-25 V): m/z = 327 [M-H]+, 657 [2M+H]+. Calcd for 
C18H19NO5: C, 65.64; H, 5.81; N, 4.25. Found: C, 65.75; H, 5.89: N, 4.28. 
 
3-Methoxy-2-methyl-6-(carboxypropyl)-9H-carbazole-1,4-quinone (11) 
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A solution of 10 (100 mg, 0.304 mmol), Pd(OAc)2 (5 mol%), K2CO3 (0.4 mg, 0.029 mmol), 
and pivalic acid (1000 mg) was weighed and transferred into a test tube. The uncapped 
test tube was placed in an oil bath and the mixture stirred under air at 120 ⁰C overnight. 
The mixture was then cooled to room temperature, diluted with EtOAc, washed with 
water, dried over MgSO4, filtered, and the filtrate evaporated under reduced pressure. 
The crude product was purified by silica gel column chromatography (DCM / 0.1% AcOH 
in EtOAc in 1:1 ratio) to afford carbazole quinone 11 (84.9 mg, 85%) as a red solid, mp 
214-217 ⁰C (decomp). 1H NMR (500 MHz, DMSO-d6) δ = 7.80 (s, 1 H, H-5), 7.44 (d, J = 8.2 
Hz, 1 H, H-8), 7.24 - 7.19 (m, 1 H, H-7), 4.02 (s, 3 H, OCH3), 2.70 (t, J = 7.6 Hz, 2 H), 2.19 
(t, J = 7.4 Hz, 2 H), 1.90 (s, 3 H, CH3), 1.86 - 1.79 (m, 2 H). 
13C NMR (125 MHz, DMSO-d6) δ 
= 180.6 (C=O), 178.5 (C=O), 157.8 (C=O), 137.7 (C), 136.6 (C), 136.1(C), 127.2 (C), 126.4 
(C), 123.9 (C), 123.4 (C), 120.4 (CH), 113.8 (CH), 113.0 (CH), 61.1 (OCH3), 34.8 (CH2), 33.7 
(CH2), 27.0 (CH2), 8.6 (CH3). IR (ATR): ν (cm
-1) = 3220, 2949, 2915, 2854, 2048, 2030, 
2009, 1696, 1628, 1592, 1536, 1430, 1399, 1377, 1289, 1245, 1206, 1103, 1044, 1001, 
951, 906, 818, 761, 745, 687, 640. (UV) (MeOH): λ (nm) = 197, 229, 260, 265 (sh), 282 
(sh), 311, 409. ESI-MS (+50 V): m/z = 350.2 [M+Na]+, 677.3 [2M+Na]+. ESI-MS (-50 V): 
m/z = 325.8 [M-H]+. Calcd for C18H17NO5: C, 66.05; H, 5.23; N, 4.28. Found: C, 66.11; H, 
5.26: N, 4.31. 
 
2-Methoxy-3-methyl-5-[(3’-(2”-carboxyethyl(anilino)]-1-4-benzoquinone (13) 
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Quinone 8 (95 mg, 0.624 mmnol) and amine 12 (59 mg, 0.357 mmol) were combined in 
methanol (4 mL). The solution was stirred at room temperature overnight under argon. 
A precipitate formed and was isolated by filtration, then washed with methanol and 
dried under vacuum to afford the quinone 13 (84.1 mg, 75%) as a violet solid, mp 141-
143 ⁰C (decomp). 1H NMR (500 MHz, chloroform-d) δ = 7.53 (s, 1 H, NH), 7.32 (t, J = 7.9 
Hz, 1 H, H-5’), 7.10 (s, 1 H, H-2’), 7.04 (d, J = 5.7 Hz, 2 H, H-6’, H-4’), 5.97 (s, 1 H, H-6), 
4.14 (s, 3 H, OCH3), 2.97 (t, J = 7.6 Hz, 2 H), 2.70 (t, J = 7.4 Hz, 2 H), 1.96 (s, 3 H, CH3). 
13C 
NMR (125 MHz, chloroform-d) δ = 184.3 (C=O), 182.8 (C=O), 176.5 (C=O), 157.9 (C), 
143.1 (C), 142.1 (C), 137.6 (C), 129.8 (CH), 125.5 (CH), 123.1 (C), 122.2 (CH), 120.2 (CH), 
98.6 (CH), 61.5 (OCH3), 35.1 (CH2), 31.9 (CH2), 8.5 (CH3). IR (ATR): ν (cm
-1) = 3297, 3031, 
2961, 2921, 2757, 2583, 2056, 1726, 1648, 1568, 1525, 1452, 1376, 1346, 1215, 1158, 
995, 975, 858, 836, 800, 757, 687, 661, 586, 548. (UV) (MeOH): λ (nm) = 209, 262, 282 
(sh), 325, 514. ESI-MS (+25 V): m/z = 316.1 [M+H]+, 653.3 [2M+Na]+. ESI-MS (-10 V): m/z 
= 628.9 [2M-H]–. Calcd for C17H17NO5: C, 64.75; H, 5.43; N, 4.44. Found: C, 64.90; H, 5.39: 
N, 4.45. 
 
3-Methoxy-2-methyl-7-(carboxyethyl)-9H-carbazole-1,4-quinone (14) 
 
 
 
A solution of 13 (440 mg, 1.40 mmol), Pd(OAc)2 (20 mol%), K2CO3 (19.2 mg, 0.507 mmol ), 
and pivalic acid (3000 mg) was weighed in air and transferred into a 25 mL round bottom 
flask. The uncapped flask was placed in an oil bath and the mixture was stirred under air 
at 120 ⁰C overnight. The solution was then cooled to room temperature, diluted with 
EtOAc, washed with water, dried over MgSO4, filtered, and the filtrate evaporated under 
reduced pressure. The crude product was purified by silica gel column chromatography 
(DCM / 0.1% AcOH in EtOAc in 1:1 ratio) to afford carbazole quinone 14 (255 mg, 51%) as 
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a pale orange solid, mp 213-215 ⁰C (decomp). 1H NMR (500 MHz, DMSO-d6) δ = 7.89 (d, J = 
8.2 Hz, 1 H, H-5), 7.31 (s, 1 H, H-8), 7.14 (d, J = 9.5 Hz, 1 H, H-6), 4.02 (s, 3 H, OCH3), 2.93 (t, 
J = 7.4 Hz, 2 H), 2.55 (t, J = 7.6 Hz, 2 H), 1.90 (s, 3 H, CH3). 
13C NMR (125 MHz, DMSO-d6) δ 
= 180.7 (C=O), 177.2 (C=O), 158.6 (C=O), 138.2 (C), 136.9 (C), 126.4 (2 x C), 126.1 (C), 122.9 
(C), 121.9 (C), 114.1 (CH), 112.8 (CH), 111.8 (CH), 61.1 (OCH3), 36.1 (CH2), 30.5 (CH2), 8.3 
(CH3). IR (ATR): ν (cm
-1) = 3232, 3021, 2928, 2860, 1708, 1654, 1625, 1535, 1457, 1431, 
1376, 13001, 1255, 1200, 1107, 995, 824, 754, 674, 627, 594. (UV) (MeOH): λ (nm) = 228, 
261, 271 (sh), 280 (sh), 313, 392. ESI-MS (+100 V): m/z = 314.1 [M+H]+, 336.1 [M+Na]+, 
627.1 [2M+H]+, 643.9 [2M+NH4]
+, 649.2 [2M+Na]+. ESI-MS (-10 V): m/z = 624.9 [2M-H]–. 
Calcd for C17H15NO5: C, 65.17; H, 4.83; N, 4.47. Found: C, 65.15; H, 4.84: N, 4.50.  
 
2-Triisopropylsilyloxyaniline (16) 
 
H2N
OTIPS  
 
A solution of 2-aminophenol 15 (0.514 g, 4.71 mmol), TIPSCl (1.28 mL, 5.99 mmol), and 
imidazole (0.478 g, 7.02 mmol) in THF (5 mL) was stirred at room temperature for 14 h. 
Water was added to quench the reaction, and the organic layer was separated. The 
aqueous layer was extracted twice with ethyl acetate. The combined organic layers 
were washed with brine, and dried over Na2SO4, then concentrated under reduced 
pressure. The resulting crude was purified by silica gel column chromatography (eluent: 
Hexane/EtOAc: 20/1) to afford the TIPS ether 16 as a brown oil in almost quantitative 
yield (1.23 g, 98%, lit.20). 1H NMR (500 MHz, chloroform-d) δ = 6.77 - 6.79 (m, 2 H), 6.74 
(dd, J = 1.6 Hz, 8.1 Hz, 1H), 6.58-6.64 (m, 1H), 1.28 - 1.36 (m, 3 H, Si(CH)CH3CH3), 1.14 (d, 
J = 7.6 Hz, 18 H, Si(CH)CH3CH3). 
13C NMR (126 MHz, chloroform-d) δ = 143.3, 137.8 
(Aromatic C), 121.5, 118.3, 117.9, 115.5 (Aromatic CH), 18.0 (6 x CH3, 3 x Si(CH)CH3CH3), 
17.7 (CH), 12.9 (CH), 12.2 (CH). IR (ATR): ν (cm-1) = 3416, 2942, 2892, 2865, 1609, 1593, 
1570, 1544, 1542, 1503, 1462, 1393, 1367, 1333, 1275, 1224, 1137, 1069, 1034, 1012, 
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995, 919, 881, 804, 741, 675. ESI-MS (+25 V): m/z = 266.1 [M+H]+, 531.3 [2M+H]+.  Calcd 
for C15H27NOSi: C, 67.87; H, 10.25; N, 5.28. Found: C, 67.77; H, 10.23; N, 5.24.     
 
2-Methoxy-3-methyl-5-[2’-(triisopropylsilyloxy)anilino]-1,4-benzoquinone (17) 
 
 
 
Amine 16 (1.97 g, 7.42 mmnol) and quinone 8 (1.48 g, 1.87 mmol) were combined in 
methanol (10 mL). The mixture was stirred at room temperature overnight under argon. 
The resulting mixture was purified by silica gel column chromatography (eluent: 
Pentane/EtOAc: 20/1) to afford the quinone 17 (2.31 g, 99 %) as a violet oil. 1H NMR 
(500 MHz, chloroform-d) δ = 8.05 (br. s., 1 H, NH), 7.36 (dd, J = 1.4, 7.7 Hz, 1 H), 7.02 - 
6.95 (m, 2 H), 6.92 (dd, J = 1.4, 7.7 Hz, 1 H), 6.11 (s, 1 H, H-6), 4.15 (s, 3 H, OCH3), 1.97 (s, 
3 H, CH3), 1.38 - 1.29 (m, 3 H, Si(CH)CH3CH3), 1.13 (d, J = 7.6 Hz, 18 H, 3 x Si(CH)CH3CH3). 
13C NMR (126 MHz, chloroform-d) δ = 184.3 (C=O), 182.6 (C=O), 157.7 (C), 147.6 (C), 
142.0 (C), 129.0 (C), 124.9 (CH), 123.3 (C), 121.3 (CH), 120.4 (CH), 118.5 (CH), 99.0 (CH), 
61.4 (OCH3), 17.7 (6 x CH3, 3 x Si(CH)CH3CH3), 12.2 (3 x CH, Si(CH)CH3CH3 ), 8.6 (CH3). IR 
(ATR): ν (cm-1) = 3476, 3378, 2943, 2892, 2866, 1611, 1558, 1588, 1542, 1502, 1461, 
1391, 1334, 1275, 1223, 1156, 1137, 1114, 1069, 1033, 997, 917, 881, 814, 740, 702, 
679. ESI-MS (+25 V): m/z = 416.3 [M+H]+, 849.6 [2M+NH4]
+. Calcd for C23H33NO4Si: C, 
66.47; H, 8.00; N, 3.37. Found: C, 66.52; H, 8.03; N, 3.39. 
 
3-Methoxy-2-methyl-8-triisopropylsilyloxy-9H-carbazole-1,4-quinone (18) 
 
N
H
H3CO
H3C
O
O
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A solution of 17 (221 mg, 0.530 mmol), Pd (OAc) 2, (5 mol %), K2CO3 (7.36 mg, 0.0530 
mmol), and pivalic acid (2000 mg) were weighed in air and transferred into a 10 mL 
bottom flask. The uncapped flask was placed in an oil bath and the mixture stirred under 
air at 120 ⁰C for 3 h. The solution was then cooled to room temperature, diluted with 
EtOAc, washed successively with saturated K2CO3, water, brine and dried over MgSO4. 
The filtrate was evaporated under reduced pressure and the crude product was purified 
by silica gel column chromatography (eluent: Pentane/EtOAc: 3/1) to afford carbazole 
quinone 18 (180 mg, 82 %) as a brown darkish solid, mp 274-276 ⁰C (Decomp). 1H NMR 
(500 MHz, chloroform-d) δ = 9.09 (br. s., 1 H, NH), 7.74 (d, J = 7.9 Hz, 1 H), 7.16 (t, J = 7.9 
Hz, 1 H, H-6), 6.81 (d, J = 7.6 Hz, 1 H), 4.15 (s, 3 H, OCH3), 2.02 (s, 3 H, CH3), 1.43 - 1.36 
(m, 3 H, Si(CH)CH3CH3), 1.15 (d, J = 7.6 Hz, 18 H, 3 x Si(CH)CH3CH3). 
13C NMR (126 MHz, 
chloroform-d) δ = 181.2, 179.4, 158.6, 143.4, 135.2, 130.4, 127.0, 126.0, 125.4, 115.7, 
115.3, 113.8, 61.7 (OCH3), 18.2, 13.1, 8.8 (CH3). ESI-MS (+10 V): m/z = 414.3 [M+H]
+, 
849.5 [2M+Na]+. Calcd for C23H31NO4Si: C, 66.79; H, 7.56; N, 3.39. Found: C, 66.82; H, 
7.60; N, 3.44. 
 
8-Hydroxy-3-methoxy-2-methyl-9H-carbazole-1,4-quinone (19) 
 
N
H
H3CO
H3C
O
O
5
7
8
9
4a
9a1
2
43 6
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8a
OH
 
 
To a solution of  18 (1.21 g, 2.93 mmol) in dry DCM (5 mL) was added 0.1 M 
tetrabutylammonium fluoride in THF (35.1 mL, 3.51 mmmol) at 0 ⁰C. After being stirred 
at the same temperature for 30 minutes, the reaction was poured into brine. The 
aqueous layer was extracted 3 times with portions of DCM. The combined extract was 
washed with brine, dried over Na2SO4, filtered and the filtrate concentrated in vacuo. 
The residue was purified by silica gel chromatography (eluent: isohexane/ethylacetate: 
3/1) to give the carbazole quinone 19 as a brown solid (396 mg, 53%), mp 266-269 ⁰C 
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(decomp). 1H NMR (500 MHz, DMSO-d6) δ = 12.67 (br. s., 1 H, NH), 10.02 (br. s., 1 H, 
OH), 7.45 (d, J = 7.9 Hz, 1 H), 7.10 (t, J = 7.7 Hz, 1 H, H-6), 6.73 (d, J = 7.6 Hz, 1 H), 4.01 (s, 
3 H, OCH3), 1.90 (s, 3 H, CH3). 
13C NMR (126 MHz, DMSO-d6) δ = 180.3 (C=O), 178.5 
(C=O), 157.6, 145.3, 135.7, 128.2, 126.5, 125.5, 125.1, 114.1, 112.0, 109.7, 61.1 (OCH3), 
8.6 (CH3). IR (ATR): ν (cm
-1) = 3056, 2916, 2012, 1976, 1940, 1905, 1794, 1738, 1633, 
1572, 1519, 1458, 1430, 1369, 1314, 1250, 1212, 1176, 1147, 1112, 1074, 1023, 976, 
934, 890, 840, 812, 756, 738, 665, 644. ESI-MS (+10 V): m/z = 258.1 [M+H]+, 532.3 
[2M+NH4]
+. Calcd for C14H11NO4: C, 65.37; H, 4.31; N, 5.44. Found: C, 65.48; H, 4.35; N, 
5.46. 
 
4-Triisopropylsilyloxyaniline (21) 
 
NH2
TIPSO
 
 
p-Aminophenol 20 (507 mg, 4.64 mmol) in DMF (6 mL) was treated with TEA (0.970 mL, 
6.96 mmol) and DMAP (283 mg, 2.32 mmol). TIPSCl (1.49 mL, 6.96 mmol) was slowly 
added and the reaction mixture was stirred at room temperature for 2 h under nitrogen 
atmosphere. The reaction was diluted with EtOAC (50 mL) and quenched with water (25 
mL). The layers were separated and the aqueous layer was extracted with EtOAc (50 
mL). The combined organic layers were washed twice with aqueous LiCl, citric acid (5% 
solution) and brine then dried over NaSO4, filtrated and the filtrate concentrated in 
vacuo. Purification by column chromatography (eluent: Pentane/EtOAc: 7/3) to afford 
the amine 21 as a brown oil (0.788 mg, 64%). 1H NMR (500 MHz, chloroform) δ = 6.74 - 
6.69 (m, 2 H), 6.60 - 6.56 (m, 2 H), 1.26 - 1.18 (m, 3 H, Si(CH)CH3CH3), 1.10 (d, J = 6.9 Hz, 
18 H, Si(CH)CH3CH3). 
13C NMR (126 MHz, chloroform) δ = 148.9 (C), 140.1 (C), 120.7 (2 x 
CH), 116.5 (2 x CH), 18.2 (6 x CH3, Si(CH)CH3CH3), 12.8 (3 x CH, Si(CH)CH3CH3). IR (ATR): ν 
(cm-1) = 3348, 3213, 3035, 2943, 2892, 2865, 1607, 1570, 1558, 1542, 1505, 1463, 1392, 
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1245, 1120, 1071, 996, 908, 881, 828, 676. ESI-MS (+10 V): m/z = 266.1 [M+H]+. Calcd for 
C15H27NOSi: C, 67.87; H, 10.25; N, 5.28. Found: C, 67.91; H, 10.31; N, 5.29. 
 
2-Methoxy-3-methyl-5-[4’-(triisopropylsilyloxy)anilino]-1,4-benzoquinone (22) 
 
 
 
Amine 21 (213 mg, 0.803 mg) and quinone 8 (244mg, 1.60 mmol) were combined in 
methanol (3 mL). The solution was stirred at room temperature for 4 h under argon. The 
resulting mixture was purified by silica gel column chromatography (eluent: 
Pentane/EtOAc: 8/1) to afford the quinone 22 (344 mg, 96 %) as a red solid, mp 143-147 
⁰C. 1H NMR (500 MHz, chloroform-d) δ = 7.38 (s, 1 H, NH), 7.09 - 7.05 (m, 2 H), 6.92 - 
6.87 (m, 2 H), 5.80 (s, 1 H, H-6), 4.14 (s, 3 H, OCH3), 1.95 (s, 3 H, CH3), 1.30 - 1.22 (m, 3 H, 
Si(CH)CH3CH3), 1.11 (d, J = 7.3 Hz, 18 H, Si(CH)CH3CH3). 
13C NMR (126 MHz, chloroform-
d) δ = 184.4 (C=O), 182.3 (C=O), 158.1 (C), 154.0 (C), 143.9 (C), 130.4 (C), 124.2 (2 x CH), 
122.8 (C), 120.8 (2 x CH), 97.7 (CH), 61.5 (OCH3), 17.9 (6 x CH3, Si(CH)CH3CH3), 12.6 (3 x 
CH, Si(CH)CH3CH3), 8.4 (CH3). IR (ATR): ν (cm
-1) = 3256, 2945, 2865, 2009, 1658, 1581, 
1540, 1500, 1416, 1376, 1342, 1281, 1266, 1210, 1156, 1137, 1107, 1065, 998, 983, 911, 
880, 843, 822, 741, 709, 618, 660. ESI-MS (+10 V): m/z = 416.3 [M+H] +, 853.6 [2M+Na] +. 
Calcd for C23H33NO4Si: C, 66.47; H, 8.00; N, 3.37. Found: C, 66.41; H, 8.03; N, 3.39. 
 
 
3-Methoxy-2-methyl-6-triisopropylsiloxy-9H-carbazole-1,4-quinone (23) 
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A solution of 22 (241 mg, 0.579 mmol), Pd (OAc) 2 (5 mol %), K2CO3 (7.99 mg, 0.0579 
mmol), and pivalic acid (2000 mg) were weighed in air and transferred into a test tube. 
The uncapped test tube was placed in an oil bath and the mixture stirred under air at 
120 ⁰C overnight. The solution was then cooled to room temperature, diluted with 
EtOAc, successively washed with saturated K2CO3, water, dried over MgSO4 and filtered. 
The filtrate was evaporated under reduced pressure and the crude product was purified 
by silica gel column chromatography (eluent: Pentane/EtOAc: 3/1) to afford carbazole 
quinone 23 (131 mg, 55 %) as a brown solid, mp 251-253 ⁰C (Decomp). 1H NMR (500 
MHz, DMSO-d6) δ = 12.80 (br. s., 1 H), 7.44 - 7.38 (m, 2 H), 6.94 (dd, J = 2.5 Hz, 8.8 Hz, 1 
H), 4.01 (s, 3 H, OCH3), 1.89 (s, 3 H, CH3), 1.30 - 1.20 (m, 3 H, Si(CH)CH3CH3), 1.08 (d, J = 
7.3 Hz, 18 H, Si(CH)CH3CH3). 
13C NMR (126 MHz, DMSO-d6) δ = 180.3 (C=O), 178.3 (C=O), 
157.8, 152.6, 136.5, 133.1, 126.4, 124.6, 120.3, 115.0, 113.2, 109.4, 61.1 (OCH3), 17.8, 
12.0, 8.5 (CH3). IR (ATR): ν (cm
-1) = 3205, 2943, 2864, 2723, 2449, 1655, 1619, 1584, 
1530, 1508, 1478, 1459, 14361389, 1373, 1304, 1284, 1250, 1206, 1133, 1105, 1074, 
1002, 962, 916, 871, 832, 817, 763, 743, 725, 681, 643. ESI-MS (+10 V): m/z = 414.3 
[M+H]+, 849.5 [2M+Na]+. Calcd for C23H31NO4Si: C, 66.79; H, 7.56; N, 3.39. Found: C, 
66.54; H, 7.47; N, 3.31. 
 
6-Hydroxy-3-methyoxy-2-methyl-9H-carbazole-1,4-quinone (24) 
 
N
H
H3CO
H3C
O
O
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To a solution of 23 (160 mg, 0.387 mmol) in dry DCM (4 mL) was added 0.1 M 
tetrabutylammonium fluoride in THF (4.64 mL, 0.464 mmol) at 0 ⁰C. After being stirred 
at the same temperature for 30 minutes, the reaction was poured into brine. The 
aqueous layer was extracted 3 times with portions of DCM. The combined extract was 
washed with brine, dried over Na2SO4, filtered and the filtrated concentrated in vacuo. 
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The residue was purified by silica gel chromatography (eluent: Isohexane/EtOAc: 3/1) to 
give the carbazole quinone 24 as a brown red solid (63 mg, 63%), mp 282-284 ºC 
(decomp). 1H NMR (500 MHz, DMSO-d6) δ = 12.66 (s, 1 H, NH), 9.49 (s, 1 H, OH), 7.35 - 
7.31 (m, 2 H), 6.86 (dd, J = 2.2, 9.1 Hz, 1 H), 4.00 (s, 3 H, OCH3), 1.88 (s, 3 H, CH3). 
13C 
NMR (126 MHz, DMSO-d6) δ = 180.0 (C=O), 178.0 (C=O), 157.6 (C), 154.7 (C), 135.6 (C), 
131.8(C), 126.2 (C), 124.6 (C), 116.8 (CH), 114.5 (CH), 112.8 (C), 104.2 (CH), 60.8 (OCH3), 
8.3 (CH3). IR (ATR): ν (cm
-1) = 3221, 1699, 1684, 1624. Calcd for C14H11NO4: C, 65.37; H, 
4.31; N, 5.44. Found: C, 65.53; H, 4.27; N, 5.52.  
 
2-Methoxy-3-methyl-5-[3’-(methoxy)anilino]-1,4-benzoquinone (26) 
 
 
 
Amine 25 (161 mg, 1.31 mmnol) and quinone 8 (400 mg, 2.63 mmol) were combined in 
methanol (5 mL). The solution was stirred at room temperature overnight under argon. 
The resulting mixture was purified by silica gel column chromatography (eluent: 
Pentane/EtOAc: 8/1) to afford quinone 26 as a brown solid (344 mg, 96 %), mp 175-175 
⁰C. 1H NMR (500 MHz, chloroform-d) δ = 7.49 (br. s., 1 H, NH), 7.29 (t, J = 8.0 Hz, 1 H), 
6.82 - 6.79 (m, 1 H), 6.75 - 6.71 (m, 2 H), 6.00 (s, 1 H, H-6), 4.15 (s, 3 H, OCH3), 3.82 (s, 3 
H, OCH3), 1.96 (s, 3 H, CH3). 
13C NMR (125 MHz, chloroform-d) δ = 184.3 (C=O), 182.5 
(C=O), 160.5 (C), 157.7 (C), 142.38 (C), 138.7(C), 130.4 (CH), 123.0 (C), 114.4 (CH), 110.8 
(CH), 108.0 (CH), 99.1 (CH), 61.5 (OCH3), 55.4 (OCH3), 8.5 (CH3). IR (ATR): ν (cm
-1) = 3312, 
2997, 2948, 2031, 1917, 1716, 1640, 1581, 1527, 1436, 1378, 1340, 1284, 1213, 1187, 
1148, 1088, 980, 862, 848, 825, 757, 716, 680, 634. ESI-MS (+25 V): m/z = 274.1 [M+H]+, 
569.1 [2M+Na]+. ESI-MS (+50 V): m/z = 291.2 [M+NH4]
+. Calcd for C15H15NO4: C, 65.92; H, 
5.53; N, 5.13. Found: C, 65.81; H, 5.50; N, 5.09. 
 
Chapter 3                            Experimental 
 
 
UCT  CHEMISTRY 83 
3,7-Dimethoxy-2-methyl-9H-carbazole-1,4-quinone (27a) 
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A solution of 26 (209 mg, 0.765 mmol), Pd (OAc)2 (5 mol %), K2CO3 (10.6 mg, 0.0765 
mmol), and pivalic acid (2000 mg) were weighed in air and transferred into a 10 mL 
bottom flask. The uncapped flask was placed in an oil bath and the mixture stirred under 
air at 120 ⁰C for 5 h. The solution was then cooled to room temperature, diluted with 
EtOAc, washed successively with saturated K2CO3, water, dried over MgSO4 and filtered. 
The filtrate was evaporated under reduced pressure and the crude product was purified 
by silica gel column chromatography (eluent: Pentane/EtOAc: 3/1) to afford carbazole 
quinone 27a (125.5 mg, 60 %) as a green solid, mp 245-247 ⁰C (Decomp). 1H NMR (500 
MHz, DMSO-d6) δ = 12.65 (br. s., 1 H, NH), 7.83 (d, J = 8.8 Hz, 1 H, H-5), 6.93 (dd, J = 2.2, 
8.5 Hz, 1 H, H-6), 6.89 (d, J = 1.9 Hz, 1 H, H-8), 3.98 (s, 3 H, OCH3), 3.80 (s, 3 H, OCH3), 
1.88 (s, 3 H, CH3). 
13C NMR (126 MHz, DMSO-d6) δ = 179.9 (C=O), 178.5 (C=O), 158.4 (C), 
157.0 (C), 138.8 (C), 135.0 (C), 126.2 (C), 122.1 (CH), 117.5 (CH), 114.9 (C), 114.0 (C), 95.0 
(CH), 60.8 (OCH3), 55.1 (OCH3), 8.4 (CH3). IR (ATR): ν (cm
-1) = 3241, 3064, 2998, 2947, 
2847, 2056, 2030, 1734, 1699, 1639, 1604, 1527, 1440, 1403, 1369, 1291, 1266, 1228, 
1191, 1159, 1099, 1025, 994, 922, 841, 815, 752, 713, 628. ESI-MS (+10 V): m/z = 272.0 
[M+H]+, 565.1 [2M+Na]+. Calcd for C15H13NO4: C, 66.41; H, 4.83; N, 5.16. Found: C, 66.35; 
H, 4.81; N, 5.13. 
 
2-Methoxy-3-methyl-5-[2’-naphthylamino]-1,4-benzoquinone (29) 
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Amine 28 (51.4 mg, 0.359 mg) and quinone 8 (99.8 mg, 0.656 mmol) were combined in 
methanol (3 mL). The solution was stirred at room temperature overnight under argon. 
The resulting mixture was purified by silica gel column chromatography (eluent: 
Pentane/EtOAc: 8/1) to afford quinone 29 (77.4 mg, 74 %) as a brown darkish solid, mp 
189-191 ⁰C. 1H NMR (500 MHz, chloroform-d) δ = 7.86 (d, J = 8.8 Hz, 1 H), 7.83 (d, J = 8.2 
Hz, 1 H), 7.79 (d, J = 8.2 Hz, 1 H), 7.71 (br. s., 1 H, NH), 7.66 (d, J = 1.9 Hz, 1 H), 7.52 (dt, J 
= 1.3, 7.6, 7.6 Hz, 1 H), 7.49 - 7.45 (m, 1 H), 7.32 (dd, J = 2.2, 8.8 Hz, 1 H), 6.16 (s, 1 H, H-
6), 4.17 (s, 3 H, OCH3), 1.99 (s, 3 H, CH3). 
13C NMR (126 MHz, chloroform-d) δ = 184.3 
(C=O), 182.7 (C=O), 157.8 (C), 142.8 (C), 135.0 (C), 133.7 (C), 130.9 (C), 129.7 (CH), 127.8 
(CH), 127.4 (CH), 127.1 (CH), 125.8 (CH), 123.1 (C), 121.4 (CH), 118.7 (CH), 99.1 (CH), 
61.5 (OCH3), 8.5 (CH3). IR (ATR): ν (cm
-1) = 3206, 3061, 3006, 2951, 2853, 2057, 1698, 
1642, 1563, 1484, 1452, 1360, 1328, 1267, 1215, 1158, 979, 897, 843, 817, 785, 718, 
745, 664. ESI-MS (+10 V): m/z = 294.1 [M+H]+, 609.1 [2M+Na]+. Calcd for C18H15NO3: C, 
73.71; H, 5.15; N, 4.78. Found: C, 73.76; H, 5.16; N, 4.82. 
 
10-methoxy-9-methyl-7H-benzo[c]carbazole-8,11-dione (30a) 
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A solution of amine 29 (447 mg, 1.52 mmol), Pd (OAc)2 (10 mol %), K2CO3 (21.1 mg, 
0.152 mmol), and pivalic acid (3500 mg) was weighed in air and transferred into a 10 mL 
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bottom flask. The uncapped flask was placed in an oil bath and the mixture stirred under 
air at 120 ⁰C overnight. The solution was then cooled to room temperature, diluted with 
EtOAc, successively washed with saturated K2CO3, water, dried over MgSO4 and filtered. 
The filtrate was evaporated under reduced pressure and the crude product was purified 
by silica gel column chromatography (eluent: Pentane/EtOAc: 3/1) to afford carbazole 
quinone 30a (33.6 mg, 8 %) as a black solid mp 292-294 ⁰C. 1H NMR (500 MHz ,DMSO-d6) 
δ = 13.33 (br. s., 1 H), 9.64 (d, J = 8.2 Hz, 1 H), 7.99 (d, J = 8.2 Hz, 1 H), 7.85 (d, J = 9.1 Hz, 
1 H), 7.63 (d, J = 9.1 Hz, 1 H), 7.58 - 7.53 (m,1 H), 7.48 - 7.37 (m, 1 H), 4.05 (s, 3 H, OCH3), 
1.95 (s, 3 H, CH3). 
13C NMR (126 MHz, DMSO-d6) δ = 180.0, 178.0, 158.4, 135.7, 135.0, 
130.7, 128.9, 128.2, 128.0, 126.7, 126.6, 126.4, 125.5, 119.9, 116.4, 114.0, 61.2 (OCH3), 
8.5 (CH3). IR (ATR): ν (cm
-1) = 3226, 3134, 305, 951, 2850, 1917, 1717, 1623, 1542, 1508, 
1457, 1421, 1395, 1367, 1322, 1281, 1249, 1207, 1104, 997, 978, 932, 863, 806, 743, 
679, 662, 636, 618. ESI-MS (+10 V): m/z = 292.0 [M+H]+, 600.1 [2M+NH4]
+, 605.2 
[2M+Na]+. Calcd for C18H13NO3: C, 74.22; H, 4.50; N, 4.81. Found: C, 74.29; H, 4.46; N, 
4.80.  
 
Trifluoromethanesulfonyl azide (32) 
 
 
Sodium azide (39.0 g, 600 mmol) was dissolved in water (100 mL) before toluene (100 
mL) was added and the mixture stirred at 0 ⁰C. Triflic anhydride (40 mL, 238 mmol) was 
added drop-wise and stirring continued for 30 min, after which the temperature was 
raised to 10 ⁰C and the biphasic mixture stirred for a further 2 h. Saturated NaHCO3 was 
added until effervescence ceased. The organic phase was separated and the aqueous 
phase extracted with toluene (2 x 50 mL). The extracts were combined to form the stock 
solution of triflic azide (maximum possible concentration ~ 1.15 M). Note: this reagent is 
shock-sensitive and should be handled with care. 
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1,3,4,6-Tetra-O-acetyl-2-azido-2-deoxy-β-D-glucopyranoside (34) 
 
O
AcO
N3
AcO
OAc
OAc
 
 
Glucosamine hydrochloride 33 (30g, 139 mmol), NaHCO3 (46.7 g, 556 mmol) and 
CuSO4.5H2O (1.40 g, 5.60 mmol) were dissolved in H2O (92.4 mL). A portion of triflic 
azide 32 stock solutions (157 mL) was added, followed by the addition of MeOH (610 
mL) to yield a homogeneous mixture that was stirred at room temperature for 15 h. 
Over the course of the reaction, the colour of the solution changed from blue to green. 
The solvents were removed under reduced pressure, and the residue left to dry on a 
high vacuum pump for 3 days. The residue was then dissolved in dry pyridine (100 mL) 
and cooled to 0 ⁰C. Acetic anhydride (100 mL) was added drop-wise to the solution, 
which was stirred for 30 min at 0 ⁰C before being warmed to room temperature and left 
to stir for a further 17 h until complete consumption of the starting material. The 
solvents were removed under reduced pressure, and the crude residue dissolved in 
EtOAc (1 L) and washed with H2O (2 x 500 mL). The aqueous fractions were extracted 
with EtOAc (2 x 500 mL), and the combined organic fractions were dried (Na2SO4) and 
reduced under reduced pressure. The syrupy residue was purified by column 
chromatography (silica gel, eluting in petroleum ether /EtOAc: 7/3) to obtain the 
product as a white precipitate of α/β isomers (46.3 g, 89 %). The β isomer was obtained 
by recrystallisation of the purified product mixture in EtOAc/Pet Ether and used for 
analysis, m.p. 93-94 ⁰C (β-isomer), lit.23 m.p. 96-97 ⁰C. 1H NMR (300 MHz, CDCl3) β-
isomer: δ 5.55 (d, J = 8.6, 1H, H-1), 5.06 (m, 2H, H-3, H-4), 4.29 (dd, J = 4.6, 12.5, 1H, H-
6), 4.08 (dd, J = 2.2, 12.5, 1H, H-6’), 3.83 – 3.77 (m, 1H, H-5), 3.70 –3.61 (m, 1H, H-2), 
2.18 (s, 3H, CH3, OAc), 2.08 (s, 3H, CH3, OAc), 2.06 (s, 3H, CH3, OAc), 2.01 (s, 3H, CH3, 
OAc). 13C NMR (75 MHz, CDCl3) β-isomer: δ 170.5 (C=O), 169.7 (C=O), 169.6 (C=O), 168.5 
(C=O), 92.6, 72.8, 72.7, 67.8, 62.6, 61.4, 20.8 (CH3, OAc), 20.6 (CH3, OAc), 20.6 (CH3, 
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OAc), 20.5 (CH3, OAc).  IR (NaCl, dry film) νmax (cm-1): 2115 (N3), 1756 (C=O). Anal. 
Calcd for C14H19N3O9: C, 45.04; H, 5.13; N, 11.26. Found: C, 45.33; H, 5.26; N, 10.91. 
 
Phenyl 3,4,6-tri-O-acetyl-2-amino-2-deoxy-1-thio-α-D-glucopyranoside (35a) 
 
 
 
The azide 34 (10.0 g, 26.8 mmol) was dissolved in dry CH2Cl2 (40 mL) and cooled to 0 
⁰C. 
To this solution, BF3.OEt2 (15.3 mL, 121 mmol) was added drop-wise and the solution 
left stirring for 30 minutes to form the oxocarbenium ion intermediate. Thiophenol 
(4.13 mL, 40.2 mmol) was then added dropwise and the solution allowed to warm to 
room temperature, before the temperature was increased and the solution refluxed for 
14 hours until the reaction was complete (determined by TLC). After cooling to room 
temperature, crushed ice was added and the reaction mixture extracted with CH2Cl2 (2 x 
150 mL). The CH2Cl2 extract was washed with 150 mL water, dried over Na2SO4, filtered 
and the filtrate concentrated in vacuo. Purification by column chromatography (Pet 
Ether/EtOAc: 8/2) to yield the product as a mixture of isomers (α/β:3/1, 9.03 g, 80%, 
lit.23). Pure crops of the α-thioglycoside were isolated by crystallisation from EtOH and 
obtained as white needles (5.19 g, 46 %), however, further separation of the isomers 
was not possible and the mother liquor remained as a mixture, m.p. 93-95 ºC. 1H NMR 
(400 MHz, CDCl3) δ = 7.45 – 7.40 (m, 2 H, Aromatic CH), 7.28 – 7.21 (m, 3 H, Aromatic 
CH), 5.56 (d, J = 5.6 Hz, 1 H, H-1), 5.26 (dd, J = 9.2, 10.6 Hz, 1 H, H-3), 4.96 (dd, J = 9.2, 
10.3 Hz, 1 H, H-4), 4.52 (ddd, J = 2.2, 5.0, 10.3 Hz, 1 H, H-5), 4.21 (dd, J = 5.2, 12.4 Hz, 1 
H, H-6’), 3.99 (dd, J = 5.6, 10.6 Hz, 1 H, H-2), 3.96 (dd, J = 2.3, 12.3 Hz, 1 H, H-6), 2.02 (s, 3 
H, CH3, OAc), 1.98 (s, 3 H, CH3, OAc), 1.95 (s, 3 H, CH3, OAc). 
13C NMR (101 MHz, CDCl3) δ 
= 170.4 (C=O), 169.7 (2 x C=O), 132.5 (Aromatic C), 132.2 (2 C, Aromatic CH), 129.2 (2 C, 
Aromatic CH), 128.1 (Aromatic CH), 86.6 (C-1), 72.1 (C-3), 68.9 (C-4), 68.6 (C-5), 62.0 (C-
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6), 61.7 (C-2), 20.6 (2 x CH3, 2 OAc), 20.6 (CH3, OAc). IR (NaCl, dry film) νmax (cm-1): 
2111 (N3), 1750 (C=O). EI-MS m/z: [M]
+ Calcd for C18H21N3O7S: 423.11; Found: 423.06. 
 
Phenyl 3,4,6-tri-O-acetyl-2-amino-2-deoxy-1-thio-α-D-glucopyranoside (36) 
 
 
 
Pd/C (10 wt %, 125 mg) was added to a round-bottomed flask before the sides of the 
flask were washed down with Et2O (5 mL). 35 (500 mg, 1.18 mmol) was added to the 
suspension, and the atmosphere of the flask flushed with H2 gas. The solution was 
stirred at room temperature under a H2 atmosphere (provided by a balloon) for 24 h. 
The mixture was filtered through a plug of Celite and the solvent removed at room 
temperature under reduced pressure. The product (482 mg, 1.21 mmol) was obtained in 
quantitative yield as syrup, which was then crystallised from Pet Ether/EtOAc and 
obtained as a colourless needles, mp 84-87 ⁰C. 1H NMR (300 MHz, CDCl3) δ = 7.60 – 7.43 
(m, 2H, Aromatic CH), 7.38 – 7.20 (m, 3 H, Aromatic CH), 5.56 (d, J = 5.2 Hz, 1 H, H-1), 
5.10 – 4.95 (m, 2 H, H-3, H-4), 4.56 (ddd, J = 2.2, 5.0, 9.7 Hz, 1 H, H-5), 4.32 (dd, J = 5.1, 
12.3 Hz, 1 H, H-6), 4.07 (dd, J = 2.3, 12.3 Hz, 1 H, H-6’), 3.32 (dd, J = 5.2, 10.2 Hz, 1 H, H-
2), 2.09 (s, 3 H, CH3, OAc), 2.04 (s, 6 H, 2 x CH3, OAc). 
13C NMR (75 MHz, CDCl3) δ = 170.7 
(C=O), 170.6 (C=O), 169.8 (C=O), 133.5 (Aromatic C), 131.9 (2 C, Aromatic CH), 129.1 (2 
C, Aromatic CH), 127.8 (Aromatic CH), 91.3 (C-1), 74.7 (C-3), 69.0 (2 C, C-4,C-5), 62.3 (C-
6), 55.2 (C-2), 20.8 (CH3, OAc), 20.7 (2 x CH3, OAc). EI-MS m/z: [M]
+ Calcd for C18H23NO7S: 
397.12; Found 397.14. HRMS (ESI-TOF): Calcd for C18H23NO7S, 397.1195; Found 
398.1265 [M+H]+, 420.1087 [M+Na]+. 
 
Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-2-[4”-(4’,9’-dihydro-3’-methoxy-2’-methyl-1’,4’-
dioxo-1H-carbazol-6’-yl)butanamido]-1-thio-α-D-glucopyranoside (37)  
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A solution of 11 (40.4 mg, 0.123 mmol), EDC.HCl (35.4 mg, 0.185 mmol), HOBt (16.6 mg, 
0.123 mmol) and DIEA (94 μL, 0.55 mmol) in THF (4 mL) at 0 ⁰C under argon was stirred for 
1 h. A freshly prepared solution of 36 (93.9 mg, 0.236 mmol) in THF (1.5 mL) was added to 
the mixture and left overnight at room temperature. A precipitate formed and was 
isolated by filtration, then washed with methanol and dried under reduced vacuum to 
afford 37 (44.9 mg, 52%) as a pale orange solid, mp 238-240 ⁰C (decomp). 1H NMR (500 
MHz, chloroform-d) δ = 9.47 (s, 1 H, NH), 7.98 (s, 1 H), 7.46 - 7.42 (m, 2 H), 7.37 (d, J = 8.5 
Hz, 1 H), 7.32 - 7.28 (m, 3 H), 7.19 (dd, J = 1.6, 8.5 Hz, 1 H), 5.92 (d, J = 8.8 Hz, 1 H, NHCO), 
5.73 (d, J = 5.4 Hz, 1 H, H-1), 5.21 - 5.13 (m, 2 H, H-3, H-4), 4.67 - 4.59 (m, 1 H, H-2), 4.55 - 
4.49 (m, 1 H, H-5), 4.29 (dd, J = 4.9, 12.5 Hz, 1 H, H-6a), 4.16 (s, 3 H, OCH3), 4.09 (dd, J = 
2.2, 12.3 Hz, 1 H, H-6b), 2.76 (t, J = 7.4 Hz, 2 H, CH2), 2.26 - 2.21 (m, 2 H, CH2), 2.07 (s, 3 H, 
OAc), 2.05 (s, 3 H, OAc), 2.01 (s, 3 H, OAc), 1.99 (CH3), 2.01 - 1.94 (m, 2 H, CH2). 
13C NMR 
(125 MHz, chloroform-d) δ = 181.0 (C=O), 179.1 (C=O), 172.7 (C=O), 171.7 (C=O), 170.7 
(C=O), 169.3 (C=O), 158.3 (C), 137.7 (C), 135.8 (C), 135.7 (C), 132.8 (C), 131.6 ( 2 x CH), 
129.2 (2 x CH), 127.9 (CH), 127.7 (CH), 126.6 (CH), 124.5 (CH), 121.7 (CH), 114.5 (CH), 
112.8 (CH), 87.7 (C-1), 71.3 (C-3), 68.9 (C-5), 68.1 (C-4), 62.0 (C-6), 61.5 (OCH3), 52.6 (C-2), 
35.9 (CH2), 35.2 (CH2), 27.4 (CH2), 20.8 (CH3, OAc),  20.7 (CH3, OAc), 20.6 (CH3, OAc), 8.5 
(CH3). IR (ATR): ν (cm
-1) = 3313, 3217, 3071, 3004, 2948, 2851, 1741, 1647, 1626, 1590, 
1536, 1481, 1434, 1375, 1296, 1223, 1090, 1037, 1007, 956, 905, 819, 763, 744, 687, 602, 
578. (UV) (MeOH): λ (nm) = 202, 229, 251 (sh), 259, 269 (sh), 284 (sh), 311, 404. ESI-MS 
(+50 V): m/z = 707.5 [M+H]+, 724.5 [M+NH4]
+, 729.5 [M+Na]+. ESI-MS (-50 V): m/z = 705.1 
[M-H]–. Calcd for C36H38N2O11S: C, 61.18; H, 5.42; N, 3.96; S, 4.54. Found: C, 61.37; H, 5.55; 
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N, 4.11; S, 5.01.  
 
Phenyl 2-deoxy-2-[4”-(4’,9’-dihydro-3’-methoxy-2’-methyl-1’,4’-dioxo-1H-carbazol-6’-
yl)butanamido]-1-thio-α-D-glucopyranoside (38)  
 
 
Methanolic solution of sodium methoxide (0.5M, 72 μL, 0.036 mmol) was added to a 
stirred solution of 37 (51 mg, 0.072 mmol) in dry methanol (2 mL) and the reaction 
mixture was stirred overnight at room temperature. A precipitate formed and was 
isolated by filtration, then washed with methanol and dried under reduced vacuum to 
afford 38 (44.9 mg, 95%) as an orange solid, mp 267-269 ⁰C (decomp). 1H NMR (500MHz, 
chloroform-d) δ = 8.06 (d, J = 6.6 Hz, 1 H, NH), 7.79 (s, 1 H), 7.45 - 7.38 (m, 3 H), 7.32 - 
7.20 (m, 3 H), 7.16 (d, J = 8.5 Hz, 1 H), 5.65 (d, J = 5.0 Hz, 1 H, H-1), 5.19 (br. s., 1 H, OH-
3), 4.94 (br. s., 1 H, OH-4), 4.58 (br. s., 1 H, OH-6), 4.01 (s, 3 H, OCH3), 3.89 - 3.82 (m, 2 H, 
H-2, H-5), 3.65 - 3.59 (m, 1 H, H-6a), 3.58 - 3.52 (m, 1 H, H-6b), 3.48 - 3.42 (m, 1 H, H-4), 
3.26 (d, J = 9.8 Hz, 1 H, H-3), 2.68 (t, J = 6.8 Hz, 2 H, CH2), 2.18 (td, J = 7.3, 11.8 Hz, 2 H, 
CH2), 1.89 (s, 3 H, CH3), 1.87 - 1.78 (m, 2 H, CH2).  
13C NMR (125 MHz, DMSO-d6) δ = 
180.9 (C=O), 178.2 (C=O), 172.6 (C=O), 157.8 (C), 137.7 (C), 135.1 (C), 131.2 (3 x CH), 
129.0 (4 x CH), 127.0 (CH), 126.3 (CH), 124.1 (CH), 120.3 (CH), 113.4 (CH), 87.7 (C-1), 74.3 
(C-5), 70.7 (C-4), 70.5 (C-3), 61.0 (OCH3), 60.1 (C-6), 60.4 (C-2), 54.8 (CH), 34.9 (CH2), 34.8 
(CH2), 27.6 (CH2), 8.5 (CH3). IR (ATR): ν (cm
-1) = 3398, 3284, 3220, 2948, 2923, 2048, 
2030, 1629, 1591, 1537, 1479, 1450, 1433, 1377, 1296, 1278, 1224, 1207, 1106, 1071, 
1046, 1007, 957, 920, 819, 763, 741, 686, 613, 549.  (UV) (MeOH): λ (nm) = 202, 228, 
250 (sh), 259, 267 (sh), 280 (sh), 311, 407. ESI-MS (+50 V): m/z = 581.3 [M+H]+, 603.3 
Chapter 3                            Experimental 
 
 
UCT  CHEMISTRY 91 
[M+Na]+. ESI-MS (-50 V): m/z = 579.0 [M-H]-. Calcd for C30H32N2O8S: C, 62.05; H, 5.55; N, 
4.82; S, 5.52. Found: C, 61.89; H, 6.07; N, 4.70; S, 5.70. (ESI-HRMS): [M+Na]+ calcd for 
C30H32N2NaO8S: 603.1777; found: 603.1789. 
 
Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-2-[3”-(4’,9’-dihydro-3’-methoxy-2’-methyl-1’,4’-
dioxo-1H-carbazol-7’-yl)propanamido]-1-thio-α-D-glucopyranoside (39) 
 
  
 
A solution of 14 (40.4 mg, 0.160 mmol), EDC.HCl (46 mg, 0.24 mmol), HOBt (21mg, 0.16 
mmol) and DIEA (123 μL, 0.720 mmol) in THF (4 mL) at 0 ⁰C under argon was stirred for 1 
h. A freshly prepared 36 (93.9 mg, 0.236 mmol) in 1.5 mL was added to the mixture and 
left overnight at room temperature. A precipitate formed and was isolated by filtration, 
then washed with methanol and dried under reduced vacuum to afford 39 (67 mg, 60%) 
as a red dark solid, mp 240-241 ⁰C (decomp). 1H NMR (500MHz, chloroform-d) δ = 8.04 
(d, J = 8.5 Hz, 1 H, NH), 7.36 - 7.30 (m, 3 H), 7.29 (m, 2 H), 7.27 - 7.25 (m, 2 H), 7.17 (dd, J 
= 1.4, 8.4 Hz, 1 H), 5.93 (d, J = 8.5 Hz, 1 H, NHCO), 5.66 (d, J = 5.4 Hz, 1 H, H-1), 5.17 - 
5.06 (m, 2 H, H-3, H-4), 4.62 - 4.56 (m, 1 H, H-2), 4.47 (dt, J = 2.8, 4.9 Hz, 1 H, H-5), 4.26 
(dd, J = 5.0, 12.3 Hz, 1 H, H-6a), 4.15 (s, 3 H, OCH3), 4.05 (dd, J = 2.2, 12.3 Hz, 1 H, H-6b), 
3.06 (q, J = 7.4 Hz, 2 H, CH2), 2.63 - 2.56 (m, 2 H, CH2), 2.05 (s, 3 H, OAc), 2.03 (s, 3 H, 
OAc), 2.01 (s, 3 H, OAc), 1.93 (s, 3 H, CH3). 
13C NMR (125 MHz, chloroform-d) δ = 180.9 
(C=O), 179.0 (C=O), 171.8 (C=O), 171.8 (C=O), 170.6 (C=O), 169.3 (C=O), 158.1 (C), 139.2 
(C), 137.3 (C), 135.6 (C), 132.6 (C), 131.1 (CH), 131.1 (CH), 129.3 (CH), 129.2 (CH), 129.2 
(CH), 127.7 (CH), 126.7 (CH), 125.1 (CH), 122.6 (C), 114.7 (C), 112.4 (CH), 87.2 (CH), 71.2 
(CH), 68.8 (CH), 68.0 (CH), 61.9 (CH), 61.5 (CH3), 52.6 (CH), 37.9 (CH2), 31.6 (CH2), 20.7 
(CH3), 20.6 (CH3), 20.6 (CH3), 8.5 (CH3). IR (ATR): ν (cm
-1) = 3255, 3061, 2935, 2850, 1741, 
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1627, 1538, 1436, 1370, 1219, 1161, 1095, 1035, 997, 913, 825, 742, 689, 596. (UV) 
(MeOH): λ (nm) = 202, 229, 253 (sh), 260, 269 (sh), 281 (sh), 314, 392. ESI-MS (+50 V): 
m/z = 693.4 [M+H]+, 715.4 [M+Na]+. ESI-MS (-25 V): m/z = 691.1 [M-H]–. Calcd for 
C35H36N2O11S: C, 60.68; H, 5.24; N, 4.04; S, 4.63. Found: C, 61.02; H, 5.32; N, 3.91; S, 
4.74. 
 
Phenyl 2-deoxy-2-[3-(4,9-dihydro-3-methoxy-2-methyl-1,4-dioxo-1H-carbazol-7-
yl)propanamido]-1-thio-α-D-glucopyranoside (40)  
 
 
 
Methanolic solution of sodium methoxide (0.5M, 172 μL, 0.0867 mmol) was added to a 
stirred solution of 39 (30 mg, 0.0433 mmol) in dry methanol (2 mL) and the reaction 
mixture was stirred overnight at room temperature. A precipitate formed and was 
isolated by filtration, then washed with methanol and dried under vacuum to afford 40 
(19.9 mg, 96%) as a red solid, mp 276-280 ⁰C (decomp). 1H NMR (500 MHz, DMSO-d6) δ 
= 7.89 (d, J = 6.9 Hz, 1 H, NH), 7.41 (d, J = 7.3 Hz, 2 H), 7.37 - 7.29 (m, 3 H), 7.27 (d, J = 7.3 
Hz, 1 H), 7.14 (d, J = 7.9 Hz, 1 H), 7.11 - 7.06 (m, 1 H), 5.60 (d, J = 5.4 Hz, 1 H, H-1), 5.18 
(d, J = 5.7 Hz, 1 H, OH), 4.89 (d, J = 6.0 Hz, 1 H, OH), 4.58 (t, J = 5.8 Hz, 1 H, OH), 4.00 (s, 3 
H, OCH3), 3.91 - 3.84 (m, 2 H), 3.61 - 3.37 (m, 5 H), 3.29 - 3.23 (m, 2 H), 2.46 - 2.40 (m, 2 
H), 1.91 (s, 3 H, CH3). 
13C NMR (125 MHz, DMSO-d6) δ = 180.7 (C=O), 177.2 (C=O), 172.1 
(C=O), 158.7 (C), 138.2 (C), 136.8 (C), 136.4 (C), 135.1 (C), 131.3 (CH), 131.3 (CH), 129.0 
(C), 128.9 (C), 128.9 (CH), 127.0 (CH), 126.1 (CH), 125.1 (CH), 123.0 (CH), 114.3 (C), 111.6 
(CH), 87.8 (CH), 74.3 (CH), 70.8 (CH), 70.6 (CH), 61.3 (OCH3), 60.4 (C-6), 54.7 (CH), 37.3 
(CH2), 30.8 (CH2), 8.3 (CH3). IR (ATR): ν (cm
-1) = 3249, 3061, 2925, 2048, 2030, 2009, 
1658, 1629, 1577, 1532, 1475, 1446, 1377, 1337, 1299, 1261, 1110, 1063, 1026, 997, 
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931, 855, 786, 741, 687, 629, 609, 554. (UV) (MeOH): λ (nm) = 202, 228, 254 (sh), 262, 
271 (sh), 282 (sh), 315, 390. ESI-MS (+25 V): m/z = 567.3 [M+H]+, 589.3 [M+Na]+. ESI-MS 
(-25 V): m/z = 656.0 [M-H]–. Calcd for C29H30N2O8S: C, 61.47; H, 5.34; N, 4.94; S, 5.66. 
Found: C, 61.60; H, 5.40; N, 4.87; S, 5.51. (ESI-HRMS): [M+Na]+ calcd for C29H30N2NaO8S: 
589.1621; found: 589.1632. 
 
3,4,5-tri-O-benzyl-D-glucal (42) 
 
O
OBn
BnO
BnO 1
2
3
4
5
6
 
 
To a solution of 3,4,5-tri-O-acetyl-D-glucal 40 (10.0 g, 36.7 mmol) in THF (60 mL) were 
added powdered NaOH (8.92 g, 22.3 mmol), TBAI (360 mg, 0.975 mmol), and benzyl 
bromide (19.8 mL, 167 mmol) successively and the reaction mixture was allowed to stir 
briskly for 5 h at room temperature. After the TLC showed completed conversion, the 
reaction mixture was poured into water and extracted with CH2Cl2. The organic layer was 
washed with water, dried over Na2SO4, and concentrated under reduced vacuum. The 
resulting crude mixture was purified by silica gel column chromatography (eluent: 
Hexane/EtOAc: 10/1) to afford benzylated glycal 42 as a colourless oil (14.1 mg, 92%, 
lit.29). 1H NMR (400 MHz, chloroform-d) δ = 7.35 - 7.23 (m, 15 H, Aromatic CH), 6.43 (d, J = 
6.0 Hz, 1 H, H-1), 4.88 (dd, J = 2.7, 6.1 Hz, 1 H, H-2), 4.84 (d, J = 11.5 Hz, 1 H, CH2-Ph ), 4.68 
- 4.53 (m, 5 H, CH2-Ph), 4.24 - 4.19 (m, 1 H, H-3), 4.10 - 4.04 (m, 1 H, H-4), 3.87 (dd, J = 6.2, 
8.6 Hz, 1 H, H-5), 3.84 - 3.74 (m, 2 H, H-6, H-6’). 13C NMR (101 MHz, chloroform-d) δ = 
144.7 (C-1), 138.4, 138.3, 138.1 (3 x Aromatic C), 128.4, 127.9, 127.8, 127.7, 127.6 
(Aromatic CH), 100.0 (C-2), 76.8 (C-4), 75.8 (C-3), 74.5 (C-5), 73.7, 73.5, 70.5 (3 x CH2-Ph), 
68.6 (C-6). (ESI-HRMS): [M+Na]+ calcd for C27H28NaO4: 439.1885; found: 439,1832.  
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Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[bis-(methoxycarbonyl)methyl]-β-D-
glucopyranoside (43) 
 
 
 
A solution of benzyl-protected glycal 42(4.02 g, 10.0 mmol), dimethyl malonate (11.5 mL, 
100 mmol) and NaHCO3 (3.36 g, 40.0 mmol) in dry methanol (35 mL) was cooled to 0 
⁰C 
under argon atmosphere. At this temperature, a solution of CAN (22.1 g, 40.3 mmol), 
which was dried in a desiccator under high vaccum overnight in methanol (50 mL) was 
added dropwise over a period of 7 h until the TLC showed completed conversion of the 
starting material. After stirring for 3 min at 0 ⁰C, an ice-cold diluted solution of sodium 
thiosulfate (350 mL) was added, and the mixture was extracted with CH2Cl2 (3 x 100 mL). 
The combined organic phases were dried Na2SO4, filtered and the filtrate concentrated in 
vacuo, and the excess of malonate was removed at 0.01 mbar in a kugelrohr. The resulting 
crude mixture was purified by silica gel column chromatography (eluent: Hexane/EtOAc: 
7/3) to afford malonate 43 as a colourless oil (5.08 g, 91%, lit.30). 1H NMR (400 MHz, 
chloroform-d) δ  = 7.32 - 7.17 (m, 13 H, Aromatic CH), 7.13 - 7.06 (m, 2 H, Aromatic CH), 
4.83 (d, J = 11.0 Hz, 1 H, CH2-Ph), 4.74 (d, J = 11.0 Hz, 1 H, CH2-Ph), 4.67 (d, J = 8.8 Hz, 1 H, 
H-1), 4.61 - 4.46 (m, 4 H, CH2-Ph), 3.85 (d, J = 3.8 Hz, 1 H, H-7), 3.75 (d, J = 8.4 Hz, 1 H, H-
4), 3.69 (br.s., 2 H, H-6, H-6’), 3.62 (s, 3 H, COOCH3), 3.60 (br. s., 1 H, H-3), 3.51 (s, 3 H, 
COOCH3), 3.45 (dd, J = 2.1, 5.4 Hz, 1 H, H-5), 3.39 (s, 3 H, OCH3), 2.48 - 2.39 (m, 1 H, H-2). 
IR (KBr, dry film) νmax (cm-1) = 1734 (C=O), 1607 (C=C), 1052 (C-O). (ESI-HRMS): [M+NH4]
+ 
calcd for C33H38NO9: 596.2860; found: 596.286.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[( methoxycarbonyl)methyl]-β-D-
glucopyranoside (44) 
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A solution of the malonate 43 (4.29 g, 7.41 mmol) and lithium iodide (1.98 g, 14.8 mmol) 
in DMSO (20 mL) was heated at 180 ⁰C for 2.5 h. DMSO was removed at 0.01 mbar and the 
crude product was purified by silica gel column chromatography (eluent: Hexane/EtOAc: 
4/1) to afford the ester 44 as a colourless oil (3.67 g, 95%, lit.30). 1H NMR (400 MHz, 
chloroform-d) δ = 7.35 - 7.21 (m, 13 H, Aromatic CH), 7.18 - 7.13 (m, 2 H, Aromatic CH ), 
4.88 (d, J = 11.2 Hz, 1 H, CH2-Ph), 4.75 (d, J = 11.0 Hz, 1 H, CH2-Ph), 4.64 - 4.52 (m, 4 H, 
CH2-Ph), 4.27 (d, J = 8.6 Hz, 1 H, H-1), 3.74 - 3.71 (m, 2 H, H-6, H-6’), 3.60 (d, J = 9.3 Hz, 1 H, 
H-4), 3.53 (s, 3 H, COOCH3), 3.51 (d, J = 2.2 Hz, 1 H, H-3), 3.48 (d, J = 9.2 Hz, 1 H, H-5), 3.45 
(s, 3 H, OCH3), 2.47 (dq, J = 5.6, 15.4 Hz, 2 H, H-7, H-7’), 2.17 - 2.08 (m, 1 H, H-2). IR (KBr, 
dry film) ν max (cm-1) = 1756 (C=O), 1600 (C=C), 1057 (C-O). (ESI-HRMS): [M+NH4]
+ calcd 
for C31H40NO7: 538.2805; found: 538.2806.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(N-methoxy-N-methylcarbonyl)methyl]-β-D-
glucopyranoside (45) 
 
 
A solution of the ester 44 (1.42 g, 2.73 mmol) and LiOH.H2O (1.15 g, 27.3 mmol) in 
MeOH/H2O (4/1: 15 mL) was heated under reflux until TLC showed complete conversion 
of the starting material. After cooling to room temperature, the pH value was adjusted 
to 3-4 with Amberlite IR-120, and the solvent was removed. The crude product was 
treated with 2-chloro-4,6-dimethoxy-1,3,5-triazine (612 mg, 3.49 mmol) and N-
methylmorpholine (881 μL, 8.01 mmol) in THF (20 mL). A white precipitate was formed 
during stirring for 1 h, and N,O-dimethylhydroxylamine hydrochloride (300 mg, 3.08 
mmol) was added. The mixture was stirred overnight and then quenched with H2O (10 
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mL) and extracted with diethyl ether (3 X 5 mL). The combined organic phases were 
washed with saturated aqueous Na2CO3 (5 mL) followed by 1N HCl (6 mL) and brine (6 
mL). The organic layer was dried over anhydrous Na2SO4, filtered and the filtrate 
concentrated in vacuo. The resulting crude mixture was purified by silica gel column 
chromatography (eluent: Hexane/EtOAc: 4/1) to afford 45 as a colourless oil (1.14 g, 
76%). 1H NMR (400 MHz, chloroform-d) δ = 7.32 - 7.17 (m, 13 H, Aromatic CH), 7.15 - 
7.09 (m, 2 H, Aromatic CH), 4.84 (d, J = 11.2 Hz, 1 H, CH2-Ph ), 4.72 (d, J = 11.0 Hz, 1 H, 
CH2-Ph), 4.61 - 4.48 (m, 4 H, CH2-Ph), 4.45 (d, J = 8.6 Hz, 1 H, H-1), 3.82 - 3.77 (m, 1 H, H-
3), 3.73 (d, J = 3.7 Hz, 1 H, H-6), 3.69 - 3.64 (m, 1 H, H-6’), 3.59 - 3.55 (m, 1H, H-4), 3.53 
(s, 3 H, OCH3), 3.46 (td, J = 3.1, 9.8 Hz, 1 H, H-5), 3.41 (s, 3 H, NOCH3), 3.03 (s, 3 H, NCH3), 
2.60 (t, J = 5.4 Hz, 2 H, H-7, H-7’), 2.17 - 2.08 (m, 1 H, H-2). 13C NMR (101 MHz, 
chloroform-d) δ = 172.54 (C=O), 138.7, 138.3, 138.3, 138.3 (Aromatic C), 128.4, 128.3, 
127.8, 127.7, 127.6, 127.5 (Aromatic CH), 103.3 (C-1), 82.0 (C-3), 80.0 (C-4), 75.1 (C-5), 
74.5, 74.5, 73.5 (3 X CH2-Ph), 69.2 (C-6), 61.1 (OCH3), 56.7 (OCH3), 44.5 (C-2), 32.4 
(NCH3), 28.7 (C-7). IR (KBr, dry film) νmax (cm
-1) = 1646 (C=O), 1265 (C-N). (ESI-HRMS): 
[M+H]+ calcd for C32H40O7: 550.2805; found 550.2799.  
 
2-Bromo-1,3,4-trimethoxybenzene (46) 
 
 
 
n-Butyl lithium in hexanes (2.5 M, 4.04 mL, 10.1 mmol) was added dropwise to a solution 
of 1,2,4–trimethoxybenzene 6 (1.54 g, 9.16 mmol) in anhydrous ether (25 mL) at -10 ⁰C 
under an argonium atmosphere. A white precipitate was formed. The reaction mixture 
was stirred additionally for 1.5 h at room temperature. Then CBr4 (3.35 g, 10.1 mmol) 
dissolved in anhydrous ether (10 mL) was added dropwise at -10 ⁰C under an argonium 
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atmosphere, and the mixture was allowed to stir overnight. The reaction was extracted 
with EtOAc (3 x 20 mL) and saturated NH4Cl until complete neutralization. The total 
organic layer was washed with brine (3 x 15 mL), dried over anhydrous Na2SO4, filtered, 
and the filtrate concentrated under reduced pressure to obtain a crude residue, which 
was subjected to silica-gel chromatography (eluent: Hexane/EtOAc: 4/1) to give 46 (1.92 
g, 85%, lit.15) as a yellow solid, mp 68-70 ⁰C. 1H NMR (400 MHz, chloroform-d) δ = 6.84 (d, J 
= 9.0 Hz, 1 H), 6.63 (d, J = 9.0 Hz, 1 H), 3.88 (s, 3 H, OCH3), 3.85 (s, 3 H, OCH3), 3.84 (s, 3 H, 
OCH3). 
13C NMR (101 MHz, chloroform-d) δ = 151.2 (C), 148.0 (C), 147.9 (C), 111.8 (CH), 
108.3 (CBr), 106.7 (CH), 60.5 (OCH3), 56.7 (OCH3), 56.7 (OCH3). (ESI-HRMS): [M+H]
+ calcd 
for C9H12BrO3: 246.9970; found 246.9972. 
 
2,3,6-trimethoxybenzaldehyde (47) 
 
 
 
A solution of 1,2,4-trimethoxybenzene 6 (5.0 g, 29.7 mmol), TMEDA (3.80 g, 32.7 mmol) 
in 30 mL THF at -78 ⁰C under argon atmosphere, was added dropwise  n-Buthyllithium 
(2.5 M in hexane, 17.8 mL, 44.6 mmol). The mixture was stirred at this temperature for 
1 h and then DMF (4.58 mL, 59.4 mmol) was added. The reaction was allowed to warm 
at room temperature and stirred overnight. The mixture was quenched with 1 N 
hydrochloride solution (10 mL). Et2O (50 mL) and saturated aqueous NaHCO3 (20 mL) 
were added, and the layers were separated. The organic layer was washed with 
saturated aqueous NH4Cl (20 mL) and dried over Mg2SO4. The sulphate magnesium was 
removed by filtration, and the filtrate concentrated in vacuo. Column chromatography 
(eluent: Petroleum ether/EtOAc: 7/3) gave the product 47 as an orange oil (4.22 g, 72%, 
lit.15). 1H NMR (400 MHz, chloroform-d) δ = 10.44 (d, J = 0.5 Hz, 1 H, CHO), 7.09 (d, J = 
9.2 Hz, 1 H, CH), 6.64 (d, J = 9.2 Hz, 1 H, CH), 3.92 (s, 3 H, OCH3), 3.85 (s, 3 H, OCH3), 3.84 
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(s, 3 H, OCH3). 
13C NMR (101 MHz, chloroform-d) δ = 189.3 (C=O), 154.6 (C), 151.8 (C), 
146.5 (C), 119.5 (C), 118.9 (CH), 106.1 (CH), 61.6 (OCH3), 56.5 (OCH3), 55.9 (OCH3). IR 
(KBr, dry film) νmax (cm
-1) = 2840 (H-C=O), 1692 (C=O), 1487 (C=C), 1099 (C-O). (ESI-
HRMS): [M+H]+ calcd for C10H13O4: 197.0814; found 197.0810. 
 
2,3,6-trimethoxybenzyl alcohol (48) 
 
 
 
The aldehyde 47 (302 mg, 1.54 mmol) was dissolved in DCM (4 mL) and MeOH (4 mL). 
Sodium borohydride (58.2 mg, 1.54 mmol) was added to the reaction mixture, the 
solution was stirred for 30 min at room temperature. Saturated aqueous NH4Cl (5 mL) 
was added, and the reaction mixture was diluted with DCM. The layers were separated, 
and the organic layer was washed with saturated aqueous NH4Cl (1 X 10 mL) and 
saturated NaCl (1 X 10 mL). The organic layer was dried over Na2SO4, filtered and the 
filtrate concentrated in vacuo. Column chromatography (eluent: Petroleum 
ether/EtOAc: 7/3) gave the product 48 as a solid (208 mg, 92%, lit.28).  1H NMR (400 
MHz, chloroform-d) δ = 6.82 (d, J = 9.0 Hz, 1 H, CH), 6.60 (d, J = 9.0 Hz, 1 H, CH), 4.78 (d, 
J = 6.8 Hz, 2 H, CH2), 3.89 (s, 3 H, OCH3), 3.84 (s, 3 H, OCH3), 3.83 (s, 3 H, OCH3), 2.54 (t, J 
= 6.8 Hz, 1 H, OH). 13C NMR (101 MHz, chloroform-d) δ = 152.4(C), 148.2(C), 147.2(C), 
123.5(C), 112.2 (CH), 105.6 (CH), 61.5 (CH2), 56.4 (OCH3), 55.9 (OCH3), 55.6 (OCH3). IR 
(KBr, dry film) νmax (cm
-1) = 3297 (O-H), 1486 (C=C), 1076 (C-O). (ESI-HRMS): [M+Na]+ 
calcd for C10H14NaO4: 221.0790; found 221.0813.  
 
2,3,6-trimethoxybenzylbromide (49) 
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To a stirred solution of alcohol 48 (249 mg, 1.26 mmol) in dry Et2O (4 mL) at room 
temperature under argon atmosphere, was added dry pyridine (0.002 mL, 0.0252 mmol) 
followed by dropwise addition of PBr3 (0.002 mL, 0.503 mmol) over 5 min. The resulting 
light yellow solution, with visible off white precipitate, was stirred for 1 h and then 
diluted with 5 mL Et2O and quenched with 7 mL H2O. The solution was allowed to stir 
further for 20 min and then the layers were separated. The aqueous layer was extracted 
further with Et2O (3 X 7 mL). The combined organic layers were washed with 20 mL of 
saturated NaHCO3 solution, dried over anhydrous MgSO4, filtered and the filtrate 
concentrated in vacuo. Column chromatography (eluent: Petroleum ether/EtOAc: 7/3) 
gave 49 as a solid (297 mg, 91%) mp 39-41⁰C. 1H NMR (400 MHz, chloroform-d) δ = 6.85 
(d, J = 9.0 Hz, 1 H, CH), 6.58 (d, J = 9.0 Hz, 1H, CH), 4.68 (s, 2 H, CH2), 3.99 (s, 3 H, OCH3), 
3.86 (s, 3 H, OCH3), 3.83 (s, 3H, OCH3). 
13C NMR (101 MHz, chloroform-d) δ = 152.2 (C), 
148.6 (C), 147.0 (C), 121.2 (C), 113.5 (CH), 105.8 (CH), 60.9 (CH2), 56.5 (OCH3), 56.2 
(OCH3), 56.1 (OCH3). IR (KBr, dry film) νmax (cm
-1) = 1484 (C=C), 1073 (C-O), 530 (C-Br). 
(ESI-HRMS): [M+H]+ calcd for C10H14BrO3: 263.0106; found: 263.0126.  
 
Attempted preparation of methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(2,3,6-
trimethoxyphenylcarbonyl)methyl]-β-D-glucopyranoside (52) 
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(a) Magnesium turnings (37.2 mg, 1.53 mmol) were treated with 2-bromo-1,3,4-
trimethoxybenzene 46 (135 mg, 0.546 mmol) in dry E2tO (1.5 mL). The reaction mixture 
was heated under reflux under Ar for 2 h and then cooled to 0 ⁰C and a solution of 
Weinreb amide 45 (300 mg, 0.546 mmol) in dry E2tO (3 mL) was added. The reaction 
was stirred at 0 ⁰C and then allowed to warm to room temperature overnight. The 
mixture was quenched with saturated NH4Cl (2 mL) and extracted with E2tO (3 x 5 mL). 
The combined organic layers were dried over anhydrous Na2SO4, filtered and the filtrate 
concentrated under vacuum, and we re-isolated all reactants instead of product 52.  
(B) A solution of the ester 44 (500 mg, 0.960 mmol) and LiOH.H2O (403 mg, 9.60 mmol) 
in MeOH/H2O (4/1: 5 mL) was heated under reflux until TLC showed complete 
conversion of the starting material. After cooling to room temperature, the pH value 
was adjusted to 3-4 with Amberlite IR-120, and, after filtration, the solvent was 
removed. The residue (acid) was diluted with dry DCM (10 mL), and oxalyl chloride (1.08 
g, 8.49 mmol) and dry DMF (3 drops) were added. After 15 min at room temperature, 
the mixture was heated under reflux for 30 min. The solvent was evaporated under 
reduced vacuum, the residue 59 dissolved in dry THF, and immediately used without 
further purification. Separately, a solution of 1,2,4-trimethoxybenzene 6 (250 mg, 1.49 
mmol) in dry THF (8 mL) was treated with n-BuLi (2.5 mL, 0.7 mL) at -18 ⁰C. After 15 min, 
a solution of freshly prepared 59 in dry THF was added, and the mixture was allowed to 
warm up at room temperature over 5 h. Saturated NH4Cl solution and Et2O were added, 
and the organic layer was washed with H2O and filtered through Na2SO4. The filtrate was 
evaporated under reduced pressure and the residue purified by silica gel (eluent: 
petroleum ether/EtOAc: 2/1), but no product 52 was formed. We did not have evidence 
of the preparation of the compound 59 but it was recovered the compound 6, which 
was obtained after protonation of 6a during work-up process.  
 
Attempted preparation of  methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[-3-(1,2,4-
trimethoxyphenyl)-2-oxo-propyl]-β-D-glucopyranoside (53) 
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Magnesium turnings (39.0 mg, 1.61 mmol) were treated with 1,2,3-
trimethoxybenzylbromide 49 (150 mg, 0.575 mmol) in Et2O (1.5 mL). The reaction 
mixture was heated under reflux for 2 h and then cooled to 0 ⁰C. Then a solution of 
Weinreb amide 45 (316 mg, 0.575 mmol) in dry Et2O (3.5 mL) was added. The reaction 
mixture was stirred at this temperature and allowed to warm to room temperature 
overnight. The mixture was quenched with saturated NH4Cl (2.5 mL) and extracted with 
Et2O (3 x 5 mL). The combined organic layers were dried over anhydrous Na2SO4, filtered 
and the filtrate concentrated under vacuum, and we re-isolated starting materials 
instead of the desired product 53.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(phenylcarbonyl)methyl]-β-D-glucopyranoside 
(57) 
 
 
 
To a solution of the Weinreb amide 45 (533 mg, 0.970 mmol) in 10 mL of anhydrous 
Et2O was added via a syringe the phenyl magnesium bromide 55 (3.0 M in Et2O, 0.65 mL, 
1.94 mmol) at 0 ⁰C. The mixture was allowed to reach the room temperature and stirred 
until the completion of starting material. The reaction mixture was quenched with 3 mL 
of saturated NH4Cl and extracted with DCM (3 X 5 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, filtered and the filtrate concentrated under 
reduced vacuum. Purification by Column chromatography (eluent: Petroleum 
ether/EtOAc: 7/3) to afford 57 (473 mg, 86%), mp 94-96 ºC as a white solid. 1H NMR (400 
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MHz, chloroform-d) δ = 7.87 - 7.83 (m, 2 H, Aromatic), 7.55 - 7.50 (m, 1 H, Aromatic), 
7.44 - 7.27 (m, 11 H, Aromatic), 7.22 - 7.18 (m, 6 H, Aromatic), 4.90 (d, J = 11.4 Hz, 1 H, 
CH2-Ph ), 4.80 (d, J = 10.8 Hz, 1 H, CH2-Ph), 4.68 - 4.55 (m, 4 H, CH2-Ph), 4.45 (d, J = 8.6 
Hz, 1 H, H-1), 3.79 - 3.76 (m, 2 H, H-6, H-6’), 3.76 - 3.72 (m, 1 H, H-3), 3.65 (t, J = 9.2 Hz, 1 
H, H-5), 3.57 - 3.51 (m, 1 H, H-4), 3.40 (s, 3 H, OCH3), 3.11 (dd, J = 2.7, 5.4 Hz, 2 H, H-7, H-
7’), 2.37-2.28 (m, 1 H, H-2). 13C NMR (101 MHz, chloroform-d) δ = 199.2 (C=O), 138.3, 
138.3, 137.3, 132.6 (Aromatic C), 128.4, 128.3, 128.2, 127.8, 127.7, 127.5 (Aromatic CH), 
103.5 (C-1), 82.1 (C-3), 80.2 (C-5), 75.2 (C-4), 74.7, 74.6, 73.5 (3 X CH2-Ph), 69.1 (C-6), 
56.7 (OCH3), 45.2 (C-2), 36.1 (C-7). IR (KBr, dry film) νmax (cm
-1) = 1690 (C=O), 1596 (C=C), 
1114 (C-O). (ESI-HRMS): [M+NH4]
+ calcd for C36H42NO6: 584.3012; found: 584.3162.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(benzylcarbonyl)methyl]-β-D-glucopyranoside 
(58) 
 
 
 
Magnesium turnings (33.0 mg, 1.36 mmol) were treated with benzyl bromide (82.1 mg, 
0.480 mmol) in Et2O (1.5 mL). A vigorous reaction ensued which was cooled in an ice 
bath. Once the reaction had dissipated, the reaction mixture was heated under reflux 
for 2 h yielding the Grignard reagent. The reaction mixture was cooled to 0 ⁰C and a 
solution of Weinreb amide 45 (264 mg, 0.480 mmol) in dry Et2O (3 mL) was added. The 
reaction was stirred briefly at this temperature and then allowed to warm to room 
temperature overnight. The mixture was quenched with saturated NH4Cl (2 mL) and 
extracted with Et2O (3 X 5 mL). The combined organic layers were dried over anhydrous 
Na2SO4, filtered and the filtrate concentrated under reduced vacuum. Purification by 
Column chromatography (eluent: Petroleum ether/EtOAc: 7/3) to afford 58 (58.1 mg, 
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67%) as a colorless syrup. 1H NMR (400 MHz, chloroform-d) δ = 7.42 - 7.15 (m, 18 H, 
Aromatic), 7.15 - 7.10 (m, 2 H, Aromatic), 4.86 (d, J = 11.2 Hz, 1 H, CH2-Ph), 4.77 (d, J = 
10.8 Hz, 1 H, CH2-Ph), 4.68 - 4.54 (m, 3 H, CH2-Ph), 4.47 (d, J = 11.2 Hz, 1 H, CH2-Ph), 4.28 
(d, J = 8.6 Hz, 1 H, H-1), 3.78 - 3.73 (m, 2 H, H-6, H-6’), 3.70 - 3.66 (m, 1 H, H-4), 3.65 - 
3.59 (m, 2 H, H-8, H-8’), 3.59 - 3.55 (m, 1 H, H-3), 3.47 (td, J = 3.2, 9.5 Hz, 1 H-5), 3.38 (s, 
3 H, OCH3), 2.69 - 2.60 (m, 1 H, H-7), 2.54 - 2.45 (m, 1 H, H-7’), 2.25 - 2.15 (m, 1 H, H-2). 
13C NMR (101MHz, chloroform-d) δ = 207.0 (C=O), 138.2, 138.1, 134.4, 130.4 (Aromatic 
C), 129.5, 128.5, 128.4, 128.3, 127.8, 127.8, 127.7, 127.7, 127.6, 126.8 (Aromatic CH), 
103.5 (C-1), 82.1 (C-3), 79.9 (C-4), 75.2 (C-5), 74.7, 74.6, 73.5 (3 X CH2-Ph), 69.0 (C-6), 
56.7 (OCH3), 49.5 (C-8), 44.8 (C-2), 39.8 (C-7). IR (KBr, dry film) νmax (cm
-1) = 1712 (C=O), 
1551 (C=C), 1108 (C-O). (ESI-HRMS): [M+NH4]
+ calcd for C36H42NO6: 598.3169; found: 
598.3184.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(ethanol)-β-D-glucopyranoside (60) 
 
 
 
 
A suspension of the ester 44 (2.11 mg, 4.05 mmol) and LiAlH4 (461 mg, 12.2 mmol) in 1,4-
dioxane (12 mL) was stirred at reflux for 3 h until TLC showed complete conversion of the 
starting material. Ethyl acetate (8 mL) and H2O (20 mL) were added sequentially. The 
mixture was filtered over celite and was extracted with DCM (4 X 20 mL). The combined 
organic layers were dried over Na2SO4, filtered and the filtrate concentrated under 
reduced vacuum. The resulting crude mixture was purified by silica gel column 
chromatography (eluent: Hexane/EtOAc: 4/1) to afford 60 as a colorless oil (1.58g, 79%, 
lit.30). 1H NMR (400 MHz, chloroform-d) δ = 7.37 - 7.25 (m, 13 H, Aromatic), 7.23 - 7.18 (m, 
2 H, Aromatic), 4.95 (d, J = 11.4 Hz, 1 H, CH2-Ph ), 4.78 (d, J = 11.0 Hz, 1 H, CH2-Ph), 4.69 - 
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4.55 (m, 4 H, CH2-Ph), 4.15 (d, J = 8.4 Hz, 1 H, H-1), 3.76 (br. s., 2 H, H-6, H-6’), 3.68 - 3.63 
(m, 3 H, H-8, H-8’, H-4), 3.53 (s, 3 H), 3.49 (d, J = 6.8 Hz, 1 H, H-5), 3.37 (d, J = 9.3 Hz, 1 H, 
H-3), 1.88 - 1.76 (m, 2 H, H-7, H-2), 1.61 (dd, J = 6.9, 14.4 Hz, 1 H, H-7’), 0.94 (t, J = 7.3 Hz, 
1 H, OH). 13C NMR (101 MHz, chloroform-d) δ = 138.2, 138.1, 138.0 (Aromatic C), 128.4, 
128.3, 127.8, 127.6 (Aromatic CH), 104.7 (C-1), 83.2 (C-3), 79.7 (C-4), 75.2 (C-5), 75.0, 74.6, 
73.5 (3 X CH2-Ph), 69.0 (C-6), 61.8 (C-8), 56.7 (OCH3), 45.9 (C-2), 30.7 (C-7). (ESI-HRMS): 
[M+NH4]
+ calcd for C30H40NO6: 510.2856; found: 510.2987. 
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(iodoethyl)-β-D-glucopyranoside (61) 
 
 
 
(A) A solution of alcohol 60 (450 mg, 0.914 mmol) in THF (8 mL) containing imidazole (93.3 
mg, 1.37 mmol) and triphenylphosphine (289 mg, 1.10 mmol) was cooled  to 0 ⁰C then 
iodine (310 mg, 1.23 mmol) was added. The mixture was stirred under reflux for 4 h, then 
evaporated and co-evaporated with toluene under reduced vacuum. The residue was 
purified by column chromatography (eluent: petroleum ether/EtOAc: 1/1), and the 
alcohol 60 was recovered instead of our desired product 61.  
 
(B) A mixture of tosylate 63 (210 mg, 0.325 mmol), sodium iodide (243 mg, 1.62 mmol), 
and DMF (4 mL) was heated at 60 ⁰C for 4 h. Water (5 mL) was added and the resulting 
mixture was extracted with pentane (3 X 8 mL). The combined organic layers were dried 
over Na2SO4, filtered and the filtrate concentrated under vacuum. The resulting crude 
mixture was purified by silica gel column chromatography (eluent: Hexane/EtOAc: 4/1) to 
afford 61 as a white solid (129 mg, 66%), mp 81-83 ⁰C. 1H NMR (400 MHz, chloroform-d) δ 
= 7.41 - 7.28 (m, 13 H, Aromatic CH), 7.25 - 7.19 (m, 2 H, Aromatic CH), 4.94 (d, J = 11.2 Hz, 
1 H, CH2-Ph ), 4.80 (d, J = 11.0 Hz, 1 H, CH2-Ph ), 4.69 - 4.55 (m, 4 H, CH2-Ph), 4.12 (d, J = 
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8.6 Hz, 1 H, H-1), 3.78 - 3.74 (m, 2 H, H-6, H-6’), 3.68 - 3.60 (m, 1 H, H-4), 3.51 (s, 3 H, 
OCH3), 3.48 - 3.41 (m, 1 H, H-5), 3.38 - 3.28 (m, 2 H, H-3, H-8), 3.28 - 3.19 (m, 1 H, H-8’), 
2.24 - 2.13 (m, 1 H, H-7), 2.04 - 1.93 (m, 1 H, H-7’), 1.77 - 1.68 (m, 1 H, H-2). 13C NMR (101 
MHz, chloroform-d) δ = 138.2, 138.0, 138.0 (Aromatic C), 128.5, 128.4, 128.3, 127.9, 
127.9, 127.8, 127.8, 127.8, 127.6 (Aromatic CH), 104.5 (C-1), 82.8 (C-3), 79.7 (C-4), 75.2, 
75.1 (2 X CH2-Ph), 74.7 (C-5), 73.5 (CH2-Ph), 69.0 (C-6), 56.7 (OCH3), 48.6 (C-2), 33.3 (C-7), 
4.3 (C-8). IR (KBr, dry film) νmax (cm
-1) = 1450 (C=C), 1110 (C-O), 463 (C-I). (ESI-HRMS): 
[M+NH4]
+ calcd for C30H39INO5: 621.1906; found 621.2006.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(bromoethyl)-β-D-glucopyranoside (62) 
 
 
(A) To a stirred solution of alcohol 60 (260 mg, 0.528 mmol) in dry Et2O (6 mL) at room 
temperature under argon atmosphere, was added dry pyridine (0.850 μL, 0.0106 mmol) 
followed by dropwise addition of PBr3 (0.020 mL, 0.211 mmol) over 5 min. The resulting 
light yellow solution, with visible off white precipitate, was stirred for 1 h and then diluted 
with 4 mL Et2O and quenched with 6 mL H2O. The solution was allowed to stir further for 
20 min and then the layers were separated. The aqueous layer was extracted further with 
Et2O (3 x 5 mL). The combined organic layers were washed with 15 mL of saturated 
NaHCO3 solution, dried over anhydrous MgSO4, filtered and the filtrate concentrated 
under reduced vacuum.  The residue was purified by column chromatography (Petroleum 
ether/ Ethyl acetate: 7/3), and the alcohol 60 was recovered instead of our desired 
product 62.  
 
(B) A mixture of tosylate 63 (340 mg, 0.526 mmol), lithium bromide (68.5 mg, 0.789 
mmol), and DMF (8 mL) was heated at 60⁰C overnight. Water (7 mL) was added and the 
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resulting mixture was extracted with ether (3 X 8 mL). The combined organic layers were 
dried over Na2SO4, filtered and the filtrate concentrated under reduced vacuum. The 
resulting crude mixture was purified by silica gel column chromatography (eluent: 
Hexane/EtOAc: 4/1) to afford 62 as a white solid (181 mg, 62%, mp 69-71 ⁰C). 1H NMR 
(400 MHz, chloroform-d) δ = 7.38 - 7.25 (m, 13 H, Aromatic CH), 7.22 - 7.17 (m, 2 H, 
Aromatic CH), 4.93 (d, J = 11.2 Hz, 1 H, CH2-Ph), 4.78 (d, J = 11.0 Hz, 1 H, CH2-Ph), 4.68 - 
4.54 (m, 4 H, CH2-Ph ), 4.11 (d, J = 8.6 Hz, 1 H, H-1), 3.74 (d, J = 4.0 Hz, 2 H, H-6, H-6’), 
3.63 (t, J = 9.2 Hz, 1 H, H-4), 3.56 - 3.51 (m, 1 H, H-5), 3.50 (s, 3 H, OCH3), 3.48 - 3.43 (m, 
2 H, H-8, H-8’), 3.37 - 3.31 (m, 1 H, H-3), 2.18 - 2.09 (m, 1 H, H-7), 2.00 - 1.89 (m, 1 H, H-
7’), 1.77 (ddd, J = 3.9, 10.8, 15.0 Hz, 1 H, H-2). 13C NMR (101 MHz, chloroform-d) δ = 
138.4, 138.2, 138.2 (Aromatic C), 138.0, 128.5 128.4, 128.3, 127.9, 127.8, 127.8, 127.8, 
127.6 (Aromatic CH), 104.7 (C-1), 82.9 (C-3), 79.7 (C-4), 75.2  (C-8), 75.0, 74.7, 73.5 (3 X 
CH2-Ph), 69.0 (C-6), 56.7 (OCH3), 46.7 (C-2), 32.0 (C-8), 31.8 (C-7). IR (KBr, dry film) νmax 
(cm-1) = 1498 (C=C), 1001 (C-O), 696 (C-Br). (ESI-HRMS): [M+NH4]
+ calcd for C30H39BrNO5: 
572.2012; found: 572.2023. 
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(tosylethyl)-β-D-glucopyranoside (63) 
 
 
p-Toluenesulfonyl chloride (847 mg, 4.40 mmol) was added to a stirred solution of 
pyridine (7 mL) and alcohol 60 (1.99 g, 4.04 mmol) at 0 ⁰C. The reaction was allowed to 
warm at room temperature, stirred for 4 h, and quenched with H2O (15 mL) extracted 
with DCM (3 x 12 mL), and the combined organic layers were washed with 3 M HCl (3 x 7 
mL) followed by 10% NaHCO3 (1 x 10 mL). The organic layer was dried over Na2SO4, 
filtered and the filtrate concentrated under reduced vacuum. The resulting crude 
mixture was purified by silica gel column chromatography (eluent: Hexane/EtOAc: 4/1) 
to afford 63 as colourless oil (1.57 g, 60%). 1H NMR (400 MHz, chloroform-d) δ = 7.74 (d, 
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J = 8.2 Hz, 2 H, Aromatic CH), 7.38 - 7.24 (m, 15 H, Aromatic CH), 7.21 - 7.15 (m, 2 H, 
Aromatic CH), 4.88 (d, J = 11.2 Hz, 1 H, CH2-Ph), 4.74 (d, J = 10.8 Hz, 1 H, CH2-Ph ), 4.66 - 
4.53 (m, 4 H, CH2-Ph), 4.20 - 4.11 (m, 1 H, H-7), 4.09 - 4.05 (m, 1 H, H-1), 4.06 - 4.00 (m, 1 
H, H-7’), 3.73 (d, J = 2.4 Hz, 2 H, H-6, H-6’), 3.62 - 3.55 (m, 1 H, H-4), 3.43 (s, 3 H, OCH3), 
3.40 (d, J = 3.1 Hz, 1 H, H-5), 3.31 (dd, J = 8.8, 10.6 Hz, 1 H, H-3), 2.42 (s, 3 H, Ar-CH3), 
2.02 - 1.91 (m, 1 H, H-8), 1.81 - 1.71 (m, 1 H, H-8’), 1.69 - 1.62 (m, 1 H, H-2). 13C NMR 
(101 MHz, chloroform-d) δ = 144.5, 138.2, 138.0, 138.0, 133.3 (Aromatic C), 129.7, 
128.5, 128.4, 128.3, 127.9, 127.7, 127.6 (Aromatic CH), 104.3 (C-1), 82.5 (C-3), 79.7 (C-4), 
75.1 (C-5), 74.8, 74.6, 73.5 (3 X CH2-Ph), 69.3 (C-7), 68.9 (C-6), 56.6 (OCH3), 44.3 (C-2), 
27.1 (C-8), 21.5 (Ar -CH3). IR (KBr, dry film) νmax (cm
-1) = 1457 (C=C), 1092 (S=O), 901 (S-
O). (ESI-HRMS): [M+NH4]
+ calcd for C37H46NO8S: 664.2944; found 664.2972. 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(2,3,6-trimethoxyphenyl)-8-ol-etthyl]-β-D-
glucopyranoside (64)  
 
 
 
Magnesium turnings (12.6 mg, 0.52 mmol) were treated with iodide 61 (209 mg, 0.480 
mmol) in Et2O (5 mL).No vigorous reaction took place after 5 h. The reaction failed to 
give the Grignard, and the aldehyde 47 (102 mg, 0.521 mmol) could not be added to the 
reaction mixture.  
 
(2,3,6-trimethoxy)boronic acid (65)  
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n-Butyl lithium in hexanes (2.5 M, 2.92 mL, 7.30 mmol) was added dropwise to a 
solution of 1,2,4–trimethoxybenzene 6 (1.12 g, 6.63 mmol) in anhydrous ether (30 mL) 
at -10 ⁰C under an argon atmosphere. A white precipitate was formed. The reaction 
mixture was stirred additionally for 1.5 h at room temperature. Then trimethylborate 
(0.367 mL, 7.30 mmol) dissolved in anhydrous ether (10 mL) was added dropwise at -10 
⁰C under an argon atmosphere, and the mixture was allowed to stir overnight. The 
reaction was extracted with EtOAc (3 x 15 mL) and saturated NH4Cl until complete 
neutralization. The total organic layer was washed with brine (3 X 10 mL), dried over 
anhydrous Na2SO4, filtered and the filtrate concentrated under reduced pressure to 
obtain a crude residue, which was subjected to silica-gel chromatography (eluent: 
Hexane/EtOAc: 4/1) to give 65 (847 mg, 60%, lit.15) as an oil. 1H NMR (400 MHz, 
chloroform-d) δ = 6.99 (d, J = 9.0 Hz, 1 H), 6.67 (d, J = 9.0 Hz, 1 H), 3.93 (s, 3 H, OCH3), 
3.87 (s, 3 H, OCH3), 3.84 (s, 3 H, OCH3). (ESI-HRMS): [M+H]
+ calcd for C9H14BO5: 
213.0934; found: 213.0939.  
 
Attempted preparation of methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(2,3,6-
trimethoxyphenyl)ethyl)]-β-D-glucopyranoside (66) 
 
 
 
(A). A mixture of iodide 61 (189 mg, 0.314 mmol), boronic acid 64 (100 mg, 0.471 
mmol), KOt-Bu (105 mg, 0.942 mmol) and tricyclohexylphosphine (10%) in dioxane (6 
mL) were degassed for 30 min under argon atmosphere. To the mixture was added 
Pd(OAc)2 (10 mol%, 26.2 mg) , and the resulting suspension was stirred at 100 
⁰C for 24 
h. The reaction mixture was then poured into Et2O (6 mL), filtered through a short pad 
of silica gel copious washings EtOAc (12 mL), the filtrate concentrated under reduced 
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vacuum and purified by column chromatography (eluent: Petroleum Ether/EtOAc: 4/1), 
and we re-isolated the glycosyl iodide 61 and the boronic acid 64 decomposed. 
 
(B). A mixture of bromide 62 (93.0 mg, 0.167 mmol), boronic acid 64 (77.0 mg, 0.335 
mmol), KOt-Bu (56.0 mg, 0.501 mmol) and tricyclohexylphosphine (10%) in dioxane (5 
mL) were degassed for 30 min under argon atmosphere. To the mixture was added and 
Pd(OAc)2 (10 mol%, 11.2 mg) , and the resulting suspension was stirred at 100 
⁰C for 24 
h. The reaction mixture was then poured into Et2O (5 mL), filtered through a short pad 
of silica gel copious washings EtOAc (10 mL), the filtrate concentrated under reduced 
vacuum and purified by column chromatography (Pet Ether/EtOAc: 4/1), and we 
isolated the glycosyl bromide 62 and the boronic acid 64 decomposed. 
 
(C). A solution of 1,2,4-trimethoxylbenzene 6 (92.2 mg,  0.548 mmol) in dry THF (10 mL) 
was cooled to -78 ⁰C. n-BuLi (2.5 M, 0.438 mL, 1.096 mmol) was added dropwise. The 
resulting mixture was stirred at the same temperature for 1 h. The electrophile (glycosyl 
iodide 61) (600 mg, 0.996 mmol) was then added dropwise and the reaction was 
allowed to warm to room temperature gradually overnight. The mixture was quenched 
with saturated aqueous NH4Cl solution (5 mL) and extracted with ether (3 x 8 mL). The 
combined organic phase was washed with water and brine, dried over MgSO4, filtered 
and the filtrate evaporated under reduced vacuum. Purified by column chromatography 
(eluent: Petroleum Ether/EtOAc: 4/1), and we isolated the glycosyl iodide 61 and the 
compound 6 after work-up process. 
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(vinyl)-β-D-glucopyranoside (67) 
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To a solution of iodide 61 (115 mg, 0.191 mmol) in DMF (4 mL) was added DBU (43.6 
mg, 0.286 mmol). The resulting mixture was heated at 80 ⁰C for 3 h. The mixture was 
cooled in ice and water, and extracted with DCM (3 x 3 mL). The combined organic 
extracts were washed with water, dilute HCl, water, saturated NaHCO3 solution, brine 
and dried over Na2SO4, filtered and the filtrate concentrated under reduced vacuum. 
The resulting crude mixture was purified by silica gel column chromatography (eluent: 
Hexane/EtOAc: 4/1) to afford 67 as a white solid (61.6 mg, 68%), mp 52-55 ⁰C. 1H NMR 
(400 MHz, chloroform-d) δ = 7.37 - 7.23 (m, 13 H, Aromatic CH), 7.21 - 7.17 (m, 2 H, 
Aromatic CH), 5.68 (ddd, J = 8.6, 10.3, 17.1 Hz, 1 H, H-7), 5.30 (td, J = 0.8, 17.2 Hz, 1 H, H-
8), 5.25 (dd, J = 1.7, 10.3 Hz, 1 H, H-8’), 4.81 (d, J = 10.8 Hz, 1 H, CH2-Ph), 4.74 - 4.64 (m, 
2 H, CH2-Ph), 4.63 - 4.53 (m, 3 H, CH2-Ph), 4.21 (d, J = 8.4 Hz, 1 H, H-1), 3.80 - 3.69 (m, 2 
H, H-6, H-6’), 3.63 - 3.57 (m, 1 H, H-4), 3.49 (s, 3 H, OCH3), 3.47 (d, J = 1.8 Hz, 1 H, H-5), 
3.46 - 3.43 (m, 1 H, H-3), 2.51 - 2.42 (m, 1 H, H-2). 13C NMR (101 MHz, chloroform-d) δ = 
138.3, 138.3, 138.3 (Aromatic C), 134.1 (C-7), 128.4, 128.3, 128.0, 127.9, 127.7, 127.7, 
127.7, 127.5 (Aromatic CH), 119.8 (C-8), 103.2 (C-1), 83.1 (C-3), 78.7 (C-4), 75.2 (C-5), 
74.9 (2 x CH2-Ph), 73.5 (CH2-Ph), 69.2 (C-6), 56.7 (OCH3), 53.1 (C-2). IR (KBr, dry film) νmax 
(cm-1) = 3100 (=C-H), 1643 (C=C), 1494 (C=C, Ar), 1119 (C-O). (ESI-HRMS): [M+NH4]
+ calcd 
for C30H38NO5: 492.2750; found: 492.2737.  
 
Attempted synthesis of methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[2-(1,3,4-
trimethoxyphenyl)vinyl]-β-D-glucopyranoside (68) 
 
 
 
(1. Heck). Aryl bromide 46 (20.0 mg, 0.0809 mmol) were added under nitrogen 
atmosphere to a stirred solution containing PPh3 (0.654 mg, 0.00249 mmol), Pd(OAc)2 
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(5mol%, 0.699 mg), Et3N (0.8 μL, 0.0632 mmol) and alkene 67 (33.4 mg, 0.0632 mmol) in 
dioxane (2 mL). The resulting solution was allowed to stir at 100 ºC for 24 h. The 
homogeneous reaction mixture was then diluted with EtOAc (4 mL) and filtered through 
a bed of silica gel layered over Celite, and the volatiles were removed in vacuo. But 
starting materials were recovered instead of product 68. 
 
(2. Suzuki). (PPh3)2PdCl2 (3.54 mg, 0.00505 mmol), boronic acid 64 (23.0 mg, 0.111 
mmol), and K2CO3 (41.8 mg, 0.303 mmol) were weighed into a round-bottom flask and 
stir under nitrogen at room temperature. The alkenyl bromide 71 (56.0 mg, 0.101 mmol) 
and H2O (0.1 mL) in 1,4-dioxane (1.5 mL) were then added by syringe. The resulting 
solution was allowed to stir at 100 ⁰C for 24 h. The homogeneous reaction mixture was 
then diluted with EtOAc (4 mL) and filtered through a bed of silica gel layered over 
Celite, and the volatiles were removed in vacuo. It was observed the consumption of 
starting materials on TLC but we were unable to identify by NMR spectroscopic.   
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(1,2-dibromoethyl)-β-D-glucopyranoside (69) 
 
 
 
A solution of alkene 67 (76.6 mg, 0.155 mmol) in DCM (3 mL) was cooled in an ice bath 
at 0 ⁰C. After a slow addition of bromine (27.3 mg, 0.171 mmol), the reaction mixture 
was stirred for 30 min at room temperature. Saturated aqueous sodium thiosulphate 
(0.5 mL) was added to the reaction mixture. After stirring for 5 min, water (1 mL) and 
DCM (2 ml) were added to the reaction mixture. The organic layer was separated and 
washed with water (1.5 mL) and brine (1.5 mL), dried with MgSO4, filtered and the 
filtrate concentrated in vacuo. The resulting crude mixture was purified by silica gel 
column chromatography (eluent: Hexane/EtOAc: 4/1) to afford 69 as diastereoisomers 
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(colourless oil, 91%, ratio: 2/1).  Isomer A: 1H NMR (400 MHz, chloroform-d) δ = 7.29 - 
7.19 (m, 13 H, Aromatic CH), 7.14 - 7.11 (m, 2 H, Aromatic CH), 4.91 (d, J = 11.4 Hz, 1 H, 
CH2-Ph), 4.69 (d, J = 11.2 Hz, 1 H, CH2-Ph), 4.60 (d, J = 8.1 Hz, 1 H, H-7), 4.55 - 4.48 (m, 4 
H, CH2-Ph), 4.47 (d, J = 7.9 Hz, 1 H, H-1), 4.06 (t, J = 9.8 Hz, 1 H, H-8), 3.79 (dd, J = 6.2, 
10.1 Hz, 1 H, H-8’), 3.72 - 3.67 (m, 3 H, H-5, H-6, H-6’), 3.67 - 3.64 (m, 1 H, H-3), 3.47 (s, 3 
H, OCH3), 3.45 - 3.42 (m, 1 H, H-4), 2.21 - 2.15 (m, 1 H, H-2).
  13C NMR (101 MHz, 
chloroform-d) δ = 138.0 (2C), 137.8 (C), 128.5 (CH), 128.4 (CH) , 128.4 (CH), 127.8 (CH), 
127.7 (CH), 103.7 (C-1), 80.5 (C-3), 79.5 (C-5), 75.3 (C-4), 75.2, 74.8, 73.6 (3 X CH2-Ph), 
68.9 (C-6), 56.6 (OCH3), 51.1 (C-7), 48.3 (C-2), 35.8 (C-8). Isomer B: 
1H NMR (400 MHz, 
chloroform-d) δ = 7.32 - 7.22 (m, 13 H, Aromatic CH), 7.05 (dd, J = 2.9, 6.6 Hz, 2 H, 
Aromatic CH), 5.00 (d, J = 11.5 Hz, 1 H, CH2-Ph), 4.80 (d, J = 11.4 Hz, 1 H, CH2-Ph), 4.72 (d, 
J = 10.8 Hz, 1 H, CH2-Ph), 4.67 - 4.64 (m, 1 H, H-7), 4.64 - 4.59 (m, 3 H, CH2-Ph), 4.24 (d, J 
= 8.1 Hz, 1 H, H-1), 4.03 - 3.97 (m, 1 H, H-8), 3.75 - 3.72 (m, 1 H, H-8’), 3.72 - 3.70 (m, 3 
H, H-5, H-6, H-6’), 3.67 - 3.66 (m, 1 H, H-3), 3.48 (s, 3 H, OCH3), 3.42 - 3.39 (m, 1 H, H-4), 
2.28 - 2.22 (m, 1 H, H-2). 13C NMR (101 MHz, chloroform -d) δ = 138.1 (2 C), 137.8 (C), 
128.5 (CH), 128.4 (CH) , 127.8 (CH) , 127.8 (CH), 127.6 (CH), 127.6 (CH), 127.5 (CH), 127.0 
(CH), 102.2 (C-1), 81.3 (C-3), 80.4 (C-5), 75.2 (C-4), 75.2, 74.8, 74.3 (3 X CH2-Ph), 68.7 (C-
6), 57.0 (OCH3), 53.0 (C-7), 48.5 (C-2), 35.9 (C-8). IR (KBr, dry film) νmax (cm
-1) = 1458 
(C=C), 1091 (C-O), 540 (C-Br). (ESI-HRMS): [M+NH4]
+ calcd for C30H38Br2NO5: 652.1096; 
found 652.1100.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(1-bromovinyl)-β-D-glucopyroside (71) 
 
 
 
(A). To a stirred solution of 1,2 dibromoalkane 69 (295 mg, 0.455 mmol) in dry THF (5 
mL) was added t-BuOK (153 mg, 1.36 mmol). The resulting mixture was stirred and 
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refluxed at 60 ⁰C for 24 h. After cooling to room temperature, the solvent was 
evaporated, the mixture diluted with H2O, and the aqueous solution extracted with 
DCM (3 X 5 mL). The organic layers were combined, washed with water, dried over 
Na2SO4, filtered and the filtrate was concentrated under reduced vacuum. The residue 
was purified by column chromatography (Pet ether/ EtOAc: 4/1) to give 71 as a colorless 
syrup (146 mg, 66%). 
 
(B). To a stirred solution of 1,2 dibromoalkane 69 (160 mg, 0.246 mmol) in dry toluene 
(3 mL) was added NaNH2 (52.0 mg, 1.33 mmol). The resulting mixture was stirred and 
refluxed at 120 ⁰C for 24 h. A saturated solution of NH4Cl (5 mL) was added portion wise 
to the mixture with vigorous stirring at -78 ⁰C. After the mixture was concentrated at 
reduced pressure, water and ether were added to the residue. The organic layer was 
separated. The combined organic layers were washed with brine, dried over anhydrous 
Na2SO4, filtered and the filtrate concentrated in vacuo. The residue was purified by 
column chromatography (Pet ether/ EtOAc: 4/1) to give 71 as colorless syrup (73.2 mg, 
61%).  
1H NMR (400 MHz, chloroform-d) δ = 7.29 - 7.23 (m, 13 H, Aromatic CH), 7.16 (dd, J = 
1.8, 7.3 Hz, 2 H, Aromatic CH), 6.21 (d, J = 13.6 Hz, 1 H, H-8), 5.90 (dd, J = 9.0, 13.6 Hz, 1 
H, H-7), 4.78 (d, J = 11.0 Hz, 1 H, CH2-Ph), 4.70 (d, J = 10.6 Hz, 1 H, CH2-Ph), 4.60 - 4.51 
(m, 4 H, CH2-Ph ), 4.13 (d, J = 8.4 Hz, 1 H, H-1), 3.71 - 3.67 (m, 2 H, H-6, H-6’), 3.59 - 3.52 
(m, 1 H, H-4), 3.43 (s, 3 H, OCH3), 3.43 - 3.40 (m, 1 H, H-5), 3.39 - 3.34 (m, 1 H, H-3), 2.43 
- 2.35 (m, 1 H, H-2). 13C NMR (101 MHz, chloroform-d) δ = 138.2, 138.1, 137.7 (Aromatic 
C), 133.2 (C-7), 128.4, 128.3, 127.9, 127.8, 127.8, 127.7, 127.6 (Aromatic CH), 108.9 (C-
8), 102.4 (C-1), 82.2 (C-3), 78.6 (C-4), 75.2 (C-5), 75.1, 74.9, 73.4 (3 X CH2-Ph), 69.0 (C-6), 
56.6 (OCH3), 52.7 (C-2). IR (KBr, dry film) νmax (cm
-1) = 3026 (=C-H), 1731 (C=C), 1453 
(C=C, Ar), 1110 (C-O), 695 (C-Br). (ESI-HRMS): [M+NH4]
+ calcd for C30H37BrNO5: 570.1855; 
found: 570.1851.  
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Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-(1-aminoethyl)-β-D-glucopyranoside (72) 
 
 
 
A mixture of tosylate 63 (80 mg, 0.124 mmol) and NaN3 (16.19 mg, 0.249 mmol) was 
stirred in DMF (1.5 mL) at 80 ⁰C for 3 h. Then, the mixture was extracted with DCM and 
water (H2O). The organic layer was concentrated, and the residue was dissolved in THF 
(2 mL), and then the Ph3P (65.3 mg, 0.249 mmol) and H2O (0.01 mL) were added. After 
stirring at 65 ⁰C for 3 h, the mixture was diluted with ethyl acetate (8 mL). The organic 
layer was washed with brine, dried over Na2SO4, filtered and the filtrate was 
concentrated. The residue was purified by column chromatography (eluent: 
DCM/MeOH: 9/1) to give the amine 72 as a white solid (41.4 mg, 68%, mp 151-152 ºC). 
1H NMR (400 MHz, chloroform-d) δ = 7.33 - 7.19 (m, 13 H, Aromatic CH ), 7.17 - 7.11 (m, 
2 H, Aromatic CH), 4.88 (d, J = 11.2 Hz, 1 H, CH2-Ph ), 4.72 (d, J = 10.8 Hz, 1 H, CH2-Ph), 
4.64 - 4.49 (m, 4 H, CH2-Ph), 4.06 (d, J = 8.6 Hz, 1 H, H-1), 3.71 - 3.67 (m, 2 H, H-6, H-6’), 
3.59 - 3.52 (m, 1 H, H-4), 3.44 (s, 3 H, OCH3), 3.40 (ddd, J = 2.5, 4.2, 9.7 Hz, 1 H, H-5), 
3.31 (dd, J = 8.7, 10.7 Hz, 1 H, H-3), 2.69 (t, J = 7.2 Hz, 2 H, H-8, H-8’), 1.67 (dt, J = 2.2, 4.1 
Hz, 1 H, H-2), 1.59 (dd, J = 4.2, 7.5 Hz, 1 H, H-7), 1.52 - 1.44 (m, 1 H, H-7’). 13C NMR (101 
MHz, chloroform-d) δ = 138.4, 138.3, 138.1 (Aromatic C), 128.4, 128.3, 127.8, 127.7, 
127.6 (Aromatic CH), 104.9 (C-1), 83.4 (C-3), 79.9 (C-4), 75.2 (C-5), 75.0, 74.7, 73.5 (3 X 
CH2-Ph), 69.2 (C-6), 56.7 (OCH3), 45.2 (C-2), 40.5 (C-8), 32.0 (C-7). IR (KBr, dry film) νmax 
(cm-1) = 3006 (N-H), 1463 (C=C, Ar), 1093 (C-O). (ESI-HRMS): [M+H]+ calcd for C30H38NO5: 
492.2750; found: 492.2760.   
 
Attempted preparation of methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(2,3,6-
trimethoxyphenylamino) ethyl]-β-D-glucopyranoside (73) 
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Under argon atmosphere, a suspension of Pd2db3 (12.77 mg, 0.0140 mmol) and (±) 
BINAP (18.5 mg, 0.0279 mmol) in toluene (1.5 mL) was stirred for 1 h at rt. To the 
mixture were added aryl bromide 46 (138 mg. 0.558 mmol) and CsCO3 (272 mg, 0.837 
mmol), and the mixture was stirred for 0.5 h at rt. Then amine 72 (137 mg, 0.279 mmol) 
was added and the mixture was stirred under reflux for 6 h. After cooling to rt, the 
mixture was filtered through a plug of celite and concentrated. Column chromatography 
(Eluent: Pet Ether/EtOAc: 1/1). It was recovered starting materials. 
 
Attempted preparation of methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-
[(triphenylphosphonium iodide) ethyl]-β-D-glucopyranoside (74) 
 
 
 
A mixture of iodide 61 (42.2 mg, 0.070 mmol), PPh3 (27.3 mg, 0.105 mmol), and toluene 
(2.5 mL) was heated at 105 ⁰C for 3 days. The reaction mixture was then cooled to room 
temperature and filtered. The filtrate was washed with tert-butyl methyl ether (5 mL) 
and dried at room temperature, and we recovered starting materials.  
 
Methyl 3,4,6-tri-O-benzyl-2-deoxy-2-C-[(2,3,6-trimethoxybenzylamino)ethyl]-β-D-
glucopyranoside (76) 
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A mixture of amine 72 (294 mg, 0.598 mmol) and aldehyde 47 (129 mg, 0.658 mmol) in 
methanol (2.5 mL) was stirred overnight. Then NaBH4 was added in small portion and 
the resulting solution was stirred for 5 h. The mixture was quenched with saturated 
aqueous NaHCO3 (3 mL) and extracted with DCM (3 x 5 mL). The combined organic 
phase was washed with water and brine, dried over MgSO4, filtered and the filtrate 
evaporated in vacuo to afford 76 as a brown oil (284 mg, 72%).1H NMR (400 MHz, 
chloroform-d) δ = 7.35 - 7.22 (m, 13 H, Aromatic CH), 7.18 - 7.13 (m, 2 H, Aromatic CH ), 
6.73 (d, J = 8.8 Hz, 1 H, Aromatic CH), 6.50 (d, J = 9.0 Hz, 1 H, Aromatic CH), 4.85 (d, J = 
11.0 Hz, 1 H, CH2-Ph), 4.74 (d, J = 10.8 Hz, 1 H, CH2-Ph), 4.63 - 4.51 (m, 4 H, CH2-Ph), 4.12 
(d, J = 8.2 Hz, 1 H, H-1), 3.82 (s, 2 H, H-9, H-9’), 3.79 (s, 3 H, OCH3), 3.78 (s, 3 H, OCH3), 
3.71 (s, 3 H, OCH3), 3.71 - 3.64 (m, 2 H, H-6, H-6’), 3.59 - 3.52 (m, 1 H, H-4), 3.44 (s, 3 H, 
OCH3), 3.43 - 3.38 (m, 1 H, H-5), 3.35 (dd, J = 8.8, 10.3 Hz, 1 H, H-3), 2.74 - 2.63 (m, 2 H, 
H-8, H-8’), 1.82 - 1.73 (m, 1 H, H-7), 1.72 - 1.61 (m, 2 H, H-2, H-7’). 13C NMR (101 MHz, 
chloroform-d) δ = 152.6, 148.6, 147.0, 138.4, 138.3, 138.2 (Aromatic C), 128.4, 128.3, 
127.8, 127.8, 127.7, 127.7, 127.6, 127.5 (Aromatic CH) , 111.6 (C-1), 105.4, 104.7 
(Aromatic CH), 83.3 (C-3), 79.8 (C-4), 75.1 (C-5), 75.0, 74.6, 73.5 (3 X CH2-Ph), 69.2 (C-6), 
61.0, 56.7, 56.3, 55.8 (4 x OCH3), 47.1 (C-8), 45.8 (C-2), 42.2 (C-9), 27.9 (C-7). IR (KBr, dry 
film) νmax (cm
-1) = 3059 (NH), 1419 (C=C), 1152 (C-O). (ESI-HRMS): [M+H]+ calcd for 
C40H50NO8: 672.3536; found: 672.3558. 
 
Attempted preparation of methyl-3,4,6-tri-O-benzyl-2-deoxy-2-C-[(3-methoxy-1,4-
benzoquinone amino)ethyl]-β-D-glucopyranoside (77) 
 
 
In a stirred solution of hybrid 76 (136 mg, 0.202 mmol) in a mixture of H2O (1mL) and 
MeOH (3 mL) was added iodobenzene diacetate (100 mg, 0.304 mmol) at room 
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temperature. The mixture was stirred for 19 h and then extracted with ether (4 mL x 3). 
The combined organic layer was washed with saturated NaHCO3, water and brine, dried 
over MgSO4, filtered and the filtrate evaporated in vacuo. The crude mixture was 
purified by column chromatography on silica gel using pentane-ethyl acetate (8:1). The 
expected product 77 was not isolated but the amine 72 was isolated. [M+H]+ calcd for 
C30H38NO5: 492.2750; found: 492.2748.  
 
2,4-Dinitrophenyl 2-acetamido-2-deoxy-1-thio-3,4,6-tri-O-acetyl-α-D-glucopyranose 
(83) 
 
 
 
A solution of the thiazoline 81 (479 mg, 2.9 mmol) in MeOH (5 mL) was cooled to 0 ⁰C, 
before addition of 2 drops of TFA and 2 drops H2O. The reaction mixture was allowed to 
warm to room temperature over a period of 2 h. The reaction mixture was concentrated 
under reduced pressure to give of the mercaptan 82 as a colorless syrup. Without 
further purification, a solution of mercaptan 81 in 10 mL DCM stirred under a N2 
atmosphere was added 1-fluoro-2,4-dinitrobenzene (89.1 μL, 1.32 mmol) and 
triethylamine (220 μL, 1.58 mmol). The mixture was allowed to stir under a N2 
atmosphere for 24 h. The reaction mixture was then concentrated and the resulting 
product was purified using flash chromatography (eluent: 2% MeOH/CH2Cl2) to give the 
compound 83 (75%, 523 mg, lit.65) as a yellow solid. 1H NMR (400 MHz, chloroform-d) δ 
= 9.03 (d, 1 H), 8.39(dd, 1 H), 8.05 (d, 1 H), 6.11 (d, 1 H), 5.22 (m, 2 H), 4.64 (m, 2 H), 4.23 
(m, 2 H), 4.03 (dd, 1 H), 2.07 (s, 3 H), 2.03 (s, 3 H), 1.99 (s, 3 H), 1.94 (s, 3 H). (ESI-HRMS): 
[M+Na]+ calcd for C20H23NaO12S: 552.09; found: 552.10. 
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2,4-Dinitrophenyl 2-acetamido-2-deoxy-1-thio-α-D-gluco-pyranose (84) 
 
 
To a solution of 83 (182 mg, mmol) in 2.8 mL of H2O (19%), 10.0 mL of MeOH (50%) and 
6.2 mL of acetone (31%), was added 2 g of Amberlite IRA-400 (OH−). The reaction 
mixture was allowed to stir for 1 h at ambient temperature. The volatile solvents were 
removed in vacuo and the residual aqueous product mixture was subjected to C-18 flash 
chromatography (eluent: 50% MeCN/H2O). Aqueous fractions containing the compound 
were collected and dried by lyophilization, resulting in 50 mg (25.1 mg, 18% yield, lit.65) 
of pure 84 as an amorphous yellow solid. 1H NMR (500 MHz, DMSO-d6) δ = 8.82 (d, 1 H), 
8.42 (dd, 1 H), 8.26 (d, 1 H), 8.15 (d, 1 H), 6.07 (d, 1 H), 5.27 (d, 1 H), 5.11 (d, 1 H), 4.57(t, 
1 H), 3.97 (m,1 H), 3.69 (m, 1 H), 3.60 (m, 2 H), 3.50 (q, 1 H), 3.29 (m, 1 H), 1.80 (s, 3 H). 
(ESI-HRMS): [M+H]+ calcd for C33H38NO9: 404.0764; found: 404.0772.  
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3.2. Appendix 
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